This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Laparoscopic right hemicolectomy
OPER_JFB31
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2232 |
4. Check minimum number of eventsNone |
2232 |
5. Include endpointsNone |
2232 |
6. Filter based on genotype QC (FinnGen only) |
2154 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Laparoscopic right hemicolectomy
based on the number of shared cases.
Similar with more cases:
- Colectomy operation
- Any gastric operation
- GASTRO-related operations
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2154 | 1119 | 1035 |
| Unadjusted period prevalence (%) | 0.43 | 0.40 | 0.47 |
| Median age at first event (years) | 72.66 | 72.69 | 72.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2232
- Matched controls
- 22320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B01AB05
ATC
enoxaparin; parenteral
5.2
313.4
1450
5897
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
42.4
309.5
187
48
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
209.1
307.7
713
50
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
144.1
307.7
562
52
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
107.4
307.7
398
45
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
24.8
307.7
343
162
130
Kela drug reimbursment
Malignant tumour
7.9
307.7
772
1408
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
127.7
307.7
219
19
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
193.2
307.7
703
53
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
132.4
307.7
471
45
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
219.0
307.7
534
32
UJF32
NOMESCO Finland
Coloscopy
9.1
307.7
1593
4783
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
+∞
307.7
2232
*
L01BC06
ATC
capecitabine; oral
17.8
307.7
608
459
JN4AD
NOMESCO Finland
Body CT examination
5.4
291.3
775
2008
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.9
262.2
572
1234
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
10.7
259.6
301
321
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
8.8
246.6
335
438
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
51.4
242.9
140
29
WX402
NOMESCO Finland
General anaesthesia
4.3
241.6
953
3294
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
52.5
240.4
138
28
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
66.2
238.4
131
21
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
38.5
216.9
134
37
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
211.4
657
1878
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.6
204.7
369
655
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
60.0
204.0
114
20
JN4BD
NOMESCO Finland
Extensive body CT
4.6
200.7
600
1658
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
80.2
200.6
107
14
A04AA02
ATC
granisetron; systemic, transdermal
5.5
182.8
404
865
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.9
182.3
306
503
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
83.6
181.0
96
12
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
61.5
179.7
100
17
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.6
175.2
376
783
WZC30
NOMESCO Finland
Teaching
3.7
169.2
757
2748
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
10.0
167.1
198
215
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
39.5
166.6
102
27
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
150.2
593
1964
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
142.8
833
3504
B01AB10
ATC
tinzaparin; parenteral
3.8
140.3
531
1702
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
5.8
139.5
278
537
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
37.9
135.7
84
23
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.4
127.2
358
923
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
56.4
125.5
71
13
UJF30
NOMESCO Finland
Ileoscopy through colon
3.6
120.8
472
1533
H02AB02
ATC
dexamethasone; systemic
3.3
106.8
492
1763
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
140.4
101.0
107
8
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
44.0
100.6
60
14
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.8
96.4
186
346
D75
ICPC
Malignant neoplasm colon/rectum
11.9
95.3
98
86
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.3
95.1
201
406
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.5
94.3
250
610
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.0
90.8
166
293
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
161.6
88.8
93
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.1
83.8
152
266
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
28.2
81.3
55
20
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
81.3
511
2150
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.3
80.8
224
564
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
19.0
79.7
63
34
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
27.6
79.3
54
20
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
77.4
786
4141
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
19.2
76.3
60
32
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
6.2
74.8
131
221
L01BC59
ATC
trifluridine, combinations; systemic
21.7
73.7
55
26
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.0
68.3
210
569
B80
ICPC
Iron deficiency anaemia
5.4
66.1
136
267
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
62.2
1000
6215
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.3
61.5
252
825
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.2
59.9
170
434
UJF32, ,
SPAT
4.2
59.3
165
415
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
109.8
59.1
64
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
59.0
898
5439
WX290
NOMESCO Finland
Other blockage of nerve
2.1
58.7
1013
6423
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
154.1
57.2
60
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
19.1
57.1
45
24
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
55.9
452
2111
WX704
NOMESCO Finland
Intubation
2.9
52.3
279
1060
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
51.6
173
496
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
51.4
249
897
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
16.0
51.3
44
28
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
11.5
51.0
53
47
B82
ICPC
Anaemia other/unspecified
4.0
49.4
149
397
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
6.1
47.8
84
142
N02BE01
ATC
paracetamol; systemic, rectal
3.8
46.3
2122
18636
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
17.9
45.5
37
21
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
45.2
652
3799
8263/2-C18.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of cecum
122.6
44.9
48
*
ZX120
NOMESCO Finland
Intravenous
2.5
43.0
302
1312
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.2
42.8
90
180
176
Kela drug reimbursment
Regorafenib
16.9
41.9
35
21
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
40.3
1615
12876
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.3
40.1
163
528
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.2
39.8
69
115
369
Kela drug reimbursment
Regorafenib
15.7
39.2
34
22
C18
ICD-10 Finland
Malignant neoplasm of colon
57.4
38.4
45
8
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4.6
38.0
93
211
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
37.6
307
1423
D50
ICD-10 Finland
Iron deficiency anaemia
4.5
36.6
90
205
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
5.9
36.2
65
112
K63.5
ICD-10 Finland
Polyp of colon
4.0
36.1
105
272
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
48.7
35.7
43
9
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.2
35.4
95
232
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
34.3
586
3563
A02BC02
ATC
pantoprazole; systemic
1.8
32.9
1658
13675
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
32.5
894
6232
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
31.2
94
250
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
11.6
30.9
32
28
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.3
30.7
80
191
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
30.6
498
2965
JN4CD
NOMESCO Finland
Very extensive body CT
2.9
29.6
141
500
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.8
29.6
32
30
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
152.0
28.7
30
*
Z31.5
ICD-10 Finland
Genetic counselling
3.2
27.9
116
380
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.7
27.9
65
142
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
27.9
811
5681
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
76.1
26.8
30
*
JEA01
NOMESCO Finland
Laparoscopic appendectomy
3.5
26.7
92
268
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.4
26.5
66
152
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
46.3
26.5
32
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
26.0
102
323
Z51.5
ICD-10 Finland
Palliative care
2.0
25.9
310
1658
E0000UV, ,
ATC
1.6
25.2
943
6984
JFA42
NOMESCO Finland
Endoscopic injection in colon
9.8
25.0
29
30
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.0
24.2
37
54
A04AA01
ATC
ondansetron; systemic, rectal
2.1
23.6
236
1180
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
9.7
23.2
27
28
A98
ICPC
Health maint/preventive medicine
3.0
23.0
2147
19978
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
5.0
23.0
49
99
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.4
23.0
170
750
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
+∞
23.0
22
*
WZC15, ,
NOMESCO Finland
5.5
22.2
43
80
3AC01, ,
NOMESCO Finland
5.3
22.0
44
84
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
21.9
1247
10045
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
63.2
21.9
25
*
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
80.9
21.7
24
*
JAH01
NOMESCO Finland
Laparoscopy
2.8
20.6
108
404
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
+∞
19.8
19
*
8263/2-C18.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS
31.6
19.3
25
8
JAH00
NOMESCO Finland
Laparotomy
2.9
19.2
90
317
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
20.2
19.1
28
14
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.8
18.2
41
87
XX2RW, ,
NOMESCO Finland
3.9
18.2
53
138
D77
ICPC
Malignant digestive neopl other/NOS
7.0
17.8
27
39
A04AA55
ATC
palonosetron, combinations; systemic
2.7
17.6
95
361
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
21.1
17.3
25
12
C189, 8211, 2
ICD-O-3
42.3
17.3
21
5
K92.1
ICD-10 Finland
Melaena
2.1
17.2
165
809
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
17.2
101
400
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
63.8
16.7
19
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
16.6
166
827
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
27.8
16.5
22
8
8263/2-C18.2
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of ascending colon
40.4
16.3
20
5
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.2
16.1
64
205
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
5.6
16.0
30
54
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
47.9
16.0
19
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
16.0
219
1218
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
16.0
124
558
C182, 8148, 2
ICD-O-3
60.5
15.8
18
*
C180, 8148, 2
ICD-O-3
60.5
15.8
18
*
JFA15, ,
SPAT
4.7
15.6
36
78
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
13.8
15.5
26
19
C189, 8148, 2
ICD-O-3
161.1
15.5
16
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
16.2
15.2
24
15
A04AD12
ATC
aprepitant; systemic
3.3
15.2
56
171
JJB10
NOMESCO Finland
Atypcal resection of liver
13.1
15.2
26
20
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.1
14.8
31
62
JJB71
NOMESCO Finland
Laparoscopic resection of liver
21.2
14.7
21
10
H01CB03
ATC
lanreotide; parenteral
11.9
14.6
26
22
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.8
14.0
31
65
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
15.9
13.9
22
14
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
3.7
13.9
43
117
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
12.8
13.9
24
19
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
13.8
630
4723
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
4.6
13.8
32
70
8244/3-C18.1
ICD-O-3
Mixed adenoneuroendocrine carcinoma of appendix
+∞
13.6
13
*
8211/2-C18.2
ICD-O-3
Tubular adenocarcinoma in situ of ascending colon
+∞
13.6
13
*
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
2.1
13.6
127
618
A79
ICPC
Malignancy NOS
3.0
13.5
58
195
1XC07, ,
NOMESCO Finland
11.5
13.3
24
21
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
5.4
13.2
26
49
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
4.0
13.1
36
90
R4110
NOMESCO Finland
Physiotherapy
1.4
13.0
639
4849
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.2
12.9
105
483
JFF10
NOMESCO Finland
Loop enterostomy
5.0
12.9
27
54
3049, ,
Kela drug reimbursment
50.3
12.8
15
*
K56.7
ICD-10 Finland
Ileus, unspecified
3.0
12.7
56
191
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
12.7
249
1539
C180, 8211, 2
ICD-O-3
32.2
12.6
16
5
D64.8
ICD-10 Finland
Other specified anaemias
2.8
12.3
63
233
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.7
12.2
38
104
SPAT1131
SPAT
Colonoscopy
2.3
12.2
90
398
UJF34
NOMESCO Finland
Left colonoscopy
4.8
12.1
27
57
WW500
NOMESCO Finland
Blood transfusion
2.2
12.0
106
504
B01AB04
ATC
dalteparin; parenteral
2.0
12.0
128
654
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
12.0
495
3625
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
11.9
814
6523
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
30.2
11.6
15
5
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
30.2
11.6
15
5
1526, ,
Kela drug reimbursment
65.3
11.6
13
*
L01EX05
ATC
regorafenib; oral
19.0
11.6
17
9
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
23.0
11.6
16
7
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
11.1
218
1346
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.2
10.8
86
392
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
5.6
10.7
20
36
JFB30
NOMESCO Finland
Right hemicolectomy
2.9
10.7
48
166
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
10.6
443
3244
B01AF02
ATC
apixaban; oral
1.5
10.5
389
2783
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
10.3
270
1793
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
18.9
10.3
15
8
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.5
10.1
64
264
JF2BD
NOMESCO Finland
Extensive colon CT
3.7
9.9
30
81
R4190
NOMESCO Finland
Nutritional therapy
2.2
9.8
84
395
L01EC03
ATC
encorafenib; oral
26.1
9.8
13
5
S18
ICPC
Laceration/cut
1.3
9.8
1090
9329
Z93.2
ICD-10 Finland
Ileostomy status
7.4
9.7
22
30
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.3
9.6
35
107
C10AC01
ATC
colestyramine; oral
2.4
9.5
65
278
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
15.1
9.5
15
10
RD211, ,
NOMESCO Finland
2.0
9.5
100
510
Z3231
NOMESCO Finland
Registered nurse
1.4
9.5
581
4540
K56.0
ICD-10 Finland
Paralytic ileus
3.4
9.0
31
91
ZX100
NOMESCO Finland
Oral
3.0
9.0
39
132
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
9.0
129
728
SPAT1153
SPAT
Removal of sutures
1.3
8.7
725
5923
D16
ICPC
Rectal bleeding
2.3
8.5
62
273
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
4.1
8.5
23
57
XF606
NOMESCO Finland
Ortostatic test
3.4
8.5
29
85
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.5
8.5
50
200
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
20.1
8.5
12
6
ZX121
NOMESCO Finland
Central venous catheter
7.9
8.4
18
23
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
8.3
252
1724
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
8.3
122
694
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
4.6
8.1
19
42
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.2
8.1
31
98
JFA98, ,
SPAT
33.5
8.1
10
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
8.1
62
280
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
4.0
8.1
22
55
L03AA02
ATC
filgrastim; parenteral
2.1
8.0
72
346
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
10.1
8.0
15
15
Z71.8
ICD-10 Finland
Other specified counselling
1.3
7.9
652
5304
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
7.8
182
1174
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.8
378
2831
TJF80
NOMESCO Finland
Ostomy education
3.2
7.7
29
91
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.6
7.6
41
157
Z2221
NOMESCO Finland
Medical doctor
1.3
7.6
529
4196
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
18.4
7.6
11
6
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
7.6
34
118
JFF13
NOMESCO Finland
Terminal enterostomy
6.7
7.6
18
27
JFB41
NOMESCO Finland
Laparoscopic resection of transverse colon
25.1
7.6
10
*
L01BC53
ATC
tegafur, combinations; systemic
10.1
7.5
14
14
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
7.5
101
560
SPAT1255
SPAT
Intravenous administration of medicine
1.6
7.4
155
973
N02AA05
ATC
oxycodone; systemic
1.4
7.4
468
3655
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
13.4
7.4
12
9
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
3.6
7.3
23
64
8249/3-C18.0
ICD-O-3
Neuroendocrine tumor, grade 2 of cecum
+∞
7.3
7
*
8210/2-C18.0
ICD-O-3
Adenocarcinoma in situ in adenomatous polyp of cecum
+∞
7.3
7
*
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
10.9
7.3
13
12
Z43.2
ICD-10 Finland
Attention to ileostomy
9.4
7.3
14
15
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
7.2
516
4109
ZXE00
NOMESCO Finland
One hour or less
1.3
7.2
765
6429
JN4SR
NOMESCO Finland
Very extensive PET-CT of receptors in whole body
30.1
7.1
9
*
8480/3-C18.4
ICD-O-3
Mucinous adenocarcinoma of transverse colon
30.1
7.1
9
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.9
7.0
89
485
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
2.9
7.0
31
107
JAD10
NOMESCO Finland
Repair of incisional hernia
3.3
7.0
25
76
TPX15
NOMESCO Finland
Removal of vascular injection port
4.4
7.0
17
39
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
4.4
7.0
17
39
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.9
348
2618
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.9
759
6391
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
4.0
6.9
19
48
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
6.8
81
433
JJB30
NOMESCO Finland
Excision of two segments of liver
9.3
6.8
13
14
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
3.7
6.6
20
54
UJD10, ,
SPAT
2.1
6.6
59
284
V03AF03
ATC
calcium folinate; systemic
7.8
6.6
14
18
S29
ICPC
Skin symptom/complaint other
1.3
6.6
438
3444
JFB96
NOMESCO Finland
Other partial excision of intestine
70.1
6.4
7
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
70.1
6.4
7
*
JFB01
NOMESCO Finland
Laparoscopic partial resection of small intestine
14.3
6.4
10
7
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
5.2
6.3
18
35
L01XE21
ATC
[U] regorafenib
11.0
6.3
11
10
JAF10
NOMESCO Finland
Repair of umbilical hernia
2.1
6.3
54
257
8490/3-C18.0
ICD-O-3
Signet ring cell carcinoma of cecum
+∞
6.3
6
*
8213/3-C18.0
ICD-O-3
Serrated adenocarcinoma of cecum
+∞
6.3
6
*
8213/3-C18.2
ICD-O-3
Serrated adenocarcinoma of ascending colon
+∞
6.3
6
*
H01CB02
ATC
octreotide; parenteral
6.3
6.2
15
24
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
6.1
373
2897
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
8.6
6.1
12
14
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
-1.5e-01
2.1e+00
6.4e+00
3.6e+01
5.2e+00
4.1e+00
3.0e+00
cases:13.04%
controls:14.78%
cases:33.78%
controls:5.70%
cases:86.16%
controls:0.99%
cases:94.89%
controls:0.03%
cases:62.74%
controls:0.89%
cases:76.63%
controls:5.38%
cases:77.43%
controls:14.32%
291
3300
1941
19020
754
1272
1478
21048
1923
222
309
22098
2118
7
114
22313
1394
197
828
22052
1633
1156
498
20322
1194
2270
348
13583
Malignant tumor of the ascending colon invasive carcinoma
C18.21 [2000500543]
C18.21 [2000500543]
—
3.9e+00
6.6e+00
1.0e+50
—
6.9e+00
6.0e+00
—
—
cases:2.11%
controls:0.04%
cases:16.85%
controls:0.03%
cases:18.06%
controls:0.00%
—
—
cases:27.22%
controls:0.04%
cases:25.68%
controls:0.08%
—
47
10
2185
22310
376
6
1856
22314
403
0
1829
22320
—
580
8
1551
21470
396
13
1146
15840
Benign neoplasm: Caecum
D12.0 [45586086]
D12.0 [45586086]
1.3e+00
3.7e+00
5.5e+00
1.0e+50
5.1e+00
3.5e+00
2.2e+00
cases:1.34%
controls:0.36%
cases:6.99%
controls:0.18%
cases:7.39%
controls:0.03%
cases:8.11%
controls:0.00%
cases:4.86%
controls:0.03%
cases:4.83%
controls:0.15%
cases:4.22%
controls:0.47%
30
81
2202
22239
156
40
2076
22280
165
7
2067
22313
181
0
2051
22320
108
7
2114
22242
103
33
2028
21445
65
75
1477
15778
Benign neoplasm: Ascending colon
D12.2 [45600580]
D12.2 [45600580]
9.9e-01
4.0e+00
5.6e+00
1.0e+50
5.3e+00
3.2e+00
1.8e+00
cases:1.43%
controls:0.54%
cases:6.85%
controls:0.14%
cases:6.81%
controls:0.03%
cases:7.57%
controls:0.00%
cases:4.46%
controls:0.02%
cases:5.07%
controls:0.21%
cases:4.54%
controls:0.78%
32
120
2200
22200
153
31
2079
22289
152
6
2080
22314
169
0
2063
22320
99
5
2123
22244
108
45
2023
21433
70
123
1472
15730
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
-3.7e-03
2.5e+00
5.3e+00
—
4.5e+00
4.3e+00
3.8e+00
cases:3.72%
controls:3.73%
cases:23.21%
controls:2.38%
cases:49.10%
controls:0.46%
—
—
cases:25.38%
controls:0.40%
cases:63.54%
controls:2.33%
cases:69.33%
controls:4.92%
83
833
2149
21487
518
532
1714
21788
1096
103
1136
22217
—
564
88
1658
22161
1354
500
777
20978
1069
780
473
15073
Malignant tumor of the caecum invasive carcinoma
C18.01 [2000500535]
C18.01 [2000500535]
-1.0e+50
3.6e+00
—
1.0e+50
—
6.6e+00
6.0e+00
cases:0.00%
controls:0.07%
cases:1.61%
controls:0.04%
—
—
cases:17.03%
controls:0.00%
—
—
cases:26.42%
controls:0.05%
cases:26.85%
controls:0.09%
0
16
2232
22304
36
10
2196
22310
—
380
0
1852
22320
—
563
10
1568
21468
414
14
1128
15839
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
-1.6e-01
1.2e+00
4.8e+00
5.3e+00
2.9e+00
9.1e-01
4.6e-01
cases:7.03%
controls:8.18%
cases:10.62%
controls:3.47%
cases:35.89%
controls:0.47%
cases:4.17%
controls:0.02%
cases:6.57%
controls:0.40%
cases:7.84%
controls:3.31%
cases:14.20%
controls:9.46%
157
1826
2075
20494
237
775
1995
21545
801
104
1431
22216
93
5
2139
22315
146
90
2076
22159
167
710
1964
20768
219
1500
1323
14353
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
-1.0e-01
1.2e+00
4.6e+00
5.4e+00
2.8e+00
9.1e-01
3.9e-01
cases:10.66%
controls:11.67%
cases:14.47%
controls:4.74%
cases:40.37%
controls:0.65%
cases:6.50%
controls:0.03%
cases:8.42%
controls:0.55%
cases:9.95%
controls:4.27%
cases:17.51%
controls:12.60%
238
2605
1994
19715
323
1057
1909
21263
901
145
1331
22175
145
7
2087
22313
187
122
2035
22127
212
917
1919
20561
270
1997
1272
13856
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
-4.6e-03
1.3e+00
4.9e+00
1.0e+50
5.2e+00
2.7e+00
1.2e+00
cases:0.99%
controls:0.99%
cases:1.57%
controls:0.44%
cases:4.66%
controls:0.04%
cases:0.27%
controls:0.00%
cases:8.73%
controls:0.05%
cases:5.02%
controls:0.35%
cases:3.11%
controls:1.00%
22
221
2210
22099
35
99
2197
22221
104
8
2128
22312
6
0
2226
22320
194
12
2028
22237
107
75
2024
21403
48
159
1494
15694
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
-1.1e-01
1.2e+00
5.1e+00
5.2e+00
2.6e+00
7.8e-01
3.3e-01
cases:14.87%
controls:16.39%
cases:20.74%
controls:7.03%
cases:58.60%
controls:0.89%
cases:6.59%
controls:0.04%
cases:9.50%
controls:0.80%
cases:12.86%
controls:6.32%
cases:24.19%
controls:18.69%
332
3658
1900
18662
463
1568
1769
20752
1308
199
924
22121
147
9
2085
22311
211
177
2011
22072
274
1358
1857
20120
373
2963
1169
12890
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
-1.4e-01
1.4e+00
4.8e+00
1.0e+50
2.2e+00
3.0e+00
2.7e+00
cases:2.46%
controls:2.82%
cases:3.63%
controls:0.88%
cases:11.65%
controls:0.11%
cases:2.64%
controls:0.00%
cases:1.17%
controls:0.13%
cases:10.23%
controls:0.56%
cases:11.61%
controls:0.83%
55
629
2177
21691
81
197
2151
22123
260
25
1972
22295
59
0
2173
22320
26
29
2196
22220
218
121
1913
21357
179
132
1363
15721
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-9.9e-02
1.2e+00
4.2e+00
4.5e+00
2.5e+00
1.1e+00
6.8e-01
cases:8.69%
controls:9.51%
cases:13.84%
controls:4.75%
cases:31.00%
controls:0.68%
cases:3.14%
controls:0.04%
cases:5.99%
controls:0.50%
cases:11.92%
controls:4.52%
cases:20.56%
controls:11.60%
194
2122
2038
20198
309
1060
1923
21260
692
151
1540
22169
70
8
2162
22312
133
112
2089
22137
254
970
1877
20508
317
1839
1225
14014
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
25587-7 [3014702]
7.0e-01
1.8e+00
4.1e+00
—
3.1e+00
2.7e+00
2.4e+00
cases:0.72%
controls:0.36%
cases:1.52%
controls:0.25%
cases:1.79%
controls:0.03%
—
—
cases:0.72%
controls:0.03%
cases:3.33%
controls:0.24%
cases:4.86%
controls:0.48%
16
80
2216
22240
34
56
2198
22264
40
7
2192
22313
—
16
7
2206
22242
71
51
2060
21427
75
76
1467
15777
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
D12.6 [45576377]
7.2e-01
2.9e+00
4.2e+00
—
3.8e+00
1.7e+00
6.7e-01
cases:1.84%
controls:0.90%
cases:4.48%
controls:0.26%
cases:3.00%
controls:0.04%
—
—
cases:1.22%
controls:0.03%
cases:1.74%
controls:0.32%
cases:2.01%
controls:1.03%
41
201
2191
22119
100
59
2132
22261
67
10
2165
22310
—
27
6
2195
22243
37
68
2094
21410
31
164
1511
15689
5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
50149-4 [3030136]
50149-4 [3030136]
-1.8e-01
1.7e+00
4.0e+00
—
2.7e+00
2.8e+00
2.8e+00
cases:0.22%
controls:0.27%
cases:0.99%
controls:0.17%
cases:1.43%
controls:0.03%
—
—
cases:0.41%
controls:0.03%
cases:2.91%
controls:0.19%
cases:4.41%
controls:0.29%
5
60
2227
22260
22
39
2210
22281
32
6
2200
22314
—
9
6
2213
22243
62
40
2069
21438
68
46
1474
15807
Inpatient Visit
IP [9201]
IP [9201]
-1.6e-01
4.2e-01
1.7e+00
8.5e+00
1.9e+00
7.2e-01
4.3e-01
cases:8.56%
controls:9.94%
cases:7.84%
controls:5.29%
cases:3.49%
controls:0.69%
cases:54.70%
controls:0.03%
cases:4.55%
controls:0.70%
cases:11.31%
controls:5.85%
cases:25.49%
controls:18.24%
191
2218
2041
20102
175
1180
2057
21140
78
153
2154
22167
1221
6
1011
22314
101
156
2121
22093
241
1257
1890
20221
393
2891
1149
12962
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
7.9e-02
1.5e+00
3.0e+00
—
4.1e+00
3.0e+00
1.7e+00
cases:1.25%
controls:1.16%
cases:3.14%
controls:0.69%
cases:2.91%
controls:0.14%
—
—
cases:7.02%
controls:0.13%
cases:12.76%
controls:0.71%
cases:8.69%
controls:1.69%
28
259
2204
22061
70
155
2162
22165
65
32
2167
22288
—
156
28
2066
22221
272
152
1859
21326
134
268
1408
15585
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
D12.5 [45552326]
5.7e-01
2.5e+00
3.5e+00
—
3.5e+00
1.8e+00
1.9e+00
cases:1.25%
controls:0.71%
cases:2.82%
controls:0.24%
cases:2.51%
controls:0.08%
—
—
cases:0.90%
controls:0.03%
cases:1.45%
controls:0.25%
cases:4.80%
controls:0.76%
28
159
2204
22161
63
54
2169
22266
56
17
2176
22303
—
20
6
2202
22243
31
54
2100
21424
74
120
1468
15733
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.9e-01
-2.4e-01
2.0e+00
3.4e+00
3.5e+00
2.8e+00
2.2e+00
cases:16.98%
controls:28.92%
cases:7.17%
controls:8.92%
cases:6.77%
controls:0.96%
cases:0.90%
controls:0.03%
cases:3.56%
controls:0.11%
cases:13.14%
controls:0.95%
cases:19.33%
controls:2.59%
379
6454
1853
15866
160
1990
2072
20330
151
215
2081
22105
20
7
2212
22313
79
25
2143
22224
280
203
1851
21275
298
410
1244
15443
Benign neoplasm: Transverse colon
D12.3 [45581282]
D12.3 [45581282]
4.6e-01
3.5e+00
4.7e+00
1.0e+50
—
2.6e+00
2.0e+00
cases:0.72%
controls:0.45%
cases:2.82%
controls:0.09%
cases:2.42%
controls:0.02%
cases:2.15%
controls:0.00%
—
—
cases:1.88%
controls:0.14%
cases:3.50%
controls:0.50%
16
101
2216
22219
63
20
2169
22300
54
5
2178
22315
48
0
2184
22320
—
40
29
2091
21449
54
79
1488
15774
Outpatient Hospital
22 [8756]
22 [8756]
-1.1e-01
5.0e-01
1.4e+00
8.1e+00
1.5e+00
7.4e-01
5.3e-01
cases:27.33%
controls:29.53%
cases:11.92%
controls:7.55%
cases:3.58%
controls:0.86%
cases:40.59%
controls:0.02%
cases:3.38%
controls:0.80%
cases:10.61%
controls:5.35%
cases:16.93%
controls:10.67%
610
6591
1622
15729
266
1685
1966
20635
80
193
2152
22127
906
5
1326
22315
75
177
2147
22072
226
1150
1905
20328
261
1691
1281
14162
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
2.7e-01
3.8e+00
3.9e+00
1.0e+50
2.7e+00
1.4e+00
8.1e-01
cases:1.75%
controls:1.34%
cases:18.86%
controls:0.53%
cases:5.60%
controls:0.12%
cases:2.15%
controls:0.00%
cases:1.89%
controls:0.13%
cases:2.67%
controls:0.68%
cases:4.54%
controls:2.06%
39
299
2193
22021
421
118
1811
22202
125
26
2107
22294
48
0
2184
22320
42
28
2180
22221
57
146
2074
21332
70
327
1472
15526
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
-1.2e-01
3.0e+00
5.0e+00
—
9.9e-01
1.8e+00
2.8e+00
cases:6.05%
controls:6.76%
cases:25.67%
controls:1.73%
cases:21.15%
controls:0.17%
—
—
cases:0.32%
controls:0.12%
cases:9.01%
controls:1.61%
cases:48.77%
controls:5.62%
135
1509
2097
20811
573
386
1659
21934
472
39
1760
22281
—
7
26
2215
22223
192
345
1939
21133
752
891
790
14962
Malignant neoplasm of colon
C18 [45576305]
C18 [45576305]
—
2.5e+00
—
—
—
5.9e+00
3.8e+00
—
—
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:9.10%
controls:0.03%
cases:2.98%
controls:0.07%
—
7
6
2225
22314
—
—
—
194
6
1937
21472
46
11
1496
15842
Inpatient Hospital
21 [8717]
21 [8717]
-1.8e-01
6.4e-01
1.5e+00
7.1e+00
2.0e+00
6.5e-01
3.6e-01
cases:30.56%
controls:34.44%
cases:17.29%
controls:9.90%
cases:5.73%
controls:1.34%
cases:40.59%
controls:0.05%
cases:8.06%
controls:1.23%
cases:13.94%
controls:7.77%
cases:20.10%
controls:14.92%
682
7687
1550
14633
386
2210
1846
20110
128
298
2104
22022
906
12
1326
22308
179
273
2043
21976
297
1669
1834
19809
310
2366
1232
13487
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
-3.5e-01
1.9e+00
3.2e+00
1.0e+50
3.2e+00
2.1e+00
1.5e+00
cases:1.66%
controls:2.33%
cases:3.05%
controls:0.48%
cases:0.76%
controls:0.03%
cases:1.88%
controls:0.00%
cases:1.35%
controls:0.05%
cases:2.39%
controls:0.30%
cases:3.70%
controls:0.83%
37
520
2195
21800
68
108
2164
22212
17
7
2215
22313
42
0
2190
22320
30
12
2192
22237
51
64
2080
21414
57
131
1485
15722
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
-2.2e-01
1.1e+00
3.9e+00
2.5e+00
2.7e+00
1.3e+00
6.1e-01
cases:14.96%
controls:18.03%
cases:24.82%
controls:9.83%
cases:43.37%
controls:1.58%
cases:0.63%
controls:0.05%
cases:18.54%
controls:1.53%
cases:30.13%
controls:10.16%
cases:37.74%
controls:24.78%
334
4024
1898
18296
554
2194
1678
20126
968
352
1264
21968
14
12
2218
22308
412
340
1810
21909
642
2182
1489
19296
582
3928
960
11925
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 [45595688]
C78.7 [45595688]
—
1.2e+00
2.2e+00
—
2.5e+00
2.7e+00
2.8e+00
—
—
cases:0.81%
controls:0.23%
cases:1.12%
controls:0.13%
—
—
cases:1.58%
controls:0.13%
cases:4.69%
controls:0.32%
cases:5.25%
controls:0.33%
—
18
52
2214
22268
25
29
2207
22291
—
35
28
2187
22221
100
68
2031
21410
81
52
1461
15801
Metastasis to intrahepatic bile ducts
OMOP5031661 [35226180]
OMOP5031661 [35226180]
—
1.2e+00
2.2e+00
—
2.5e+00
2.7e+00
2.8e+00
—
—
cases:0.81%
controls:0.23%
cases:1.12%
controls:0.13%
—
—
cases:1.58%
controls:0.13%
cases:4.69%
controls:0.32%
cases:5.25%
controls:0.33%
—
18
52
2214
22268
25
29
2207
22291
—
35
28
2187
22221
100
68
2031
21410
81
52
1461
15801
Metastasis to liver
OMOP5000224 [36770544]
OMOP5000224 [36770544]
—
1.2e+00
2.2e+00
—
2.5e+00
2.7e+00
2.8e+00
—
—
cases:0.81%
controls:0.23%
cases:1.12%
controls:0.13%
—
—
cases:1.58%
controls:0.13%
cases:4.69%
controls:0.32%
cases:5.25%
controls:0.33%
—
18
52
2214
22268
25
29
2207
22291
—
35
28
2187
22221
100
68
2031
21410
81
52
1461
15801
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
83084-4 [42529201]
-5.7e-02
1.2e+00
2.2e+00
—
3.1e+00
2.9e+00
2.0e+00
cases:0.54%
controls:0.57%
cases:1.25%
controls:0.37%
cases:0.67%
controls:0.07%
—
—
cases:2.16%
controls:0.10%
cases:7.04%
controls:0.43%
cases:5.71%
controls:0.80%
12
127
2220
22193
28
83
2204
22237
15
16
2217
22304
—
48
22
2174
22227
150
93
1981
21385
88
127
1454
15726
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
-8.6e-02
1.8e+00
4.0e+00
—
1.7e+00
2.2e+00
1.7e+00
cases:1.52%
controls:1.66%
cases:6.32%
controls:1.15%
cases:10.80%
controls:0.21%
—
—
cases:1.13%
controls:0.21%
cases:10.32%
controls:1.29%
cases:16.34%
controls:3.59%
34
370
2198
21950
141
257
2091
22063
241
47
1991
22273
—
25
47
2197
22202
220
277
1911
21201
252
569
1290
15284
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
5.8e-02
2.9e+00
5.3e+00
—
3.1e+00
3.4e-01
2.0e-01
cases:10.17%
controls:9.66%
cases:34.90%
controls:2.92%
cases:33.96%
controls:0.26%
—
—
cases:4.46%
controls:0.20%
cases:3.19%
controls:2.28%
cases:9.08%
controls:7.58%
227
2155
2005
20165
779
652
1453
21668
758
58
1474
22262
—
99
45
2123
22204
68
490
2063
20988
140
1201
1402
14652
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
8.6e-03
6.0e-01
2.4e+00
4.7e+00
2.4e+00
7.5e-01
4.3e-01
cases:71.95%
controls:71.78%
cases:78.94%
controls:67.32%
cases:76.88%
controls:22.57%
cases:62.54%
controls:1.55%
cases:76.42%
controls:22.49%
cases:83.53%
controls:70.62%
cases:92.87%
controls:89.48%
1606
16021
626
6299
1762
15026
470
7294
1716
5038
516
17282
1396
345
836
21975
1698
5003
524
17246
1780
15167
351
6311
1432
14186
110
1667
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
-5.4e-02
6.8e-01
2.9e+00
3.6e+00
3.2e+00
5.6e-01
3.0e-01
cases:61.11%
controls:62.39%
cases:66.62%
controls:50.37%
cases:66.26%
controls:9.96%
cases:19.13%
controls:0.65%
cases:73.58%
controls:9.83%
cases:65.98%
controls:52.56%
cases:85.15%
controls:80.92%
1364
13926
868
8394
1487
11243
745
11077
1479
2223
753
20097
427
144
1805
22176
1635
2186
587
20063
1406
11288
725
10190
1313
12828
229
3025
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
-1.7e-01
5.8e-01
2.9e+00
5.3e+00
1.8e+00
4.9e-01
1.8e-01
cases:21.59%
controls:24.56%
cases:20.25%
controls:12.42%
cases:22.72%
controls:1.65%
cases:13.93%
controls:0.08%
cases:9.50%
controls:1.69%
cases:19.05%
controls:12.65%
cases:37.61%
controls:33.41%
482
5482
1750
16838
452
2772
1780
19548
507
369
1725
21951
311
18
1921
22302
211
376
2011
21873
406
2718
1725
18760
580
5297
962
10556
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
-1.7e-01
1.5e+00
4.9e+00
—
2.7e+00
1.4e+00
6.5e-01
cases:2.28%
controls:2.70%
cases:5.73%
controls:1.34%
cases:17.56%
controls:0.16%
—
—
cases:2.39%
controls:0.17%
cases:5.21%
controls:1.29%
cases:7.20%
controls:3.89%
51
603
2181
21717
128
299
2104
22021
392
35
1840
22285
—
53
37
2169
22212
111
276
2020
21202
111
616
1431
15237
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.2e-02
7.3e-01
2.8e+00
3.2e+00
3.0e+00
9.8e-01
4.7e-01
cases:67.83%
controls:67.36%
cases:74.24%
controls:58.10%
cases:71.64%
controls:13.38%
cases:18.10%
controls:0.86%
cases:74.66%
controls:13.21%
cases:80.15%
controls:60.30%
cases:90.92%
controls:86.17%
1514
15034
718
7286
1657
12968
575
9352
1599
2986
633
19334
404
192
1828
22128
1659
2940
563
19309
1708
12951
423
8527
1402
13660
140
2193
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
-5.0e-02
6.7e-01
2.9e+00
3.5e+00
3.2e+00
5.5e-01
2.9e-01
cases:61.60%
controls:62.79%
cases:66.94%
controls:50.99%
cases:66.44%
controls:10.17%
cases:17.88%
controls:0.65%
cases:73.63%
controls:10.03%
cases:66.26%
controls:53.04%
cases:85.21%
controls:81.21%
1375
14014
857
8306
1494
11381
738
10939
1483
2270
749
20050
399
146
1833
22174
1636
2232
586
20017
1412
11393
719
10085
1314
12875
228
2978
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
5.5e-02
3.2e+00
5.3e+00
—
—
8.8e-01
1.5e+00
cases:3.63%
controls:3.44%
cases:23.12%
controls:1.21%
cases:19.22%
controls:0.12%
—
—
—
—
cases:3.24%
controls:1.36%
cases:18.29%
controls:4.55%
81
768
2151
21552
516
271
1716
22049
429
26
1803
22294
—
—
69
293
2062
21185
282
722
1260
15131
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
-1.9e-01
1.1e+00
2.2e+00
3.0e+00
2.4e+00
1.6e+00
6.0e-01
cases:17.47%
controls:20.31%
cases:26.57%
controls:11.04%
cases:18.10%
controls:2.29%
cases:2.55%
controls:0.13%
cases:19.13%
controls:2.11%
cases:39.47%
controls:11.24%
cases:41.12%
controls:27.67%
390
4534
1842
17786
593
2465
1639
19855
404
512
1828
21808
57
30
2175
22290
425
469
1797
21780
841
2414
1290
19064
634
4386
908
11467
Malignant tumor of flexura hepatica invasive carcinoma
C18.31 [2000500547]
C18.31 [2000500547]
—
—
—
1.0e+50
—
5.8e+00
5.1e+00
—
—
—
—
—
—
cases:5.24%
controls:0.00%
—
—
cases:7.32%
controls:0.02%
cases:7.46%
controls:0.05%
—
—
—
117
0
2115
22320
—
156
5
1975
21473
115
8
1427
15845
Neoplasm of uncertain or unknown behaviour: Colon
D37.4 [45552347]
D37.4 [45552347]
2.2e-01
5.0e+00
—
1.0e+50
—
3.3e+00
2.5e+00
cases:0.27%
controls:0.22%
cases:6.45%
controls:0.04%
—
—
cases:4.53%
controls:0.00%
—
—
cases:1.92%
controls:0.07%
cases:2.20%
controls:0.18%
6
48
2226
22272
144
10
2088
22310
—
101
0
2131
22320
—
41
16
2090
21462
34
28
1508
15825
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
-1.1e-01
1.7e+00
3.8e+00
1.0e+50
3.4e+00
1.2e+00
8.2e-01
cases:2.42%
controls:2.69%
cases:5.47%
controls:1.08%
cases:3.18%
controls:0.08%
cases:13.08%
controls:0.00%
cases:2.39%
controls:0.09%
cases:2.58%
controls:0.80%
cases:4.80%
controls:2.16%
54
601
2178
21719
122
242
2110
22078
71
17
2161
22303
292
0
1940
22320
53
19
2169
22230
55
171
2076
21307
74
343
1468
15510
capecitabine
L01BC06 [21601440]
L01BC06 [21601440]
-2.8e-01
7.0e-01
—
—
3.0e+00
5.0e+00
2.7e+00
cases:0.40%
controls:0.53%
cases:0.67%
controls:0.34%
—
—
—
—
cases:1.13%
controls:0.06%
cases:25.67%
controls:0.24%
cases:5.77%
controls:0.39%
9
119
2223
22201
15
75
2217
22245
—
—
25
13
2197
22236
547
51
1584
21427
89
62
1453
15791
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.2e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.8e-01
4.6e-01
cases:67.88%
controls:67.40%
cases:74.42%
controls:58.12%
cases:71.59%
controls:13.41%
cases:11.83%
controls:0.86%
cases:74.66%
controls:13.26%
cases:80.20%
controls:60.38%
cases:90.86%
controls:86.22%
1515
15043
717
7277
1661
12973
571
9347
1598
2992
634
19328
264
192
1968
22128
1659
2950
563
19299
1709
12969
422
8509
1401
13668
141
2185
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.3e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.8e-01
4.7e-01
cases:67.79%
controls:67.28%
cases:74.24%
controls:58.01%
cases:71.59%
controls:13.36%
cases:11.65%
controls:0.86%
cases:74.66%
controls:13.18%
cases:80.10%
controls:60.19%
cases:90.86%
controls:86.12%
1513
15018
719
7302
1657
12948
575
9372
1598
2981
634
19339
260
192
1972
22128
1659
2932
563
19317
1707
12928
424
8550
1401
13653
141
2200
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.0e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.7e-01
4.8e-01
cases:67.83%
controls:67.40%
cases:74.33%
controls:58.11%
cases:71.59%
controls:13.38%
cases:11.65%
controls:0.86%
cases:74.71%
controls:13.21%
cases:80.10%
controls:60.31%
cases:90.99%
controls:86.19%
1514
15043
718
7277
1659
12970
573
9350
1598
2986
634
19334
260
193
1972
22127
1660
2940
562
19309
1707
12953
424
8525
1403
13664
139
2189
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.5e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.8e-01
4.7e-01
cases:67.79%
controls:67.23%
cases:74.28%
controls:57.99%
cases:71.59%
controls:13.36%
cases:11.65%
controls:0.86%
cases:74.66%
controls:13.21%
cases:80.06%
controls:60.17%
cases:90.86%
controls:86.13%
1513
15006
719
7314
1658
12944
574
9376
1598
2981
634
19339
260
193
1972
22127
1659
2938
563
19311
1706
12923
425
8555
1401
13654
141
2199
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.2e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.8e-01
4.7e-01
cases:67.83%
controls:67.34%
cases:74.33%
controls:58.07%
cases:71.59%
controls:13.35%
cases:11.65%
controls:0.86%
cases:74.66%
controls:13.21%
cases:80.10%
controls:60.28%
cases:90.86%
controls:86.19%
1514
15031
718
7289
1659
12962
573
9358
1598
2980
634
19340
260
192
1972
22128
1659
2939
563
19310
1707
12946
424
8532
1401
13663
141
2190
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.4e-02
7.4e-01
2.8e+00
2.7e+00
3.0e+00
9.7e-01
4.6e-01
cases:67.88%
controls:67.35%
cases:74.33%
controls:58.09%
cases:71.59%
controls:13.37%
cases:11.65%
controls:0.86%
cases:74.66%
controls:13.22%
cases:80.10%
controls:60.31%
cases:90.86%
controls:86.20%
1515
15033
717
7287
1659
12966
573
9354
1598
2985
634
19335
260
192
1972
22128
1659
2942
563
19307
1707
12954
424
8524
1401
13665
141
2188
Benign neoplasm: Rectum
D12.8 [45595734]
D12.8 [45595734]
4.3e-01
2.4e+00
4.1e+00
—
—
2.2e+00
1.9e+00
cases:1.03%
controls:0.67%
cases:2.11%
controls:0.20%
cases:1.88%
controls:0.03%
—
—
—
—
cases:2.11%
controls:0.23%
cases:4.41%
controls:0.72%
23
150
2209
22170
47
45
2185
22275
42
7
2190
22313
—
—
45
50
2086
21428
68
114
1474
15739
Endoscopic polypectomy in colon
JFA15 [2001304850]
JFA15 [2001304850]
7.6e-01
3.1e+00
4.3e+00
1.0e+50
-1.0e+50
9.1e-01
1.4e+00
cases:2.02%
controls:0.95%
cases:6.32%
controls:0.32%
cases:2.69%
controls:0.04%
cases:0.22%
controls:0.00%
cases:0.00%
controls:0.02%
cases:0.80%
controls:0.32%
cases:5.19%
controls:1.38%
45
212
2187
22108
141
71
2091
22249
60
8
2172
22312
5
0
2227
22320
0
5
2222
22244
17
69
2114
21409
80
219
1462
15634
Malignant tumor of the caecum without histology
C18.00 [2000500534]
C18.00 [2000500534]
-1.0e+50
—
—
1.0e+50
—
5.9e+00
4.5e+00
cases:0.00%
controls:0.06%
—
—
—
—
cases:9.86%
controls:0.00%
—
—
cases:7.56%
controls:0.02%
cases:5.45%
controls:0.06%
0
13
2232
22307
—
—
220
0
2012
22320
—
161
5
1970
21473
84
10
1458
15843
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
-1.6e-01
4.8e-01
2.1e+00
—
5.6e+00
1.4e+00
6.7e-01
cases:8.20%
controls:9.51%
cases:4.17%
controls:2.63%
cases:2.82%
controls:0.34%
—
—
cases:50.54%
controls:0.37%
cases:8.45%
controls:2.20%
cases:11.41%
controls:6.19%
183
2123
2049
20197
93
586
2139
21734
63
77
2169
22243
—
1123
83
1099
22166
180
473
1951
21005
176
982
1366
14871
Outpatient Visit
OP [9202]
OP [9202]
1.2e-01
5.5e-01
1.6e+00
5.2e+00
1.1e+00
9.0e-01
8.4e-01
cases:89.43%
controls:88.19%
cases:80.73%
controls:70.81%
cases:47.22%
controls:14.80%
cases:56.32%
controls:0.69%
cases:32.09%
controls:14.00%
cases:84.47%
controls:68.90%
cases:96.11%
controls:91.41%
1996
19683
236
2637
1802
15804
430
6516
1054
3303
1178
19017
1257
155
975
22165
713
3114
1509
19135
1800
14799
331
6679
1482
14491
60
1362
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
-1.4e-01
6.6e-01
2.2e+00
4.2e+00
2.1e+00
5.8e-01
4.1e-01
cases:9.09%
controls:10.33%
cases:4.21%
controls:2.22%
cases:2.64%
controls:0.31%
cases:1.52%
controls:0.02%
cases:2.39%
controls:0.29%
cases:3.14%
controls:1.78%
cases:5.84%
controls:3.94%
203
2306
2029
20014
94
495
2138
21825
59
69
2173
22251
34
5
2198
22315
53
64
2169
22185
67
382
2064
21096
90
624
1452
15229
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
2.1e-01
3.1e+00
3.5e+00
—
2.2e+00
1.0e+00
3.4e-01
cases:2.78%
controls:2.27%
cases:17.88%
controls:0.93%
cases:4.53%
controls:0.14%
—
—
cases:1.53%
controls:0.18%
cases:2.91%
controls:1.07%
cases:4.67%
controls:3.37%
62
506
2170
21814
399
207
1833
22113
101
32
2131
22288
—
34
40
2188
22209
62
229
2069
21249
72
534
1470
15319
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
3.5e-02
5.3e-01
2.6e+00
2.9e+00
2.6e+00
7.9e-01
4.4e-01
cases:58.42%
controls:57.58%
cases:52.73%
controls:39.52%
cases:50.54%
controls:7.35%
cases:8.02%
controls:0.47%
cases:50.90%
controls:7.43%
cases:58.09%
controls:38.71%
cases:74.71%
controls:65.55%
1304
12852
928
9468
1177
8821
1055
13499
1128
1641
1104
20679
179
105
2053
22215
1131
1652
1091
20597
1238
8315
893
13163
1152
10391
390
5462
Malignant neoplasm: Small intestine, unspecified
C17.9 [45561788]
C17.9 [45561788]
—
—
3.2e+00
1.0e+50
—
3.3e+00
3.3e+00
—
—
—
—
cases:0.63%
controls:0.03%
cases:0.58%
controls:0.00%
—
—
cases:1.64%
controls:0.06%
cases:1.88%
controls:0.07%
—
—
14
6
2218
22314
13
0
2219
22320
—
35
13
2096
21465
29
11
1513
15842
Malignant tumor of the transverse colon invasive carcinoma
C18.41 [2000500551]
C18.41 [2000500551]
-1.0e+50
—
—
1.0e+50
1.0e+50
5.3e+00
4.5e+00
cases:0.00%
controls:0.02%
—
—
—
—
cases:2.78%
controls:0.00%
cases:2.93%
controls:0.00%
cases:4.32%
controls:0.02%
cases:4.28%
controls:0.05%
0
5
2232
22315
—
—
62
0
2170
22320
65
0
2157
22249
92
5
2039
21473
66
8
1476
15845
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
-2.4e-01
2.4e+00
4.3e+00
—
—
1.2e+00
1.9e+00
cases:1.57%
controls:1.98%
cases:5.69%
controls:0.56%
cases:4.66%
controls:0.07%
—
—
—
—
cases:1.50%
controls:0.47%
cases:11.09%
controls:1.79%
35
443
2197
21877
127
125
2105
22195
104
15
2128
22305
—
—
32
102
2099
21376
171
283
1371
15570
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
-1.1e-02
7.4e-01
2.8e+00
2.0e+00
2.9e+00
6.8e-01
5.0e-01
cases:65.14%
controls:65.39%
cases:72.72%
controls:55.95%
cases:69.00%
controls:12.19%
cases:5.69%
controls:0.78%
cases:72.37%
controls:12.17%
cases:73.35%
controls:58.29%
cases:90.01%
controls:84.55%
1454
14596
778
7724
1623
12487
609
9833
1540
2721
692
19599
127
173
2105
22147
1608
2708
614
19541
1563
12519
568
8959
1388
13403
154
2450
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
-5.3e-02
1.8e+00
4.0e+00
—
2.1e+00
1.3e+00
4.3e-01
cases:4.12%
controls:4.34%
cases:15.19%
controls:2.82%
cases:19.85%
controls:0.43%
—
—
cases:3.15%
controls:0.39%
cases:10.00%
controls:3.06%
cases:12.39%
controls:8.41%
92
968
2140
21352
339
630
1893
21690
443
97
1789
22223
—
70
87
2152
22162
213
658
1918
20820
191
1333
1351
14520
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
-5.0e-01
6.5e-01
1.9e+00
—
4.6e+00
1.8e+00
6.7e-01
cases:0.99%
controls:1.61%
cases:1.66%
controls:0.87%
cases:1.39%
controls:0.20%
—
—
cases:14.40%
controls:0.18%
cases:5.07%
controls:0.90%
cases:5.25%
controls:2.75%
22
360
2210
21960
37
194
2195
22126
31
45
2201
22275
—
320
39
1902
22210
108
193
2023
21285
81
436
1461
15417
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
-3.0e-02
1.9e+00
4.0e+00
—
2.1e+00
1.2e+00
3.9e-01
cases:4.44%
controls:4.57%
cases:16.67%
controls:2.95%
cases:20.43%
controls:0.45%
—
—
cases:3.29%
controls:0.42%
cases:9.95%
controls:3.25%
cases:13.04%
controls:9.20%
99
1019
2133
21301
372
659
1860
21661
456
100
1776
22220
—
73
93
2149
22156
212
698
1919
20780
201
1459
1341
14394
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
-7.2e-02
1.9e+00
4.0e+00
—
2.1e+00
1.1e+00
4.5e-01
cases:4.70%
controls:5.04%
cases:18.10%
controls:3.17%
cases:20.97%
controls:0.47%
—
—
cases:3.51%
controls:0.45%
cases:10.18%
controls:3.48%
cases:14.27%
controls:9.63%
105
1124
2127
21196
404
708
1828
21612
468
106
1764
22214
—
78
101
2144
22148
217
747
1914
20731
220
1527
1322
14326
Malignant neoplasm: Ileum
C17.2 [45600484]
C17.2 [45600484]
-1.0e+50
—
2.8e+00
1.0e+50
—
3.4e+00
3.4e+00
cases:0.00%
controls:0.06%
—
—
cases:0.36%
controls:0.02%
cases:0.58%
controls:0.00%
—
—
cases:0.94%
controls:0.03%
cases:1.17%
controls:0.04%
0
13
2232
22307
—
8
5
2224
22315
13
0
2219
22320
—
20
7
2111
21471
18
6
1524
15847
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
D50.0 [45566697]
2.1e-01
3.3e+00
4.3e+00
1.0e+50
—
1.6e+00
6.8e-01
cases:0.58%
controls:0.47%
cases:4.93%
controls:0.18%
cases:2.02%
controls:0.03%
cases:0.63%
controls:0.00%
—
—
cases:1.03%
controls:0.20%
cases:1.23%
controls:0.63%
13
105
2219
22215
110
41
2122
22279
45
6
2187
22314
14
0
2218
22320
—
22
43
2109
21435
19
100
1523
15753
Melaena
K92.1 [45533624]
K92.1 [45533624]
-2.9e-01
2.2e+00
4.0e+00
—
3.1e+00
-1.0e-01
2.3e-01
cases:0.63%
controls:0.84%
cases:2.82%
controls:0.33%
cases:1.25%
controls:0.02%
—
—
cases:0.50%
controls:0.02%
cases:0.28%
controls:0.31%
cases:1.49%
controls:1.19%
14
187
2218
22133
63
73
2169
22247
28
5
2204
22315
—
11
5
2211
22244
6
67
2125
21411
23
189
1519
15664
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
7.3e-02
2.4e+00
3.6e+00
—
1.9e+00
1.1e+00
3.6e-01
cases:9.68%
controls:9.06%
cases:34.95%
controls:4.74%
cases:18.06%
controls:0.62%
—
—
cases:3.96%
controls:0.60%
cases:13.66%
controls:5.01%
cases:20.30%
controls:15.14%
216
2022
2016
20298
780
1059
1452
21261
403
139
1829
22181
—
88
134
2134
22115
291
1076
1840
20402
313
2400
1229
13453
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
-5.4e-02
5.8e-01
1.3e+00
5.5e+00
8.2e-01
7.7e-01
3.3e-01
cases:15.55%
controls:16.27%
cases:10.39%
controls:6.08%
cases:2.69%
controls:0.76%
cases:6.27%
controls:0.03%
cases:1.67%
controls:0.74%
cases:11.68%
controls:5.76%
cases:21.79%
controls:16.65%
347
3632
1885
18688
232
1356
2000
20964
60
170
2172
22150
140
6
2092
22314
37
165
2185
22084
249
1237
1882
20241
336
2640
1206
13213
Polyp of colon
K63.5 [45601184]
K63.5 [45601184]
1.1e-01
2.7e+00
—
1.0e+50
3.5e+00
2.1e+00
1.0e+00
cases:0.27%
controls:0.24%
cases:2.15%
controls:0.15%
—
—
cases:1.21%
controls:0.00%
cases:1.04%
controls:0.03%
cases:1.13%
controls:0.14%
cases:1.69%
controls:0.62%
6
54
2226
22266
48
33
2184
22287
—
27
0
2205
22320
23
7
2199
22242
24
31
2107
21447
26
98
1516
15755
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
-4.3e-01
1.5e+00
2.9e+00
1.0e+50
3.0e+00
1.3e+00
6.9e-01
cases:0.99%
controls:1.50%
cases:3.54%
controls:0.85%
cases:1.79%
controls:0.10%
cases:3.90%
controls:0.00%
cases:2.61%
controls:0.14%
cases:3.89%
controls:1.11%
cases:8.11%
controls:4.25%
22
335
2210
21985
79
190
2153
22130
40
23
2192
22297
87
0
2145
22320
58
31
2164
22218
83
239
2048
21239
125
673
1417
15180
Gastroenterology
10 [38004455]
10 [38004455]
-1.2e-01
2.3e+00
3.7e+00
—
1.4e+00
9.9e-01
8.1e-01
cases:7.53%
controls:8.42%
cases:24.87%
controls:3.27%
cases:19.85%
controls:0.60%
—
—
cases:1.80%
controls:0.47%
cases:8.17%
controls:3.19%
cases:18.35%
controls:9.10%
168
1879
2064
20441
555
729
1677
21591
443
133
1789
22187
—
40
105
2182
22144
174
686
1957
20792
283
1442
1259
14411
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
A04AA02 [21600494]
2.4e-01
2.2e-01
—
—
2.9e+00
3.9e+00
2.3e+00
cases:1.08%
controls:0.85%
cases:0.54%
controls:0.43%
—
—
—
—
cases:0.90%
controls:0.05%
cases:13.70%
controls:0.34%
cases:5.19%
controls:0.52%
24
189
2208
22131
12
96
2220
22224
—
—
20
11
2202
22238
292
72
1839
21406
80
83
1462
15770
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.6e-02
5.7e-01
2.3e+00
2.6e+00
2.4e+00
7.7e-01
4.0e-01
cases:42.52%
controls:42.14%
cases:50.00%
controls:36.14%
cases:47.89%
controls:8.47%
cases:7.44%
controls:0.59%
cases:51.35%
controls:8.36%
cases:56.69%
controls:37.82%
cases:69.13%
controls:60.11%
949
9405
1283
12915
1116
8067
1116
14253
1069
1890
1163
20430
166
131
2066
22189
1141
1861
1081
20388
1208
8124
923
13354
1066
9530
476
6323
Simple adjuvant cytostatic therapy
WB103 [2001310627]
WB103 [2001310627]
-3.1e-01
6.2e-01
-1.0e+50
—
2.8e+00
4.3e+00
1.8e+00
cases:0.40%
controls:0.55%
cases:0.36%
controls:0.19%
cases:0.00%
controls:0.02%
—
—
cases:0.36%
controls:0.02%
cases:7.37%
controls:0.11%
cases:1.23%
controls:0.21%
9
123
2223
22197
8
43
2224
22277
0
5
2232
22315
—
8
5
2214
22244
157
23
1974
21455
19
33
1523
15820
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
-9.0e-02
8.9e-01
1.5e+00
1.8e+00
3.4e+00
8.3e-01
3.1e-01
cases:50.09%
controls:52.34%
cases:56.23%
controls:34.44%
cases:26.34%
controls:7.16%
cases:3.63%
controls:0.60%
cases:69.08%
controls:6.91%
cases:55.80%
controls:35.40%
cases:73.09%
controls:66.64%
1118
11682
1114
10638
1255
7688
977
14632
588
1597
1644
20723
81
135
2151
22185
1535
1537
687
20712
1189
7603
942
13875
1127
10565
415
5288
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
3.7e-02
6.5e-01
2.4e+00
2.0e+00
2.5e+00
6.3e-01
5.4e-01
cases:46.68%
controls:45.78%
cases:56.50%
controls:40.35%
cases:50.63%
controls:8.57%
cases:4.03%
controls:0.55%
cases:54.91%
controls:8.77%
cases:58.75%
controls:43.16%
cases:79.64%
controls:69.55%
1042
10217
1190
12103
1261
9006
971
13314
1130
1912
1102
20408
90
122
2142
22198
1220
1952
1002
20297
1252
9270
879
12208
1228
11026
314
4827
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
-2.3e-01
2.2e-01
2.8e+00
—
2.4e+00
2.4e+00
1.1e+00
cases:2.78%
controls:3.47%
cases:1.93%
controls:1.55%
cases:3.18%
controls:0.20%
—
—
cases:2.61%
controls:0.24%
cases:13.37%
controls:1.37%
cases:11.74%
controls:4.36%
62
775
2170
21545
43
346
2189
21974
71
44
2161
22276
—
58
54
2164
22195
285
295
1846
21183
181
691
1361
15162
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
-1.3e-01
4.0e-01
5.3e-01
5.0e+00
1.8e+00
6.6e-01
3.2e-01
cases:17.25%
controls:19.24%
cases:14.78%
controls:10.44%
cases:3.00%
controls:1.78%
cases:13.26%
controls:0.10%
cases:9.18%
controls:1.69%
cases:19.01%
controls:10.79%
cases:33.53%
controls:26.83%
385
4295
1847
18025
330
2331
1902
19989
67
398
2165
21922
296
23
1936
22297
204
376
2018
21873
405
2317
1726
19161
517
4253
1025
11600
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
-3.9e-01
1.5e+00
3.3e+00
—
2.5e+00
9.1e-01
8.3e-01
cases:3.76%
controls:5.45%
cases:7.84%
controls:1.91%
cases:7.35%
controls:0.30%
—
—
cases:2.79%
controls:0.22%
cases:4.69%
controls:1.94%
cases:11.93%
controls:5.60%
84
1217
2148
21103
175
427
2057
21893
164
67
2068
22253
—
62
50
2160
22199
100
417
2031
21061
184
887
1358
14966
Emergency Room Visit
ER [9203]
ER [9203]
-9.4e-02
8.2e-01
1.2e+00
4.1e+00
1.5e+00
6.0e-01
2.4e-01
cases:39.74%
controls:42.01%
cases:25.94%
controls:13.41%
cases:5.78%
controls:1.82%
cases:2.46%
controls:0.04%
cases:6.84%
controls:1.59%
cases:20.08%
controls:12.07%
cases:33.79%
controls:28.63%
887
9377
1345
12943
579
2994
1653
19326
129
407
2103
21913
55
9
2177
22311
152
354
2070
21895
428
2592
1703
18886
521
4538
1021
11315
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
1.2e-01
2.1e+00
3.4e+00
—
1.6e+00
9.6e-01
4.0e-01
cases:13.98%
controls:12.63%
cases:41.04%
controls:7.73%
cases:25.63%
controls:1.13%
—
—
cases:5.04%
controls:1.10%
cases:19.66%
controls:8.59%
cases:31.78%
controls:23.79%
312
2819
1920
19501
916
1725
1316
20595
572
252
1660
22068
—
112
244
2110
22005
419
1845
1712
19633
490
3772
1052
12081
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
-1.4e-01
4.1e-01
4.7e-01
4.9e+00
1.7e+00
7.0e-01
2.9e-01
cases:19.00%
controls:21.26%
cases:17.20%
controls:12.11%
cases:3.32%
controls:2.09%
cases:13.04%
controls:0.11%
cases:9.54%
controls:1.93%
cases:22.52%
controls:12.60%
cases:38.07%
controls:31.58%
424
4745
1808
17575
384
2703
1848
19617
74
467
2158
21853
291
25
1941
22295
212
429
2010
21820
480
2706
1651
18772
587
5006
955
10847
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
-1.1e-01
9.2e-01
1.8e+00
2.2e+00
1.8e+00
1.1e+00
5.7e-01
cases:34.41%
controls:36.84%
cases:42.43%
controls:22.66%
cases:21.51%
controls:4.30%
cases:2.06%
controls:0.24%
cases:20.97%
controls:4.27%
cases:48.10%
controls:23.07%
cases:61.35%
controls:47.25%
768
8222
1464
14098
947
5058
1285
17262
480
960
1752
21360
46
53
2186
22267
466
951
1756
21298
1025
4954
1106
16524
946
7491
596
8362
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
3.1e-02
3.2e-01
1.2e+00
5.1e+00
1.6e+00
4.5e-01
2.7e-02
cases:6.90%
controls:6.70%
cases:4.39%
controls:3.24%
cases:2.15%
controls:0.67%
cases:5.06%
controls:0.03%
cases:3.02%
controls:0.64%
cases:6.10%
controls:3.97%
cases:11.61%
controls:11.34%
154
1496
2078
20824
98
723
2134
21597
48
149
2184
22171
113
7
2119
22313
67
143
2155
22106
130
853
2001
20625
179
1797
1363
14056
Iron deficiency anaemia
B80 [2002000291]
B80 [2002000291]
2.4e-01
2.9e+00
3.7e+00
—
—
1.7e+00
7.1e-01
cases:0.45%
controls:0.35%
cases:2.78%
controls:0.15%
cases:1.48%
controls:0.04%
—
—
—
—
cases:0.61%
controls:0.12%
cases:0.97%
controls:0.48%
10
79
2222
22241
62
34
2170
22286
33
8
2199
22312
—
—
13
25
2118
21453
15
76
1527
15777
Follow-up examination after surgery for malignant neoplasm
Z08.0 [45556811]
Z08.0 [45556811]
0.0e+00
—
—
—
—
3.9e+00
4.3e+00
cases:0.31%
controls:0.31%
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.06%
cases:8.63%
controls:0.13%
7
70
2225
22250
—
—
—
—
57
12
2074
21466
133
20
1409
15833
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
3.1e-02
8.1e-01
1.1e+00
4.0e+00
1.8e+00
4.6e-01
2.0e-01
cases:9.45%
controls:9.19%
cases:12.28%
controls:5.84%
cases:2.51%
controls:0.81%
cases:1.66%
controls:0.03%
cases:4.68%
controls:0.82%
cases:11.22%
controls:7.42%
cases:26.01%
controls:22.42%
211
2052
2021
20268
274
1303
1958
21017
56
181
2176
22139
37
7
2195
22313
104
182
2118
22067
239
1593
1892
19885
401
3554
1141
12299
Other transluminal endoscopic local operation on intestine
JFA98 [2001304883]
JFA98 [2001304883]
7.4e-01
3.2e+00
—
—
—
2.2e+00
2.7e+00
cases:0.67%
controls:0.32%
cases:1.84%
controls:0.08%
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:1.56%
controls:0.11%
15
72
2217
22248
41
17
2191
22303
—
—
—
10
11
2121
21467
24
17
1518
15836
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
-4.4e-02
1.0e-01
9.8e-01
5.9e+00
4.7e-01
7.1e-01
3.9e-01
cases:7.89%
controls:8.21%
cases:3.23%
controls:2.92%
cases:1.16%
controls:0.44%
cases:7.84%
controls:0.02%
cases:0.63%
controls:0.40%
cases:5.07%
controls:2.56%
cases:10.05%
controls:7.01%
176
1833
2056
20487
72
652
2160
21668
26
98
2206
22222
175
5
2057
22315
14
88
2208
22161
108
549
2023
20929
155
1111
1387
14742
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
-3.3e-02
8.9e-02
1.2e+00
4.9e+00
1.5e+00
3.6e-01
2.4e-01
cases:10.04%
controls:10.34%
cases:5.96%
controls:5.48%
cases:3.18%
controls:0.97%
cases:6.45%
controls:0.05%
cases:3.87%
controls:0.91%
cases:8.26%
controls:5.91%
cases:15.37%
controls:12.46%
224
2308
2008
20012
133
1223
2099
21097
71
216
2161
22104
144
11
2088
22309
86
202
2136
22047
176
1269
1955
20209
237
1976
1305
13877
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-9.8e-02
3.7e-01
2.1e+00
2.7e+00
2.3e+00
4.7e-01
-9.9e-02
cases:45.61%
controls:48.05%
cases:47.72%
controls:38.75%
cases:43.77%
controls:8.63%
cases:7.84%
controls:0.56%
cases:47.30%
controls:8.64%
cases:51.67%
controls:40.04%
cases:58.88%
controls:61.25%
1018
10724
1214
11596
1065
8649
1167
13671
977
1927
1255
20393
175
125
2057
22195
1051
1922
1171
20327
1101
8599
1030
12879
908
9710
634
6143
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
-2.3e-02
7.1e-01
2.1e+00
2.9e+00
1.2e+00
6.5e-01
4.0e-01
cases:22.31%
controls:22.71%
cases:23.25%
controls:12.91%
cases:27.51%
controls:4.45%
cases:4.75%
controls:0.28%
cases:13.37%
controls:4.55%
cases:22.24%
controls:13.01%
cases:36.19%
controls:27.59%
498
5068
1734
17252
519
2882
1713
19438
614
993
1618
21327
106
63
2126
22257
297
1012
1925
21237
474
2794
1657
18684
558
4374
984
11479
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
-8.6e-02
2.3e+00
3.1e+00
—
1.3e+00
6.8e-01
5.8e-01
cases:6.41%
controls:6.94%
cases:16.76%
controls:2.05%
cases:3.72%
controls:0.18%
—
—
cases:0.59%
controls:0.16%
cases:3.33%
controls:1.72%
cases:10.25%
controls:5.99%
143
1549
2089
20771
374
457
1858
21863
83
40
2149
22280
—
13
36
2209
22213
71
370
2060
21108
158
950
1384
14903
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
-5.3e-02
1.8e-01
1.2e+00
4.9e+00
1.3e+00
3.4e-01
3.2e-02
cases:33.42%
controls:34.61%
cases:20.25%
controls:17.44%
cases:9.50%
controls:3.11%
cases:17.88%
controls:0.17%
cases:10.22%
controls:3.07%
cases:24.64%
controls:18.89%
cases:42.80%
controls:42.01%
746
7724
1486
14596
452
3892
1780
18428
212
695
2020
21625
399
37
1833
22283
227
682
1995
21567
525
4058
1606
17420
660
6660
882
9193
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
-3.9e-03
9.6e-01
2.8e+00
—
2.1e+00
1.3e+00
6.9e-01
cases:3.54%
controls:3.55%
cases:4.03%
controls:1.59%
cases:2.82%
controls:0.18%
—
—
cases:1.62%
controls:0.21%
cases:5.35%
controls:1.46%
cases:8.56%
controls:4.50%
79
793
2153
21527
90
354
2142
21966
63
41
2169
22279
—
36
47
2186
22202
114
314
2017
21164
132
713
1410
15140
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
6.1e-02
1.0e+00
2.4e+00
—
2.4e+00
1.2e+00
7.2e-01
cases:3.05%
controls:2.87%
cases:3.81%
controls:1.41%
cases:1.93%
controls:0.18%
—
—
cases:1.71%
controls:0.16%
cases:4.13%
controls:1.27%
cases:8.17%
controls:4.15%
68
641
2164
21679
85
314
2147
22006
43
40
2189
22280
—
38
35
2184
22214
88
272
2043
21206
126
658
1416
15195
Malignant tumour
130 [2001600128]
130 [2001600128]
-3.7e-01
7.2e-01
2.1e+00
—
—
4.5e+00
1.1e+00
cases:0.72%
controls:1.04%
cases:1.03%
controls:0.50%
cases:0.40%
controls:0.05%
—
—
—
—
cases:23.37%
controls:0.34%
cases:2.85%
controls:0.96%
16
232
2216
22088
23
112
2209
22208
9
11
2223
22309
—
—
498
72
1633
21406
44
152
1498
15701
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
-4.6e-02
2.0e-02
3.9e-01
7.1e+00
-1.6e-01
3.4e-01
2.5e-01
cases:26.43%
controls:27.33%
cases:10.39%
controls:10.21%
cases:1.84%
controls:1.25%
cases:30.96%
controls:0.04%
cases:1.04%
controls:1.21%
cases:12.90%
controls:9.56%
cases:32.49%
controls:27.24%
590
6100
1642
16220
232
2278
2000
20042
41
280
2191
22040
691
8
1541
22312
23
270
2199
21979
275
2053
1856
19425
501
4318
1041
11535
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
-2.0e-01
8.8e-01
6.6e-01
2.8e+00
1.7e+00
1.3e+00
6.0e-01
cases:19.62%
controls:23.05%
cases:29.21%
controls:14.59%
cases:6.50%
controls:3.46%
cases:3.23%
controls:0.21%
cases:16.16%
controls:3.27%
cases:38.39%
controls:14.82%
cases:43.32%
controls:29.63%
438
5144
1794
17176
652
3256
1580
19064
145
772
2087
21548
72
47
2160
22273
359
727
1863
21522
818
3182
1313
18296
668
4698
874
11155
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
-1.7e-01
-1.7e-01
1.6e+00
4.6e+00
1.5e+00
4.5e-01
-5.7e-02
cases:2.87%
controls:3.37%
cases:1.43%
controls:1.70%
cases:1.48%
controls:0.30%
cases:2.73%
controls:0.03%
cases:1.35%
controls:0.32%
cases:2.82%
controls:1.81%
cases:4.47%
controls:4.72%
64
752
2168
21568
32
379
2200
21941
33
67
2199
22253
61
6
2171
22314
30
71
2192
22178
60
388
2071
21090
69
749
1473
15104
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
D41.0 [45581311]
-8.2e-01
5.5e-01
2.3e+00
—
2.4e+00
1.8e+00
1.0e+00
cases:0.22%
controls:0.51%
cases:0.45%
controls:0.26%
cases:0.45%
controls:0.04%
—
—
cases:0.54%
controls:0.05%
cases:1.41%
controls:0.23%
cases:1.43%
controls:0.50%
5
113
2227
22207
10
58
2222
22262
10
10
2222
22310
—
12
11
2210
22238
30
49
2101
21429
22
80
1520
15773
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
-1.2e-01
1.1e+00
3.0e+00
—
8.2e-01
2.1e+00
1.3e+00
cases:1.48%
controls:1.67%
cases:2.11%
controls:0.69%
cases:2.82%
controls:0.15%
—
—
cases:0.32%
controls:0.14%
cases:4.55%
controls:0.55%
cases:4.22%
controls:1.15%
33
373
2199
21947
47
155
2185
22165
63
33
2169
22287
—
7
31
2215
22218
97
119
2034
21359
65
183
1477
15670
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
-4.1e-02
—
2.4e+00
—
3.0e+00
2.1e+00
8.1e-01
cases:0.54%
controls:0.56%
—
—
cases:0.45%
controls:0.04%
—
—
cases:0.45%
controls:0.02%
cases:1.31%
controls:0.17%
cases:0.84%
controls:0.38%
12
125
2220
22195
—
10
9
2222
22311
—
10
5
2212
22244
28
36
2103
21442
13
60
1529
15793
EKG study
11524-6 [3013512]
11524-6 [3013512]
-5.6e-02
2.6e-01
2.8e+00
3.0e+00
1.5e+00
2.2e-01
5.5e-03
cases:14.87%
controls:15.59%
cases:11.16%
controls:8.80%
cases:14.92%
controls:1.08%
cases:0.85%
controls:0.04%
cases:4.32%
controls:1.00%
cases:11.22%
controls:9.23%
cases:22.70%
controls:22.60%
332
3480
1900
18840
249
1965
1983
20355
333
242
1899
22078
19
10
2213
22310
96
223
2126
22026
239
1983
1892
19495
350
3583
1192
12270
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
-2.5e-01
4.1e-01
4.7e-01
3.1e+00
3.0e+00
6.5e-01
2.8e-01
cases:7.35%
controls:9.25%
cases:6.54%
controls:4.43%
cases:0.90%
controls:0.56%
cases:0.90%
controls:0.04%
cases:11.12%
controls:0.63%
cases:9.06%
controls:4.93%
cases:18.42%
controls:14.51%
164
2064
2068
20256
146
989
2086
21331
20
126
2212
22194
20
9
2212
22311
247
140
1975
22109
193
1058
1938
20420
284
2301
1258
13552
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
-5.3e-02
5.2e-01
3.2e+00
1.8e+00
1.4e+00
3.1e-01
1.9e-01
cases:35.13%
controls:36.35%
cases:28.09%
controls:18.86%
cases:34.05%
controls:2.02%
cases:0.63%
controls:0.10%
cases:8.33%
controls:2.23%
cases:23.84%
controls:18.66%
cases:48.12%
controls:43.49%
784
8113
1448
14207
627
4210
1605
18110
760
450
1472
21870
14
23
2218
22297
185
496
2037
21753
508
4008
1623
17470
742
6895
800
8958
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
-9.4e-02
1.6e+00
2.2e+00
—
1.8e+00
1.1e+00
5.2e-01
cases:6.27%
controls:6.85%
cases:9.41%
controls:1.99%
cases:2.37%
controls:0.27%
—
—
cases:1.67%
controls:0.27%
cases:6.15%
controls:2.08%
cases:11.09%
controls:6.89%
140
1528
2092
20792
210
445
2022
21875
53
60
2179
22260
—
37
60
2185
22189
131
447
2000
21031
171
1092
1371
14761
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
8.0e-02
9.3e-01
1.7e+00
-1.0e+50
3.1e+00
9.4e-01
5.3e-01
cases:7.84%
controls:7.28%
cases:4.88%
controls:1.99%
cases:0.94%
controls:0.17%
cases:0.00%
controls:0.02%
cases:3.83%
controls:0.17%
cases:4.32%
controls:1.74%
cases:9.01%
controls:5.53%
175
1625
2057
20695
109
444
2123
21876
21
39
2211
22281
0
5
2232
22315
85
38
2137
22211
92
373
2039
21105
139
877
1403
14976
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
-1.7e-01
4.6e-01
1.7e+00
2.4e+00
1.4e+00
8.9e-01
3.4e-01
cases:9.50%
controls:11.11%
cases:7.75%
controls:5.05%
cases:3.54%
controls:0.70%
cases:0.40%
controls:0.04%
cases:2.88%
controls:0.70%
cases:11.64%
controls:5.14%
cases:18.94%
controls:14.31%
212
2479
2020
19841
173
1128
2059
21192
79
156
2153
22164
9
8
2223
22312
64
155
2158
22094
248
1103
1883
20375
292
2269
1250
13584
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
1.4e-01
1.1e+00
3.4e+00
—
1.1e+00
1.3e+00
1.4e+00
cases:6.90%
controls:6.03%
cases:3.36%
controls:1.18%
cases:3.81%
controls:0.13%
—
—
cases:0.36%
controls:0.12%
cases:3.14%
controls:0.87%
cases:6.10%
controls:1.58%
154
1346
2078
20974
75
264
2157
22056
85
29
2147
22291
—
8
27
2214
22222
67
186
2064
21292
94
250
1448
15603
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
-2.1e-01
4.9e-01
3.3e+00
—
2.0e+00
7.5e-01
6.3e-01
cases:3.45%
controls:4.22%
cases:3.14%
controls:1.94%
cases:7.62%
controls:0.30%
—
—
cases:1.85%
controls:0.25%
cases:3.66%
controls:1.76%
cases:8.17%
controls:4.54%
77
943
2155
21377
70
433
2162
21887
170
67
2062
22253
—
41
56
2181
22193
78
377
2053
21101
126
719
1416
15134
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
-1.7e-01
1.2e+00
3.2e+00
—
2.1e+00
7.6e-01
2.3e-01
cases:9.77%
controls:11.39%
cases:13.04%
controls:4.47%
cases:11.07%
controls:0.52%
—
—
cases:4.05%
controls:0.53%
cases:9.53%
controls:4.70%
cases:17.44%
controls:14.35%
218
2542
2014
19778
291
998
1941
21322
247
115
1985
22205
—
90
118
2132
22131
203
1009
1928
20469
269
2275
1273
13578
Anaemia other/unspecified
B82 [2002000293]
B82 [2002000293]
-1.8e-01
3.0e+00
4.0e+00
—
—
7.9e-01
-8.1e-03
cases:0.40%
controls:0.48%
cases:3.76%
controls:0.19%
cases:1.25%
controls:0.02%
—
—
—
—
cases:0.47%
controls:0.21%
cases:0.71%
controls:0.72%
9
108
2223
22212
84
42
2148
22278
28
5
2204
22315
—
—
10
46
2121
21432
11
114
1531
15739
dalteparin; parenteral
B01AB04 [21600975]
B01AB04 [21600975]
-1.4e-01
—
1.6e+00
—
3.3e+00
2.1e+00
1.6e+00
cases:0.36%
controls:0.41%
—
—
cases:0.27%
controls:0.05%
—
—
cases:1.44%
controls:0.05%
cases:1.60%
controls:0.19%
cases:1.56%
controls:0.31%
8
92
2224
22228
—
6
12
2226
22308
—
32
12
2190
22237
34
41
2097
21437
24
49
1518
15804
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
-2.0e-01
6.3e-01
1.3e+00
1.7e+00
1.9e+00
1.0e+00
4.9e-01
cases:8.29%
controls:9.95%
cases:9.41%
controls:5.26%
cases:3.76%
controls:1.08%
cases:0.40%
controls:0.08%
cases:7.25%
controls:1.11%
cases:13.80%
controls:5.35%
cases:19.13%
controls:12.61%
185
2220
2047
20100
210
1174
2022
21146
84
242
2148
22078
9
17
2223
22303
161
247
2061
22002
294
1148
1837
20330
295
1999
1247
13854
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
1.1e-01
2.2e+00
1.5e+00
—
1.9e+00
1.4e+00
4.0e-01
cases:1.88%
controls:1.69%
cases:6.41%
controls:0.72%
cases:0.81%
controls:0.18%
—
—
cases:0.90%
controls:0.14%
cases:2.86%
controls:0.74%
cases:3.50%
controls:2.38%
42
377
2190
21943
143
160
2089
22160
18
40
2214
22280
—
20
31
2202
22218
61
160
2070
21318
54
377
1488
15476
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-3.0e-03
6.6e-01
1.7e+00
1.9e+00
1.6e+00
5.5e-01
4.8e-01
cases:16.04%
controls:16.08%
cases:23.25%
controls:13.57%
cases:15.10%
controls:3.01%
cases:1.21%
controls:0.18%
cases:13.86%
controls:3.06%
cases:22.67%
controls:14.44%
cases:37.81%
controls:27.28%
358
3589
1874
18731
519
3028
1713
19292
337
671
1895
21649
27
41
2205
22279
308
680
1914
21569
483
3102
1648
18376
583
4325
959
11528
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
-2.9e-02
7.9e-01
2.4e+00
2.5e+00
9.2e-01
4.2e-01
1.7e-01
cases:23.25%
controls:23.77%
cases:20.92%
controls:10.75%
cases:11.87%
controls:1.25%
cases:0.63%
controls:0.05%
cases:3.33%
controls:1.35%
cases:14.92%
controls:10.30%
cases:32.75%
controls:29.08%
519
5305
1713
17015
467
2400
1765
19920
265
279
1967
22041
14
12
2218
22308
74
301
2148
21948
318
2212
1813
19266
505
4610
1037
11243
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
1.5e-01
4.7e-01
9.1e-01
4.3e+00
9.6e-01
3.0e-01
2.1e-01
cases:14.43%
controls:12.63%
cases:10.62%
controls:6.92%
cases:3.45%
controls:1.42%
cases:4.79%
controls:0.07%
cases:3.51%
controls:1.37%
cases:9.20%
controls:6.99%
cases:16.08%
controls:13.50%
322
2819
1910
19501
237
1545
1995
20775
77
317
2155
22003
107
15
2125
22305
78
305
2144
21944
196
1502
1935
19976
248
2140
1294
13713
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 [3028531]
15060-7 [3028531]
1.9e-01
1.4e+00
2.6e+00
—
—
2.0e+00
9.5e-01
cases:0.36%
controls:0.30%
cases:0.58%
controls:0.14%
cases:0.36%
controls:0.03%
—
—
—
—
cases:1.08%
controls:0.15%
cases:1.36%
controls:0.53%
8
66
2224
22254
13
32
2219
22288
8
6
2224
22314
—
—
23
32
2108
21446
21
84
1521
15769
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
-6.3e-02
8.9e-01
2.7e+00
—
2.3e+00
5.6e-01
5.2e-01
cases:14.87%
controls:15.69%
cases:12.77%
controls:5.68%
cases:7.21%
controls:0.54%
—
—
cases:5.27%
controls:0.56%
cases:8.78%
controls:5.21%
cases:22.70%
controls:14.87%
332
3503
1900
18817
285
1267
1947
21053
161
120
2071
22200
—
117
125
2105
22124
187
1119
1944
20359
350
2357
1192
13496
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
9.0e-02
1.3e-01
1.3e+00
4.5e+00
1.0e+00
1.7e-01
8.4e-02
cases:5.69%
controls:5.22%
cases:2.73%
controls:2.41%
cases:1.70%
controls:0.46%
cases:2.82%
controls:0.03%
cases:1.26%
controls:0.44%
cases:3.33%
controls:2.84%
cases:7.13%
controls:6.60%
127
1166
2105
21154
61
537
2171
21783
38
102
2194
22218
63
7
2169
22313
28
99
2194
22150
71
609
2060
20869
110
1046
1432
14807
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
-5.8e-01
3.7e-01
—
1.0e+50
2.4e+00
2.6e+00
1.8e+00
cases:0.49%
controls:0.87%
cases:0.45%
controls:0.31%
—
—
cases:11.16%
controls:0.00%
cases:0.36%
controls:0.03%
cases:2.44%
controls:0.19%
cases:3.18%
controls:0.52%
11
195
2221
22125
10
69
2222
22251
—
249
0
1983
22320
8
7
2214
22242
52
40
2079
21438
49
83
1493
15770
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
-6.8e-01
2.5e-01
1.9e+00
—
3.1e+00
1.2e+00
6.4e-01
cases:0.58%
controls:1.15%
cases:0.49%
controls:0.39%
cases:0.45%
controls:0.07%
—
—
cases:1.62%
controls:0.07%
cases:1.45%
controls:0.45%
cases:2.33%
controls:1.24%
13
256
2219
22064
11
86
2221
22234
10
15
2222
22305
—
36
16
2186
22233
31
97
2100
21381
36
197
1506
15656
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
-2.1e-01
3.8e-02
2.2e+00
2.4e+00
2.1e+00
1.9e-01
-1.4e-01
cases:6.59%
controls:7.97%
cases:3.58%
controls:3.45%
cases:3.76%
controls:0.42%
cases:0.40%
controls:0.04%
cases:4.01%
controls:0.49%
cases:3.38%
controls:2.82%
cases:4.47%
controls:5.09%
147
1780
2085
20540
80
771
2152
21549
84
93
2148
22227
9
8
2223
22312
89
110
2133
22139
72
606
2059
20872
69
807
1473
15046
Intestinal bypass and anastomosis status
Z98.0 [45561677]
Z98.0 [45561677]
-1.0e+50
-1.0e+50
—
—
—
2.6e+00
4.2e+00
cases:0.00%
controls:0.07%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:3.57%
controls:0.06%
0
16
2232
22304
0
6
2232
22314
—
—
—
8
6
2123
21472
55
9
1487
15844
aprepitant; oral, parenteral
A04AD12 [21600505]
A04AD12 [21600505]
1.1e-01
-1.0e+50
—
—
—
4.0e+00
2.7e+00
cases:0.27%
controls:0.24%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.69%
controls:0.03%
cases:0.97%
controls:0.06%
6
54
2226
22266
0
14
2232
22306
—
—
—
36
7
2095
21471
15
10
1527
15843
General Surgery
2 [38004447]
2 [38004447]
-8.3e-02
4.4e-01
2.4e+00
—
2.5e+00
1.0e+00
4.1e-01
cases:14.65%
controls:15.72%
cases:6.59%
controls:4.35%
cases:5.73%
controls:0.57%
—
—
cases:5.85%
controls:0.53%
cases:9.53%
controls:3.65%
cases:14.33%
controls:10.00%
327
3509
1905
18811
147
971
2085
21349
128
127
2104
22193
—
130
117
2092
22132
203
784
1928
20694
221
1586
1321
14267
loperamide oxide; oral
A07DA05 [21600648]
A07DA05 [21600648]
-2.3e-01
2.8e-01
—
—
2.0e+00
3.1e+00
1.6e+00
cases:1.48%
controls:1.85%
cases:1.43%
controls:1.08%
—
—
—
—
cases:1.71%
controls:0.24%
cases:18.96%
controls:1.05%
cases:9.92%
controls:2.23%
33
414
2199
21906
32
242
2200
22078
—
—
38
53
2184
22196
404
226
1727
21252
153
353
1389
15500
loperamide; oral
A07DA03 [21600646]
A07DA03 [21600646]
-2.3e-01
2.8e-01
—
—
2.0e+00
3.1e+00
1.6e+00
cases:1.48%
controls:1.85%
cases:1.43%
controls:1.08%
—
—
—
—
cases:1.71%
controls:0.24%
cases:18.96%
controls:1.05%
cases:9.92%
controls:2.23%
33
414
2199
21906
32
242
2200
22078
—
—
38
53
2184
22196
404
226
1727
21252
153
353
1389
15500
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
5.1e-02
5.6e-01
8.7e-01
2.7e+00
1.9e+00
5.4e-01
1.6e-01
cases:12.50%
controls:11.95%
cases:11.42%
controls:6.88%
cases:2.37%
controls:1.01%
cases:0.81%
controls:0.05%
cases:6.53%
controls:0.99%
cases:11.59%
controls:7.09%
cases:22.31%
controls:19.69%
279
2668
1953
19652
255
1536
1977
20784
53
225
2179
22095
18
12
2214
22308
145
220
2077
22029
247
1522
1884
19956
344
3122
1198
12731
Emergency Medicine
93 [38004510]
93 [38004510]
-8.1e-03
6.9e-01
1.1e+00
3.0e+00
1.4e+00
3.7e-01
1.6e-01
cases:25.04%
controls:25.20%
cases:24.15%
controls:13.79%
cases:5.56%
controls:1.95%
cases:1.39%
controls:0.07%
cases:8.10%
controls:2.09%
cases:21.02%
controls:15.51%
cases:43.51%
controls:39.58%
559
5624
1673
16696
539
3078
1693
19242
124
436
2108
21884
31
15
2201
22305
180
466
2042
21783
448
3331
1683
18147
671
6275
871
9578
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
-3.5e-01
7.0e-01
2.6e+00
—
2.6e+00
1.3e+00
8.0e-01
cases:0.94%
controls:1.33%
cases:0.58%
controls:0.29%
cases:0.31%
controls:0.02%
—
—
cases:0.50%
controls:0.04%
cases:0.89%
controls:0.24%
cases:1.36%
controls:0.62%
21
296
2211
22024
13
65
2219
22255
7
5
2225
22315
—
11
8
2211
22241
19
51
2112
21427
21
98
1521
15755
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
-3.2e-03
2.7e-01
3.1e-01
—
2.4e+00
3.0e+00
1.2e+00
cases:4.39%
controls:4.40%
cases:2.46%
controls:1.89%
cases:0.36%
controls:0.26%
—
—
cases:2.75%
controls:0.26%
cases:26.65%
controls:1.72%
cases:11.02%
controls:3.72%
98
983
2134
21337
55
422
2177
21898
8
59
2224
22261
—
61
57
2161
22192
568
370
1563
21108
170
589
1372
15264
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
-1.7e-01
-4.2e-01
-1.0e+50
—
3.9e+00
1.8e+00
8.5e-01
cases:1.39%
controls:1.64%
cases:0.31%
controls:0.47%
cases:0.00%
controls:0.08%
—
—
cases:2.79%
controls:0.06%
cases:2.30%
controls:0.40%
cases:2.79%
controls:1.21%
31
367
2201
21953
7
106
2225
22214
0
18
2232
22302
—
62
13
2160
22236
49
85
2082
21393
43
192
1499
15661
Multiple adjuvant cytostatic therapy
WB113 [2001310629]
WB113 [2001310629]
2.1e-01
6.9e-02
-1.0e+50
—
—
4.6e+00
1.9e+00
cases:0.81%
controls:0.65%
cases:0.27%
controls:0.25%
cases:0.00%
controls:0.06%
—
—
—
—
cases:10.23%
controls:0.11%
cases:1.56%
controls:0.24%
18
146
2214
22174
6
56
2226
22264
0
13
2232
22307
—
—
218
24
1913
21454
24
38
1518
15815
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
-1.4e-01
9.7e-01
9.0e-01
3.3e+00
5.1e-01
4.0e-01
3.8e-01
cases:16.26%
controls:18.20%
cases:24.73%
controls:11.09%
cases:5.06%
controls:2.11%
cases:2.69%
controls:0.10%
cases:3.42%
controls:2.09%
cases:15.91%
controls:11.27%
cases:31.71%
controls:24.10%
363
4063
1869
18257
552
2476
1680
19844
113
472
2119
21848
60
23
2172
22297
76
464
2146
21785
339
2420
1792
19058
489
3820
1053
12033
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
-1.4e-01
9.7e-01
8.9e-01
3.2e+00
5.3e-01
4.2e-01
3.6e-01
cases:16.89%
controls:18.99%
cases:25.81%
controls:11.62%
cases:5.15%
controls:2.17%
cases:2.69%
controls:0.11%
cases:3.65%
controls:2.18%
cases:17.27%
controls:12.04%
cases:34.05%
controls:26.39%
377
4239
1855
18081
576
2594
1656
19726
115
485
2117
21835
60
24
2172
22296
81
484
2141
21765
368
2586
1763
18892
525
4184
1017
11669
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
-1.4e-01
9.8e-01
8.8e-01
3.2e+00
5.3e-01
4.3e-01
3.7e-01
cases:17.07%
controls:19.09%
cases:26.03%
controls:11.66%
cases:5.11%
controls:2.18%
cases:2.69%
controls:0.11%
cases:3.65%
controls:2.18%
cases:17.36%
controls:12.07%
cases:34.18%
controls:26.49%
381
4261
1851
18059
581
2603
1651
19717
114
486
2118
21834
60
24
2172
22296
81
486
2141
21763
370
2592
1761
18886
527
4199
1015
11654
Neoplasm of uncertain or unknown behaviour: Small intestine
D37.2 [45542697]
D37.2 [45542697]
—
2.9e+00
1.0e+50
1.0e+50
1.0e+50
3.5e+00
—
—
—
cases:0.72%
controls:0.04%
cases:1.25%
controls:0.00%
cases:0.99%
controls:0.00%
cases:0.86%
controls:0.00%
cases:0.80%
controls:0.02%
—
—
—
16
9
2216
22311
28
0
2204
22320
22
0
2210
22320
19
0
2203
22249
17
5
2114
21473
—
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
-1.4e-01
9.7e-01
9.1e-01
3.2e+00
4.8e-01
4.0e-01
3.8e-01
cases:16.13%
controls:18.12%
cases:24.73%
controls:11.07%
cases:5.11%
controls:2.11%
cases:2.69%
controls:0.11%
cases:3.33%
controls:2.09%
cases:16.00%
controls:11.28%
cases:31.84%
controls:24.23%
360
4044
1872
18276
552
2471
1680
19849
114
472
2118
21848
60
24
2172
22296
74
465
2148
21784
341
2423
1790
19055
491
3841
1051
12012
Malignant neoplasm colon/rectum
D75 [2002000373]
D75 [2002000373]
—
—
—
—
—
3.5e+00
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.04%
cases:2.27%
controls:0.13%
—
—
—
—
—
28
9
2103
21469
35
20
1507
15833
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
-1.6e-01
9.7e-01
8.7e-01
3.2e+00
5.3e-01
4.1e-01
3.4e-01
cases:17.25%
controls:19.72%
cases:26.52%
controls:12.05%
cases:5.20%
controls:2.24%
cases:2.69%
controls:0.11%
cases:3.74%
controls:2.24%
cases:17.64%
controls:12.43%
cases:34.37%
controls:27.09%
385
4401
1847
17919
592
2690
1640
19630
116
499
2116
21821
60
24
2172
22296
83
499
2139
21750
376
2669
1755
18809
530
4294
1012
11559
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
-1.3e-01
9.6e-01
8.9e-01
3.2e+00
5.0e-01
3.9e-01
3.8e-01
cases:16.40%
controls:18.29%
cases:24.64%
controls:11.10%
cases:5.06%
controls:2.15%
cases:2.69%
controls:0.11%
cases:3.42%
controls:2.11%
cases:15.91%
controls:11.32%
cases:31.71%
controls:24.11%
366
4082
1866
18238
550
2478
1682
19842
113
479
2119
21841
60
24
2172
22296
76
469
2146
21780
339
2431
1792
19047
489
3822
1053
12031
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
-2.0e-02
5.5e-01
8.5e-01
2.5e+00
1.9e+00
5.3e-01
2.1e-01
cases:10.30%
controls:10.49%
cases:9.95%
controls:5.98%
cases:2.06%
controls:0.89%
cases:0.54%
controls:0.04%
cases:5.63%
controls:0.86%
cases:9.95%
controls:6.13%
cases:20.04%
controls:16.90%
230
2341
2002
19979
222
1335
2010
20985
46
198
2186
22122
12
10
2220
22310
125
191
2097
22058
212
1317
1919
20161
309
2679
1233
13174
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
-3.5e-01
1.8e-01
1.3e+00
—
4.0e+00
1.0e+00
2.7e-01
cases:1.08%
controls:1.52%
cases:0.85%
controls:0.71%
cases:0.49%
controls:0.13%
—
—
cases:2.88%
controls:0.05%
cases:2.53%
controls:0.92%
cases:3.63%
controls:2.79%
24
339
2208
21981
19
159
2213
22161
11
30
2221
22290
—
64
12
2158
22237
54
197
2077
21281
56
443
1486
15410
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
-1.5e-01
9.6e-01
9.0e-01
3.2e+00
4.9e-01
3.7e-01
3.5e-01
cases:16.31%
controls:18.45%
cases:24.91%
controls:11.28%
cases:5.11%
controls:2.14%
cases:2.69%
controls:0.11%
cases:3.47%
controls:2.15%
cases:16.00%
controls:11.63%
cases:31.97%
controls:24.88%
364
4119
1868
18201
556
2517
1676
19803
114
478
2118
21842
60
24
2172
22296
77
478
2145
21771
341
2498
1790
18980
493
3944
1049
11909
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
-3.3e-02
2.6e-01
1.8e+00
—
1.9e+00
1.9e+00
7.2e-01
cases:8.47%
controls:8.73%
cases:4.21%
controls:3.29%
cases:2.55%
controls:0.42%
—
—
cases:2.66%
controls:0.43%
cases:17.83%
controls:3.12%
cases:17.25%
controls:9.23%
189
1948
2043
20372
94
735
2138
21585
57
93
2175
22227
—
59
95
2163
22154
380
671
1751
20807
266
1463
1276
14390
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.4e-02
5.1e-01
7.6e-01
2.7e+00
1.8e+00
5.0e-01
1.2e-01
cases:13.71%
controls:13.08%
cases:12.37%
controls:7.80%
cases:2.55%
controls:1.21%
cases:0.81%
controls:0.05%
cases:6.84%
controls:1.19%
cases:12.72%
controls:8.15%
cases:24.97%
controls:22.78%
306
2920
1926
19400
276
1742
1956
20578
57
269
2175
22051
18
12
2214
22308
152
264
2070
21985
271
1751
1860
19727
385
3611
1157
12242
Very extensive body CT
JN4CD [2001310902]
JN4CD [2001310902]
-2.4e-01
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:0.54%
controls:0.69%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:1.13%
controls:0.11%
cases:1.36%
controls:0.17%
12
153
2220
22167
24
39
2208
22281
—
—
—
24
24
2107
21454
21
27
1521
15826
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
-1.4e-01
9.6e-01
8.3e-01
3.2e+00
4.9e-01
4.2e-01
3.5e-01
cases:17.74%
controls:19.88%
cases:26.43%
controls:12.09%
cases:5.15%
controls:2.32%
cases:2.69%
controls:0.12%
cases:3.65%
controls:2.27%
cases:17.83%
controls:12.43%
cases:34.76%
controls:27.24%
396
4438
1836
17882
590
2699
1642
19621
115
518
2117
21802
60
26
2172
22294
81
505
2141
21744
380
2670
1751
18808
536
4319
1006
11534
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
-1.7e-02
5.7e-01
8.8e-01
2.3e+00
1.9e+00
5.2e-01
1.5e-01
cases:9.86%
controls:10.01%
cases:9.41%
controls:5.56%
cases:1.93%
controls:0.81%
cases:0.40%
controls:0.04%
cases:5.40%
controls:0.81%
cases:9.10%
controls:5.64%
cases:17.70%
controls:15.59%
220
2234
2012
20086
210
1241
2022
21079
43
181
2189
22139
9
9
2223
22311
120
181
2102
22068
194
1211
1937
20267
273
2472
1269
13381
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
-1.2e-01
5.3e-01
2.0e+00
1.0e+50
2.3e+00
1.2e+00
6.7e-01
cases:2.20%
controls:2.46%
cases:1.25%
controls:0.74%
cases:0.67%
controls:0.09%
cases:22.58%
controls:0.00%
cases:0.50%
controls:0.05%
cases:2.58%
controls:0.79%
cases:4.93%
controls:2.58%
49
550
2183
21770
28
165
2204
22155
15
20
2217
22300
504
0
1728
22320
11
11
2211
22238
55
169
2076
21309
76
409
1466
15444
Acute appendicitis with peritoneal abscess
K35.1 [45586713]
K35.1 [45586713]
—
3.7e+00
—
1.0e+50
—
2.4e+00
—
—
—
cases:0.94%
controls:0.02%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.38%
controls:0.03%
—
—
—
21
5
2211
22315
—
9
0
2223
22320
—
8
7
2123
21471
—
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
-1.5e-01
9.5e-01
9.0e-01
3.2e+00
4.8e-01
3.5e-01
3.3e-01
cases:15.99%
controls:18.05%
cases:24.33%
controls:11.06%
cases:5.02%
controls:2.11%
cases:2.51%
controls:0.11%
cases:3.29%
controls:2.05%
cases:15.49%
controls:11.41%
cases:30.80%
controls:24.29%
357
4028
1875
18292
543
2468
1689
19852
112
471
2120
21849
56
24
2176
22296
73
457
2149
21792
330
2450
1801
19028
475
3850
1067
12003
Dalteparin and tinzaparin (treatment for more than 6 months)
166 [2001600165]
166 [2001600165]
-1.0e+50
-1.0e+50
—
—
—
3.3e+00
2.9e+00
cases:0.00%
controls:0.06%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.61%
controls:0.02%
cases:1.10%
controls:0.06%
0
14
2232
22306
0
19
2232
22301
—
—
—
13
5
2118
21473
17
10
1525
15843
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
-5.6e-02
5.3e-01
8.0e-01
2.5e+00
1.8e+00
5.3e-01
2.3e-01
cases:8.47%
controls:8.91%
cases:6.36%
controls:3.85%
cases:1.08%
controls:0.49%
cases:0.27%
controls:0.02%
cases:3.02%
controls:0.51%
cases:5.77%
controls:3.47%
cases:10.77%
controls:8.71%
189
1989
2043
20331
142
859
2090
21461
24
109
2208
22211
6
5
2226
22315
67
114
2155
22135
123
746
2008
20732
166
1381
1376
14472
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
-1.1e-01
8.6e-01
9.5e-01
3.5e+00
4.1e-01
4.1e-01
4.3e-01
cases:11.56%
controls:12.71%
cases:17.03%
controls:7.97%
cases:3.85%
controls:1.52%
cases:2.64%
controls:0.09%
cases:2.39%
controls:1.60%
cases:11.54%
controls:7.95%
cases:23.41%
controls:16.57%
258
2837
1974
19483
380
1779
1852
20541
86
339
2146
21981
59
19
2173
22301
53
355
2169
21894
246
1707
1885
19771
361
2627
1181
13226
Medical Oncology
90 [38004507]
90 [38004507]
-1.5e-02
8.0e-02
2.4e-01
—
2.1e+00
2.6e+00
1.4e+00
cases:7.17%
controls:7.27%
cases:5.24%
controls:4.86%
cases:2.02%
controls:1.59%
—
—
cases:10.53%
controls:1.47%
cases:41.15%
controls:4.72%
cases:22.50%
controls:6.79%
160
1623
2072
20697
117
1084
2115
21236
45
354
2187
21966
—
234
327
1988
21922
877
1014
1254
20464
347
1077
1195
14776
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
-3.7e-01
6.8e-01
—
—
3.6e+00
1.3e+00
4.6e-01
cases:1.39%
controls:1.99%
cases:1.84%
controls:0.94%
—
—
—
—
cases:2.79%
controls:0.08%
cases:3.94%
controls:1.08%
cases:5.19%
controls:3.33%
31
444
2201
21876
41
209
2191
22111
—
—
62
17
2160
22232
84
233
2047
21245
80
528
1462
15325
Benign neoplasm: Appendix
D12.1 [45581281]
D12.1 [45581281]
—
—
—
1.0e+50
—
3.2e+00
2.9e+00
—
—
—
—
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.66%
controls:0.03%
cases:0.58%
controls:0.03%
—
—
—
10
0
2222
22320
—
14
6
2117
21472
9
5
1533
15848
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
-1.1e-01
6.9e-01
1.8e+00
—
2.5e+00
1.1e+00
3.1e-01
cases:1.25%
controls:1.39%
cases:1.43%
controls:0.73%
cases:0.63%
controls:0.11%
—
—
cases:1.44%
controls:0.12%
cases:2.53%
controls:0.85%
cases:3.89%
controls:2.88%
28
311
2204
22009
32
162
2200
22158
14
24
2218
22296
—
32
27
2190
22222
54
183
2077
21295
60
456
1482
15397
Hyperplasia of prostate
N40 [45563015]
N40 [45563015]
5.8e-02
2.6e-01
7.9e-01
4.3e+00
9.1e-01
2.7e-01
4.9e-02
cases:8.38%
controls:7.94%
cases:4.61%
controls:3.58%
cases:1.25%
controls:0.57%
cases:2.33%
controls:0.03%
cases:1.53%
controls:0.62%
cases:4.79%
controls:3.71%
cases:10.05%
controls:9.62%
187
1773
2045
20547
103
800
2129
21520
28
128
2204
22192
52
7
2180
22313
34
138
2188
22111
102
797
2029
20681
155
1525
1387
14328
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
-1.3e-01
2.3e+00
3.3e+00
—
—
4.0e-01
3.8e-01
cases:4.17%
controls:4.73%
cases:13.44%
controls:1.49%
cases:3.14%
controls:0.12%
—
—
—
—
cases:1.97%
controls:1.34%
cases:6.94%
controls:4.85%
93
1055
2139
21265
300
333
1932
21987
70
26
2162
22294
—
—
42
287
2089
21191
107
769
1435
15084
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
-3.0e-02
4.9e-01
9.6e-01
2.3e+00
1.8e+00
4.5e-01
1.4e-01
cases:13.84%
controls:14.20%
cases:11.78%
controls:7.57%
cases:2.73%
controls:1.06%
cases:0.58%
controls:0.06%
cases:6.39%
controls:1.11%
cases:11.45%
controls:7.59%
cases:23.02%
controls:20.56%
309
3170
1923
19150
263
1690
1969
20630
61
237
2171
22083
13
13
2219
22307
142
247
2080
22002
244
1631
1887
19847
355
3259
1187
12594
Capsular endoscopy
UJF92 [2001305032]
UJF92 [2001305032]
—
1.8e+00
—
—
—
2.5e+00
1.6e+00
—
—
cases:0.45%
controls:0.07%
—
—
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.91%
controls:0.18%
—
10
16
2222
22304
—
—
—
6
5
2125
21473
14
28
1528
15825
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
2.5e-01
9.1e-01
1.8e+00
—
2.6e+00
1.4e+00
1.0e+00
cases:1.70%
controls:1.33%
cases:0.94%
controls:0.38%
cases:0.27%
controls:0.04%
—
—
cases:0.72%
controls:0.05%
cases:1.31%
controls:0.32%
cases:1.62%
controls:0.57%
38
297
2194
22023
21
85
2211
22235
6
10
2226
22310
—
16
12
2206
22237
28
69
2103
21409
25
91
1517
15762
Malignant tumor of the sigmoid without histology
C18.70 [2000500562]
C18.70 [2000500562]
—
2.0e+00
2.2e+00
—
2.3e+00
1.6e+00
1.7e+00
—
—
cases:0.54%
controls:0.07%
cases:0.36%
controls:0.04%
—
—
cases:0.23%
controls:0.02%
cases:0.33%
controls:0.07%
cases:0.52%
controls:0.09%
—
12
16
2220
22304
8
9
2224
22311
—
5
5
2217
22244
7
14
2124
21464
8
15
1534
15838
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
-3.0e-01
8.2e-02
7.8e-01
4.4e+00
1.0e+00
-7.9e-02
-1.1e-01
cases:7.17%
controls:9.41%
cases:5.65%
controls:5.22%
cases:2.28%
controls:1.06%
cases:3.45%
controls:0.04%
cases:2.75%
controls:1.00%
cases:5.30%
controls:5.71%
cases:10.38%
controls:11.49%
160
2100
2072
20220
126
1166
2106
21154
51
236
2181
22084
77
10
2155
22310
61
222
2161
22027
113
1227
2018
20251
160
1822
1382
14031
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
4.3e-02
6.2e-01
1.3e+00
—
3.0e+00
9.8e-01
1.0e-01
cases:2.15%
controls:2.06%
cases:2.15%
controls:1.17%
cases:0.72%
controls:0.20%
—
—
cases:2.93%
controls:0.16%
cases:3.52%
controls:1.35%
cases:5.38%
controls:4.89%
48
460
2184
21860
48
262
2184
22058
16
44
2216
22276
—
65
35
2157
22214
75
290
2056
21188
83
776
1459
15077
Malignant tumor of the sigmoid invasive carcinoma
C18.71 [2000500563]
C18.71 [2000500563]
1.5e-01
8.6e-01
1.6e+00
—
1.6e+00
1.3e+00
1.4e+00
cases:0.31%
controls:0.27%
cases:0.54%
controls:0.23%
cases:0.49%
controls:0.10%
—
—
cases:0.41%
controls:0.09%
cases:0.94%
controls:0.27%
cases:1.30%
controls:0.31%
7
60
2225
22260
12
51
2220
22269
11
23
2221
22297
—
9
19
2213
22230
20
57
2111
21421
20
49
1522
15804
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-5.5e-02
1.4e+00
4.4e+00
—
9.4e-01
2.9e-01
-2.4e-01
cases:7.08%
controls:7.45%
cases:9.41%
controls:2.44%
cases:17.34%
controls:0.26%
—
—
cases:0.54%
controls:0.21%
cases:2.53%
controls:1.90%
cases:6.36%
controls:7.97%
158
1662
2074
20658
210
545
2022
21775
387
58
1845
22262
—
12
47
2210
22202
54
409
2077
21069
98
1264
1444
14589
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
-6.5e-01
3.6e-01
1.8e+00
—
1.7e+00
1.5e+00
7.6e-01
cases:0.40%
controls:0.77%
cases:0.63%
controls:0.44%
cases:0.58%
controls:0.09%
—
—
cases:0.45%
controls:0.08%
cases:1.69%
controls:0.39%
cases:2.01%
controls:0.95%
9
171
2223
22149
14
98
2218
22222
13
21
2219
22299
—
10
18
2212
22231
36
84
2095
21394
31
150
1511
15703
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
-2.1e-01
4.5e-01
1.9e+00
—
2.7e+00
7.5e-01
1.7e-01
cases:3.09%
controls:3.78%
cases:3.09%
controls:1.99%
cases:1.97%
controls:0.31%
—
—
cases:4.46%
controls:0.31%
cases:4.88%
controls:2.36%
cases:9.08%
controls:7.77%
69
843
2163
21477
69
444
2163
21876
44
69
2188
22251
—
99
70
2123
22179
104
506
2027
20972
140
1232
1402
14621
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
-1.2e-01
4.3e-01
9.1e-01
2.7e+00
1.4e+00
3.1e-01
4.0e-02
cases:14.34%
controls:15.92%
cases:11.20%
controls:7.62%
cases:2.51%
controls:1.02%
cases:0.67%
controls:0.04%
cases:4.37%
controls:1.15%
cases:10.93%
controls:8.26%
cases:23.41%
controls:22.70%
320
3553
1912
18767
250
1700
1982
20620
56
228
2176
22092
15
10
2217
22310
97
255
2125
21994
233
1775
1898
19703
361
3598
1181
12255
Neoplasm of uncertain or unknown behaviour: Appendix
D37.3 [45542698]
D37.3 [45542698]
—
2.9e+00
1.0e+50
1.0e+50
—
2.8e+00
1.7e+00
—
—
cases:0.40%
controls:0.02%
cases:0.58%
controls:0.00%
cases:0.67%
controls:0.00%
—
—
cases:0.38%
controls:0.02%
cases:0.32%
controls:0.06%
—
9
5
2223
22315
13
0
2219
22320
15
0
2217
22320
—
8
5
2123
21473
5
9
1537
15844
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
WD405 [2001310688]
3.0e-01
7.7e-01
—
—
—
2.8e+00
2.9e+00
cases:0.40%
controls:0.30%
cases:0.49%
controls:0.23%
—
—
—
—
—
—
cases:2.82%
controls:0.18%
cases:4.60%
controls:0.27%
9
67
2223
22253
11
51
2221
22269
—
—
—
60
38
2071
21440
71
43
1471
15810
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
-3.6e-02
1.1e-01
1.4e+00
—
3.4e+00
9.0e-01
3.0e-01
cases:1.25%
controls:1.30%
cases:0.72%
controls:0.64%
cases:0.54%
controls:0.13%
—
—
cases:2.43%
controls:0.09%
cases:2.02%
controls:0.83%
cases:3.63%
controls:2.73%
28
290
2204
22030
16
143
2216
22177
12
30
2220
22290
—
54
19
2168
22230
43
178
2088
21300
56
432
1486
15421
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
-2.1e-02
7.7e-02
9.2e-01
3.9e+00
7.6e-01
1.3e-01
7.1e-02
cases:7.12%
controls:7.26%
cases:4.88%
controls:4.54%
cases:2.06%
controls:0.83%
cases:2.20%
controls:0.04%
cases:1.85%
controls:0.87%
cases:5.11%
controls:4.53%
cases:9.66%
controls:9.06%
159
1621
2073
20699
109
1013
2123
21307
46
185
2186
22135
49
10
2183
22310
41
194
2181
22055
109
974
2022
20504
149
1437
1393
14416
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
UJF45 [2001305031]
1.2e-01
1.5e+00
1.9e+00
1.0e+50
—
1.1e+00
1.0e+00
cases:1.43%
controls:1.27%
cases:1.70%
controls:0.39%
cases:0.31%
controls:0.04%
cases:0.54%
controls:0.00%
—
—
cases:1.03%
controls:0.34%
cases:2.85%
controls:1.04%
32
283
2200
22037
38
88
2194
22232
7
10
2225
22310
12
0
2220
22320
—
22
72
2109
21406
44
165
1498
15688
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
WD125 [2001310680]
-5.7e-02
2.8e-01
—
—
7.0e-01
2.8e+00
2.8e+00
cases:0.54%
controls:0.57%
cases:0.54%
controls:0.41%
—
—
—
—
cases:0.27%
controls:0.13%
cases:5.54%
controls:0.34%
cases:5.97%
controls:0.40%
12
127
2220
22193
12
91
2220
22229
—
—
6
30
2216
22219
118
74
2013
21404
92
64
1450
15789
Benign neoplasm: Descending colon
D12.4 [45571597]
D12.4 [45571597]
2.4e-01
2.1e+00
1.0e+50
—
—
2.0e+00
1.5e+00
cases:0.31%
controls:0.25%
cases:0.99%
controls:0.13%
cases:1.08%
controls:0.00%
—
—
—
—
cases:0.47%
controls:0.07%
cases:1.43%
controls:0.32%
7
55
2225
22265
22
28
2210
22292
24
0
2208
22320
—
—
10
14
2121
21464
22
50
1520
15803
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
1.1e-01
5.6e-01
7.4e-01
2.4e+00
2.0e+00
5.7e-01
2.0e-01
cases:5.65%
controls:5.09%
cases:5.60%
controls:3.29%
cases:1.12%
controls:0.54%
cases:0.45%
controls:0.04%
cases:3.69%
controls:0.50%
cases:6.43%
controls:3.74%
cases:12.26%
controls:10.29%
126
1137
2106
21183
125
735
2107
21585
25
120
2207
22200
10
9
2222
22311
82
112
2140
22137
137
803
1994
20675
189
1631
1353
14222
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.5e-02
6.3e-01
1.2e+00
1.7e+00
1.2e+00
5.5e-01
2.7e-01
cases:61.60%
controls:61.24%
cases:62.72%
controls:47.27%
cases:23.52%
controls:8.46%
cases:2.02%
controls:0.36%
cases:22.55%
controls:8.31%
cases:62.65%
controls:49.25%
cases:84.37%
controls:80.53%
1375
13669
857
8651
1400
10551
832
11769
525
1888
1707
20432
45
80
2187
22240
501
1848
1721
20401
1335
10577
796
10901
1301
12767
241
3086
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
JN1CG [2001305527]
-3.5e-01
8.8e-01
—
—
—
3.6e+00
2.0e+00
cases:0.27%
controls:0.38%
cases:0.27%
controls:0.11%
—
—
—
—
—
—
cases:1.64%
controls:0.05%
cases:1.36%
controls:0.20%
6
85
2226
22235
6
25
2226
22295
—
—
—
35
10
2096
21468
21
31
1521
15822
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
-2.3e-01
1.3e-01
1.4e+00
—
3.3e+00
8.0e-01
2.2e-01
cases:2.20%
controls:2.74%
cases:1.48%
controls:1.30%
cases:0.67%
controls:0.17%
—
—
cases:4.19%
controls:0.16%
cases:3.33%
controls:1.52%
cases:6.23%
controls:5.05%
49
611
2183
21709
33
290
2199
22030
15
38
2217
22282
—
93
36
2129
22213
71
327
2060
21151
96
800
1446
15053
Metastasis to peritoneum
OMOP5031802 [35226253]
OMOP5031802 [35226253]
—
—
-1.0e+50
—
1.6e+00
2.7e+00
2.7e+00
—
—
—
—
cases:0.00%
controls:0.06%
—
—
cases:0.23%
controls:0.04%
cases:0.99%
controls:0.07%
cases:2.20%
controls:0.15%
—
—
0
14
2232
22306
—
5
10
2217
22239
21
15
2110
21463
34
23
1508
15830
Metastasis to retroperitoneum
OMOP5031838 [35226284]
OMOP5031838 [35226284]
—
—
-1.0e+50
—
1.6e+00
2.7e+00
2.7e+00
—
—
—
—
cases:0.00%
controls:0.06%
—
—
cases:0.23%
controls:0.04%
cases:0.99%
controls:0.07%
cases:2.20%
controls:0.15%
—
—
0
14
2232
22306
—
5
10
2217
22239
21
15
2110
21463
34
23
1508
15830
Secondary malignant neoplasm of retroperitoneum and peritoneum
C78.6 [45547522]
C78.6 [45547522]
—
—
-1.0e+50
—
1.6e+00
2.7e+00
2.7e+00
—
—
—
—
cases:0.00%
controls:0.06%
—
—
cases:0.23%
controls:0.04%
cases:0.99%
controls:0.07%
cases:2.20%
controls:0.15%
—
—
0
14
2232
22306
—
5
10
2217
22239
21
15
2110
21463
34
23
1508
15830
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
WD415 [2001310689]
2.2e-01
8.0e-01
—
—
—
2.8e+00
2.6e+00
cases:0.27%
controls:0.22%
cases:0.27%
controls:0.12%
—
—
—
—
—
—
cases:1.31%
controls:0.08%
cases:1.62%
controls:0.13%
6
48
2226
22272
6
27
2226
22293
—
—
—
28
17
2103
21461
25
20
1517
15833
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
-2.2e-01
5.7e-02
1.2e+00
—
3.4e+00
8.0e-01
2.2e-01
cases:2.46%
controls:3.05%
cases:1.48%
controls:1.40%
cases:0.67%
controls:0.21%
—
—
cases:4.50%
controls:0.16%
cases:3.57%
controls:1.63%
cases:6.49%
controls:5.26%
55
681
2177
21639
33
312
2199
22008
15
46
2217
22274
—
100
35
2122
22214
76
350
2055
21128
100
834
1442
15019
Malignant tumor of the ascending colon without histology
C18.20 [2000500542]
C18.20 [2000500542]
—
—
1.0e+50
1.0e+50
—
—
5.3e+00
—
—
—
—
cases:16.85%
controls:0.00%
cases:10.80%
controls:0.00%
—
—
—
—
cases:7.00%
controls:0.04%
—
—
376
0
1856
22320
241
0
1991
22320
—
—
108
6
1434
15847
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
-5.2e-02
5.0e-01
7.2e-01
2.3e+00
2.0e+00
5.0e-01
8.0e-02
cases:4.61%
controls:4.85%
cases:5.42%
controls:3.35%
cases:1.12%
controls:0.55%
cases:0.36%
controls:0.04%
cases:3.60%
controls:0.52%
cases:6.34%
controls:3.96%
cases:12.45%
controls:11.61%
103
1082
2129
21238
121
748
2111
21572
25
122
2207
22198
8
8
2224
22312
80
116
2142
22133
135
850
1996
20628
192
1840
1350
14013
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
-2.5e-01
5.4e-02
8.4e-01
3.6e+00
8.4e-01
-1.1e-01
1.5e-01
cases:2.78%
controls:3.55%
cases:2.20%
controls:2.08%
cases:0.90%
controls:0.39%
cases:0.81%
controls:0.02%
cases:0.90%
controls:0.39%
cases:2.25%
controls:2.51%
cases:6.94%
controls:6.05%
62
793
2170
21527
49
465
2183
21855
20
87
2212
22233
18
5
2214
22315
20
87
2202
22162
48
540
2083
20938
107
959
1435
14894
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
-3.2e-01
8.1e-01
2.4e+00
1.0e+50
1.3e+00
1.8e+00
1.0e+00
cases:1.03%
controls:1.41%
cases:0.85%
controls:0.38%
cases:0.45%
controls:0.04%
cases:0.22%
controls:0.00%
cases:0.27%
controls:0.08%
cases:2.16%
controls:0.36%
cases:3.11%
controls:1.16%
23
314
2209
22006
19
85
2213
22235
10
9
2222
22311
5
0
2227
22320
6
17
2216
22232
46
77
2085
21401
48
184
1494
15669
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
-6.7e-01
-4.3e-01
-1.0e+50
—
2.1e+00
2.1e+00
1.0e+00
cases:0.54%
controls:1.04%
cases:0.40%
controls:0.62%
cases:0.00%
controls:0.11%
—
—
cases:0.72%
controls:0.09%
cases:4.97%
controls:0.61%
cases:3.83%
controls:1.43%
12
233
2220
22087
9
138
2223
22182
0
25
2232
22295
—
16
20
2206
22229
106
132
2025
21346
59
227
1483
15626
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
-1.1e-01
3.6e-01
7.7e-01
2.0e+00
1.7e+00
3.7e-01
8.3e-02
cases:28.18%
controls:30.53%
cases:21.42%
controls:15.96%
cases:4.79%
controls:2.28%
cases:0.90%
controls:0.12%
cases:11.70%
controls:2.42%
cases:21.45%
controls:15.80%
cases:39.75%
controls:37.77%
629
6814
1603
15506
478
3562
1754
18758
107
509
2125
21811
20
26
2212
22294
260
538
1962
21711
457
3394
1674
18084
613
5988
929
9865
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
19176-7 [3015916]
-4.9e-02
1.3e+00
—
—
—
2.3e+00
1.6e+00
cases:0.36%
controls:0.38%
cases:0.67%
controls:0.19%
—
—
—
—
—
—
cases:2.16%
controls:0.21%
cases:2.20%
controls:0.44%
8
84
2224
22236
15
43
2217
22277
—
—
—
46
46
2085
21432
34
69
1508
15784
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
-2.7e-01
-2.9e-02
1.3e+00
—
3.2e+00
7.4e-01
1.7e-01
cases:2.69%
controls:3.49%
cases:1.57%
controls:1.61%
cases:0.81%
controls:0.22%
—
—
cases:4.46%
controls:0.19%
cases:3.75%
controls:1.83%
cases:6.74%
controls:5.75%
60
779
2172
21541
35
360
2197
21960
18
50
2214
22270
—
99
43
2123
22206
80
394
2051
21084
104
912
1438
14941
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
-8.9e-02
8.4e-01
1.5e+00
1.0e+50
2.0e+00
8.4e-01
2.0e-01
cases:2.33%
controls:2.54%
cases:2.11%
controls:0.92%
cases:0.54%
controls:0.12%
cases:0.81%
controls:0.00%
cases:0.81%
controls:0.11%
cases:2.30%
controls:1.01%
cases:3.89%
controls:3.22%
52
567
2180
21753
47
205
2185
22115
12
26
2220
22294
18
0
2214
22320
18
25
2204
22224
49
216
2082
21262
60
511
1482
15342
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
C79.8 [45547524]
—
-1.3e-01
—
—
1.2e+00
1.9e+00
2.1e+00
—
—
cases:0.31%
controls:0.36%
—
—
—
—
cases:0.59%
controls:0.18%
cases:2.91%
controls:0.43%
cases:5.12%
controls:0.69%
—
7
80
2225
22240
—
—
13
39
2209
22210
62
93
2069
21385
79
109
1463
15744
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
-2.8e-01
-1.4e-02
1.3e+00
—
3.2e+00
6.7e-01
1.7e-01
cases:2.69%
controls:3.51%
cases:1.57%
controls:1.59%
cases:0.76%
controls:0.22%
—
—
cases:4.59%
controls:0.19%
cases:3.57%
controls:1.85%
cases:6.68%
controls:5.69%
60
784
2172
21536
35
355
2197
21965
17
48
2215
22272
—
102
42
2120
22207
76
397
2055
21081
103
902
1439
14951
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
-2.6e-01
-4.7e-02
1.3e+00
—
3.2e+00
7.0e-01
1.9e-01
cases:2.73%
controls:3.50%
cases:1.52%
controls:1.59%
cases:0.81%
controls:0.22%
—
—
cases:4.41%
controls:0.19%
cases:3.66%
controls:1.85%
cases:6.81%
controls:5.70%
61
781
2171
21539
34
356
2198
21964
18
50
2214
22270
—
98
42
2124
22207
78
398
2053
21080
105
904
1437
14949
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
-2.6e-01
-5.2e-02
1.3e+00
—
3.2e+00
7.0e-01
1.9e-01
cases:2.73%
controls:3.50%
cases:1.52%
controls:1.60%
cases:0.81%
controls:0.22%
—
—
cases:4.41%
controls:0.19%
cases:3.66%
controls:1.86%
cases:6.81%
controls:5.70%
61
782
2171
21538
34
358
2198
21962
18
50
2214
22270
—
98
43
2124
22206
78
399
2053
21079
105
903
1437
14950
Metastasis
OMOP4998856 [36769180]
OMOP4998856 [36769180]
—
-1.3e-01
—
—
1.2e+00
1.9e+00
2.0e+00
—
—
cases:0.31%
controls:0.36%
—
—
—
—
cases:0.59%
controls:0.18%
cases:2.91%
controls:0.44%
cases:5.19%
controls:0.73%
—
7
80
2225
22240
—
—
13
39
2209
22210
62
94
2069
21384
80
115
1462
15738
Ileostomy status
Z93.2 [45542492]
Z93.2 [45542492]
-1.0e+50
-1.0e+50
—
—
—
2.9e+00
2.2e+00
cases:0.00%
controls:0.05%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.70%
controls:0.04%
cases:0.39%
controls:0.04%
0
11
2232
22309
0
7
2232
22313
—
—
—
15
8
2116
21470
6
7
1536
15846
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
OMOP4822000 [32411]
-9.1e-03
—
—
—
-1.0e+50
3.0e+00
2.1e+00
cases:0.49%
controls:0.50%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:2.96%
controls:0.15%
cases:3.57%
controls:0.45%
11
111
2221
22209
—
—
—
0
6
2222
22243
63
32
2068
21446
55
71
1487
15782
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
-2.3e-01
1.4e+00
2.0e+00
—
—
9.6e-01
7.3e-01
cases:1.66%
controls:2.07%
cases:2.46%
controls:0.60%
cases:0.67%
controls:0.09%
—
—
—
—
cases:1.60%
controls:0.62%
cases:4.99%
controls:2.47%
37
462
2195
21858
55
133
2177
22187
15
21
2217
22299
—
—
34
133
2097
21345
77
392
1465
15461
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
-4.4e-01
-2.4e-01
—
1.0e+50
1.9e+00
2.2e+00
9.3e-01
cases:0.63%
controls:0.97%
cases:0.27%
controls:0.34%
—
—
cases:1.12%
controls:0.00%
cases:0.32%
controls:0.04%
cases:2.16%
controls:0.25%
cases:2.14%
controls:0.86%
14
216
2218
22104
6
76
2226
22244
—
25
0
2207
22320
7
10
2215
22239
46
54
2085
21424
33
136
1509
15717
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
-6.1e-01
2.0e-01
1.8e+00
1.0e+50
3.3e+00
7.3e-01
7.8e-02
cases:0.58%
controls:1.06%
cases:0.49%
controls:0.40%
cases:0.31%
controls:0.05%
cases:2.60%
controls:0.00%
cases:0.95%
controls:0.04%
cases:1.08%
controls:0.52%
cases:1.49%
controls:1.38%
13
237
2219
22083
11
90
2221
22230
7
12
2225
22308
58
0
2174
22320
21
8
2201
22241
23
112
2108
21366
23
219
1519
15634
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
-1.2e-01
8.4e-01
1.2e+00
1.0e+50
1.7e+00
1.3e+00
1.1e+00
cases:5.73%
controls:6.40%
cases:2.87%
controls:1.25%
cases:0.31%
controls:0.10%
cases:21.91%
controls:0.00%
cases:0.54%
controls:0.09%
cases:2.86%
controls:0.79%
cases:4.99%
controls:1.67%
128
1429
2104
20891
64
280
2168
22040
7
22
2225
22298
489
0
1743
22320
12
21
2210
22228
61
169
2070
21309
77
264
1465
15589
Genetic counselling
Z31.5 [45590715]
Z31.5 [45590715]
6.9e-02
—
—
—
-1.0e+50
2.7e+00
2.4e+00
cases:0.40%
controls:0.38%
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:2.02%
controls:0.14%
cases:3.63%
controls:0.35%
9
84
2223
22236
—
—
—
0
9
2222
22240
43
31
2088
21447
56
56
1486
15797
Intravenous administration of medicine
SPAT1255 [2001700356]
SPAT1255 [2001700356]
1.6e-01
1.2e+00
3.0e+00
—
—
8.0e-01
2.2e-01
cases:1.52%
controls:1.29%
cases:1.43%
controls:0.43%
cases:1.12%
controls:0.06%
—
—
—
—
cases:1.03%
controls:0.47%
cases:1.75%
controls:1.41%
34
289
2198
22031
32
96
2200
22224
25
13
2207
22307
—
—
22
100
2109
21378
27
224
1515
15629
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
8.4e-02
1.4e+00
2.2e+00
—
—
1.4e+00
8.1e-01
cases:0.45%
controls:0.41%
cases:1.08%
controls:0.27%
cases:0.36%
controls:0.04%
—
—
—
—
cases:0.84%
controls:0.21%
cases:1.36%
controls:0.61%
10
92
2222
22228
24
61
2208
22259
8
9
2224
22311
—
—
18
46
2113
21432
21
97
1521
15756
Counselling and guidance which enhance independent living
R2130 [2001310196]
R2130 [2001310196]
8.7e-03
3.4e-01
3.6e+00
—
1.9e+00
1.3e+00
3.8e-01
cases:1.57%
controls:1.55%
cases:0.81%
controls:0.58%
cases:2.24%
controls:0.06%
—
—
cases:0.27%
controls:0.04%
cases:1.92%
controls:0.52%
cases:2.27%
controls:1.57%
35
347
2197
21973
18
129
2214
22191
50
14
2182
22306
—
6
9
2216
22240
41
112
2090
21366
35
249
1507
15604
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
3.4e-01
5.5e-01
2.8e+00
1.0e+50
—
1.1e+00
9.6e-01
cases:3.94%
controls:2.83%
cases:0.81%
controls:0.47%
cases:0.99%
controls:0.06%
cases:4.03%
controls:0.00%
—
—
cases:1.17%
controls:0.40%
cases:2.20%
controls:0.86%
88
631
2144
21689
18
104
2214
22216
22
13
2210
22307
90
0
2142
22320
—
25
86
2106
21392
34
136
1508
15717
Malignant neoplasm of prostate
C61 [45547509]
C61 [45547509]
5.6e-02
1.0e-01
7.0e-01
3.4e+00
7.9e-01
3.2e-01
2.8e-01
cases:4.30%
controls:4.08%
cases:3.58%
controls:3.24%
cases:1.84%
controls:0.92%
cases:2.06%
controls:0.07%
cases:1.98%
controls:0.91%
cases:4.55%
controls:3.36%
cases:6.10%
controls:4.67%
96
910
2136
21410
80
724
2152
21596
41
206
2191
22114
46
16
2186
22304
44
203
2178
22046
97
721
2034
20757
94
741
1448
15112
Demanding adjuvant cytostatic therapy
WB123 [2001310631]
WB123 [2001310631]
—
—
—
—
—
4.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.02%
—
—
—
—
—
—
—
61
5
2070
21473
—
Implantation of vascular injection port
TPX10 [2001309608]
TPX10 [2001309608]
—
1.5e+00
—
—
—
2.7e+00
2.2e+00
—
—
cases:0.36%
controls:0.08%
—
—
—
—
—
—
cases:1.55%
controls:0.11%
cases:2.08%
controls:0.25%
—
8
18
2224
22302
—
—
—
33
23
2098
21455
32
39
1510
15814
Body temperature
8310-5 [3020891]
8310-5 [3020891]
-2.5e-01
6.7e-03
2.1e+00
—
2.7e+00
1.4e-01
1.5e-01
cases:1.03%
controls:1.32%
cases:0.67%
controls:0.67%
cases:0.40%
controls:0.05%
—
—
cases:1.62%
controls:0.11%
cases:0.94%
controls:0.81%
cases:2.92%
controls:2.51%
23
295
2209
22025
15
149
2217
22171
9
11
2223
22309
—
36
24
2186
22225
20
175
2111
21303
45
398
1497
15455
Malignant digestive neopl other/NOS
D77 [2002000375]
D77 [2002000375]
-1.0e+50
-1.0e+50
—
—
—
2.6e+00
2.2e+00
cases:0.00%
controls:0.06%
cases:0.00%
controls:0.04%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:0.39%
controls:0.04%
0
13
2232
22307
0
10
2232
22310
—
—
—
11
8
2120
21470
6
7
1536
15846
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
-1.4e-01
7.6e-01
2.5e+00
1.0e+50
9.4e-01
9.4e-01
5.6e-01
cases:4.57%
controls:5.21%
cases:4.17%
controls:1.99%
cases:2.51%
controls:0.20%
cases:8.38%
controls:0.00%
cases:0.54%
controls:0.21%
cases:4.69%
controls:1.89%
cases:9.14%
controls:5.46%
102
1163
2130
21157
93
444
2139
21876
56
45
2176
22275
187
0
2045
22320
12
47
2210
22202
100
405
2031
21073
141
865
1401
14988
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
7900-4 [3017895]
-4.3e-01
2.0e+00
2.8e+00
—
—
2.1e-01
-2.2e-01
cases:0.72%
controls:1.09%
cases:2.11%
controls:0.29%
cases:0.36%
controls:0.02%
—
—
—
—
cases:0.33%
controls:0.27%
cases:0.84%
controls:1.05%
16
244
2216
22076
47
65
2185
22255
8
5
2224
22315
—
—
7
57
2124
21421
13
167
1529
15686
PET-CT of receptors in whole body
JN5ER [2001300741]
JN5ER [2001300741]
—
—
—
—
—
2.6e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.71%
controls:0.08%
—
—
—
—
—
8
6
2123
21472
11
13
1531
15840
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
5.2e-02
5.5e-01
2.9e+00
—
1.1e+00
7.6e-01
5.2e-01
cases:2.82%
controls:2.68%
cases:2.06%
controls:1.20%
cases:2.87%
controls:0.16%
—
—
cases:0.45%
controls:0.15%
cases:2.63%
controls:1.25%
cases:5.58%
controls:3.41%
63
599
2169
21721
46
267
2186
22053
64
35
2168
22285
—
10
34
2212
22215
56
268
2075
21210
86
540
1456
15313
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
-3.5e-01
3.6e-01
2.3e+00
—
2.4e+00
9.1e-01
7.4e-01
cases:0.58%
controls:0.82%
cases:0.49%
controls:0.34%
cases:0.31%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:0.70%
controls:0.28%
cases:1.10%
controls:0.53%
13
184
2219
22136
11
77
2221
22243
7
7
2225
22313
—
10
9
2212
22240
15
61
2116
21417
17
84
1525
15769
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
-3.6e-01
3.5e-01
2.3e+00
—
2.4e+00
8.8e-01
7.4e-01
cases:0.58%
controls:0.83%
cases:0.49%
controls:0.35%
cases:0.31%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:0.70%
controls:0.29%
cases:1.10%
controls:0.53%
13
186
2219
22134
11
78
2221
22242
7
7
2225
22313
—
10
9
2212
22240
15
63
2116
21415
17
84
1525
15769
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
-3.5e-01
3.6e-01
2.3e+00
—
2.4e+00
9.1e-01
7.4e-01
cases:0.58%
controls:0.82%
cases:0.49%
controls:0.34%
cases:0.31%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:0.70%
controls:0.28%
cases:1.10%
controls:0.53%
13
184
2219
22136
11
77
2221
22243
7
7
2225
22313
—
10
9
2212
22240
15
61
2116
21417
17
84
1525
15769
Other iron deficiency anaemias
D50.8 [45571629]
D50.8 [45571629]
5.1e-01
3.1e+00
—
1.0e+50
—
1.6e+00
6.3e-01
cases:0.27%
controls:0.16%
cases:1.39%
controls:0.06%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.47%
controls:0.10%
cases:0.52%
controls:0.28%
6
36
2226
22284
31
14
2201
22306
—
5
0
2227
22320
—
10
21
2121
21457
8
44
1534
15809
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
-2.1e-01
2.6e-01
-4.2e-01
-1.0e+50
2.7e+00
1.5e+00
4.7e-01
cases:6.00%
controls:7.29%
cases:4.35%
controls:3.38%
cases:0.31%
controls:0.47%
cases:0.00%
controls:0.03%
cases:6.30%
controls:0.46%
cases:15.30%
controls:3.75%
cases:16.41%
controls:10.96%
134
1627
2098
20693
97
754
2135
21566
7
106
2225
22214
0
6
2232
22314
140
102
2082
22147
326
805
1805
20673
253
1737
1289
14116
palonosetron, combinations
A04AA55 [45893275]
A04AA55 [45893275]
-1.3e-01
7.2e-01
—
—
—
3.0e+00
1.6e+00
cases:0.31%
controls:0.36%
cases:0.36%
controls:0.17%
—
—
—
—
—
—
cases:2.53%
controls:0.13%
cases:1.56%
controls:0.31%
7
80
2225
22240
8
39
2224
22281
—
—
—
54
27
2077
21451
24
49
1518
15804
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
-2.6e-01
4.1e-01
1.6e+00
—
1.4e+00
1.2e+00
5.3e-01
cases:2.87%
controls:3.67%
cases:2.91%
controls:1.94%
cases:1.03%
controls:0.22%
—
—
cases:0.81%
controls:0.20%
cases:5.58%
controls:1.83%
cases:10.12%
controls:6.24%
64
820
2168
21500
65
434
2167
21886
23
49
2209
22271
—
18
44
2204
22205
119
394
2012
21084
156
989
1386
14864
Active surveillance of a diagnosed cancer
XZZ00 [2001311159]
XZZ00 [2001311159]
-9.6e-02
—
—
—
—
2.5e+00
2.1e+00
cases:0.27%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.12%
cases:3.05%
controls:0.38%
6
66
2226
22254
—
—
—
—
31
25
2100
21453
47
61
1495
15792
octreotide; parenteral
H01CB02 [21602716]
H01CB02 [21602716]
-1.0e+50
—
—
—
—
2.0e+00
2.7e+00
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
cases:0.71%
controls:0.05%
0
18
2232
22302
—
—
—
—
10
14
2121
21464
11
8
1531
15845
Preparatory care for subsequent treatment, not elsewhere classified
Z51.4 [45542437]
Z51.4 [45542437]
—
2.7e+00
1.0e+50
—
—
-1.0e+50
1.9e+00
—
—
cases:0.40%
controls:0.03%
cases:0.94%
controls:0.00%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.84%
controls:0.13%
—
9
6
2223
22314
21
0
2211
22320
—
—
0
10
2131
21468
13
20
1529
15833
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
-1.3e-02
4.9e-01
6.3e-01
2.5e+00
1.6e+00
2.6e-01
1.2e-01
cases:7.53%
controls:7.62%
cases:6.27%
controls:3.92%
cases:0.99%
controls:0.53%
cases:0.31%
controls:0.03%
cases:2.57%
controls:0.50%
cases:5.11%
controls:3.98%
cases:12.78%
controls:11.46%
168
1701
2064
20619
140
875
2092
21445
22
118
2210
22202
7
6
2225
22314
57
112
2165
22137
109
855
2022
20623
197
1817
1345
14036
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
9.0e-02
4.2e-01
1.2e+00
9.4e-01
1.3e+00
7.4e-01
4.6e-01
cases:90.77%
controls:89.99%
cases:89.25%
controls:84.44%
cases:66.53%
controls:37.91%
cases:6.50%
controls:2.65%
cases:69.17%
controls:37.76%
cases:93.10%
controls:86.52%
cases:98.38%
controls:97.46%
2026
20086
206
2234
1992
18847
240
3473
1485
8461
747
13859
145
592
2087
21728
1537
8402
685
13847
1984
18582
147
2896
1517
15450
25
403
Major dressing of wound of skin of trunk
QBB10 [2001309842]
QBB10 [2001309842]
-7.0e-01
—
—
—
2.9e+00
1.7e+00
6.8e-01
cases:0.27%
controls:0.54%
—
—
—
—
—
—
cases:0.63%
controls:0.04%
cases:0.80%
controls:0.14%
cases:0.65%
controls:0.33%
6
120
2226
22200
—
—
—
14
8
2208
22241
17
31
2114
21447
10
52
1532
15801
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
-2.1e-02
-2.3e-01
—
—
1.4e+00
2.4e+00
7.9e-01
cases:3.45%
controls:3.52%
cases:1.39%
controls:1.73%
—
—
—
—
cases:0.86%
controls:0.22%
cases:16.28%
controls:1.70%
cases:10.70%
controls:5.15%
77
786
2155
21534
31
387
2201
21933
—
—
19
49
2203
22200
347
365
1784
21113
165
816
1377
15037
lanreotide; parenteral
H01CB03 [21602717]
H01CB03 [21602717]
-1.0e+50
-1.0e+50
—
—
—
2.2e+00
2.4e+00
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.80%
controls:0.09%
cases:0.91%
controls:0.08%
0
21
2232
22299
0
22
2232
22298
—
—
—
17
20
2114
21458
14
13
1528
15840
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.7e-02
7.6e-01
2.2e+00
—
-1.0e+50
8.7e-01
7.6e-01
cases:3.63%
controls:3.57%
cases:2.15%
controls:1.01%
cases:0.90%
controls:0.10%
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.72%
cases:4.80%
controls:2.30%
81
797
2151
21523
48
226
2184
22094
20
23
2212
22297
—
0
17
2222
22232
36
154
2095
21324
74
365
1468
15488
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.7e-02
7.6e-01
2.2e+00
—
-1.0e+50
8.7e-01
7.6e-01
cases:3.63%
controls:3.57%
cases:2.15%
controls:1.01%
cases:0.90%
controls:0.10%
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.72%
cases:4.80%
controls:2.30%
81
797
2151
21523
48
226
2184
22094
20
23
2212
22297
—
0
17
2222
22232
36
154
2095
21324
74
365
1468
15488
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.7e-02
7.6e-01
2.2e+00
—
-1.0e+50
8.7e-01
7.6e-01
cases:3.63%
controls:3.57%
cases:2.15%
controls:1.01%
cases:0.90%
controls:0.10%
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.72%
cases:4.80%
controls:2.30%
81
797
2151
21523
48
226
2184
22094
20
23
2212
22297
—
0
17
2222
22232
36
154
2095
21324
74
365
1468
15488
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.7e-02
7.6e-01
2.2e+00
—
-1.0e+50
8.7e-01
7.6e-01
cases:3.63%
controls:3.57%
cases:2.15%
controls:1.01%
cases:0.90%
controls:0.10%
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.72%
cases:4.80%
controls:2.30%
81
797
2151
21523
48
226
2184
22094
20
23
2212
22297
—
0
17
2222
22232
36
154
2095
21324
74
365
1468
15488
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.7e-02
7.6e-01
2.2e+00
—
-1.0e+50
8.7e-01
7.6e-01
cases:3.63%
controls:3.57%
cases:2.15%
controls:1.01%
cases:0.90%
controls:0.10%
—
—
cases:0.00%
controls:0.08%
cases:1.69%
controls:0.72%
cases:4.80%
controls:2.30%
81
797
2151
21523
48
226
2184
22094
20
23
2212
22297
—
0
17
2222
22232
36
154
2095
21324
74
365
1468
15488
Neutrophils [#/volume] in Blood
26499-4 [3017732]
26499-4 [3017732]
-1.1e-01
9.7e-01
1.6e+00
—
1.4e+00
6.1e-01
1.8e-01
cases:1.79%
controls:1.99%
cases:3.45%
controls:1.33%
cases:0.94%
controls:0.20%
—
—
cases:0.90%
controls:0.22%
cases:3.00%
controls:1.65%
cases:7.13%
controls:6.03%
40
445
2192
21875
77
297
2155
22023
21
44
2211
22276
—
20
50
2202
22199
64
354
2067
21124
110
956
1432
14897
Nutritional therapy
R4190 [2001310243]
R4190 [2001310243]
2.9e-01
8.4e-02
1.8e+00
—
—
1.9e+00
8.6e-01
cases:0.45%
controls:0.34%
cases:0.22%
controls:0.21%
cases:0.31%
controls:0.05%
—
—
—
—
cases:1.41%
controls:0.21%
cases:1.30%
controls:0.56%
10
75
2222
22245
5
46
2227
22274
7
12
2225
22308
—
—
30
45
2101
21433
20
88
1522
15765
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
-2.4e-01
-1.1e-01
5.6e-01
-1.0e+50
3.8e+00
6.9e-01
3.0e-01
cases:3.27%
controls:4.11%
cases:1.57%
controls:1.74%
cases:0.63%
controls:0.36%
cases:0.00%
controls:0.03%
cases:11.25%
controls:0.27%
cases:4.08%
controls:2.10%
cases:8.63%
controls:6.54%
73
917
2159
21403
35
389
2197
21931
14
80
2218
22240
0
7
2232
22313
250
61
1972
22188
87
450
2044
21028
133
1037
1409
14816
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
-3.3e-01
5.1e-01
1.7e+00
1.0e+50
2.9e+00
1.6e+00
5.8e-01
cases:0.49%
controls:0.69%
cases:0.45%
controls:0.27%
cases:0.27%
controls:0.05%
cases:0.27%
controls:0.00%
cases:0.50%
controls:0.03%
cases:1.36%
controls:0.29%
cases:1.82%
controls:1.02%
11
153
2221
22167
10
60
2222
22260
6
11
2226
22309
6
0
2226
22320
11
6
2211
22243
29
62
2102
21416
28
162
1514
15691
Adenocarcinoma, NOS, of colon, NOS
8140/3-C18.9 [44502464]
8140/3-C18.9 [44502464]
-1.0e+50
4.5e+00
1.0e+50
1.0e+50
—
—
—
cases:0.00%
controls:0.04%
cases:3.41%
controls:0.04%
cases:2.87%
controls:0.00%
cases:1.79%
controls:0.00%
—
—
—
—
—
—
0
10
2232
22310
76
9
2156
22311
64
0
2168
22320
40
0
2192
22320
—
—
—
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
-4.0e-01
2.2e-01
—
—
3.3e+00
1.1e+00
1.9e-01
cases:1.16%
controls:1.72%
cases:0.49%
controls:0.39%
—
—
—
—
cases:1.08%
controls:0.04%
cases:1.08%
controls:0.34%
cases:1.69%
controls:1.39%
26
384
2206
21936
11
88
2221
22232
—
—
24
9
2198
22240
23
74
2108
21404
26
221
1516
15632
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
-5.3e-01
6.5e-01
1.5e+00
—
2.7e+00
1.7e+00
5.5e-01
cases:0.45%
controls:0.76%
cases:0.54%
controls:0.28%
cases:0.22%
controls:0.05%
—
—
cases:0.41%
controls:0.03%
cases:1.22%
controls:0.22%
cases:1.43%
controls:0.83%
10
170
2222
22150
12
63
2220
22257
5
11
2227
22309
—
9
6
2213
22243
26
47
2105
21431
22
131
1520
15722
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
Y83.9 [45547252]
-8.4e-01
—
-1.0e+50
—
3.1e+00
1.3e+00
8.7e-01
cases:0.22%
controls:0.52%
—
—
cases:0.00%
controls:0.04%
—
—
cases:0.72%
controls:0.03%
cases:0.56%
controls:0.15%
cases:1.10%
controls:0.47%
5
116
2227
22204
—
0
8
2232
22312
—
16
7
2206
22242
12
33
2119
21445
17
74
1525
15779
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
C77.2 [45576338]
C77.2 [45576338]
-1.0e+50
-1.0e+50
—
—
—
2.5e+00
1.9e+00
cases:0.00%
controls:0.04%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.45%
controls:0.07%
0
10
2232
22310
0
7
2232
22313
—
—
—
10
8
2121
21470
7
11
1535
15842
Other specified anaemias
D64.8 [45595771]
D64.8 [45595771]
3.1e-01
2.9e+00
—
1.0e+50
—
1.5e+00
8.6e-01
cases:0.27%
controls:0.20%
cases:1.25%
controls:0.07%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.52%
controls:0.11%
cases:0.84%
controls:0.36%
6
44
2226
22276
28
16
2204
22304
—
5
0
2227
22320
—
11
24
2120
21454
13
57
1529
15796
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
WD105 [2001310678]
-5.9e-02
—
—
—
—
2.0e+00
2.4e+00
cases:0.45%
controls:0.47%
—
—
—
—
—
—
—
—
cases:2.63%
controls:0.35%
cases:4.93%
controls:0.49%
10
106
2222
22214
—
—
—
—
56
76
2075
21402
76
77
1466
15776
Family history of malignant neoplasm of digestive organs
Z80.0 [45542462]
Z80.0 [45542462]
—
—
—
—
—
2.3e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:0.78%
controls:0.10%
—
—
—
—
—
12
12
2119
21466
12
16
1530
15837
Malignant neoplasm: Caecum
C18.0 [45542586]
C18.0 [45542586]
—
1.0e+50
1.0e+50
—
1.0e+50
1.0e+50
4.4e+00
—
—
cases:0.27%
controls:0.00%
cases:0.76%
controls:0.00%
—
—
cases:1.85%
controls:0.00%
cases:6.76%
controls:0.00%
cases:2.85%
controls:0.04%
—
6
0
2226
22320
17
0
2215
22320
—
41
0
2181
22249
144
0
1987
21478
44
6
1498
15847
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
-3.6e-02
3.2e-02
-1.5e-01
—
3.5e+00
4.8e-01
3.3e-01
cases:11.38%
controls:11.75%
cases:3.23%
controls:3.13%
cases:0.22%
controls:0.26%
—
—
cases:6.89%
controls:0.22%
cases:4.08%
controls:2.57%
cases:9.73%
controls:7.21%
254
2623
1978
19697
72
698
2160
21622
5
58
2227
22262
—
153
48
2069
22201
87
553
2044
20925
150
1143
1392
14710
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
-1.1e-01
1.5e+00
1.4e+00
—
9.7e-01
4.5e-01
5.0e-02
cases:5.51%
controls:6.08%
cases:16.04%
controls:4.27%
cases:1.70%
controls:0.42%
—
—
cases:1.31%
controls:0.50%
cases:8.26%
controls:5.44%
cases:20.62%
controls:19.81%
123
1358
2109
20962
358
954
1874
21366
38
93
2194
22227
—
29
111
2193
22138
176
1168
1955
20310
318
3141
1224
12712
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
-1.6e-01
5.6e-01
2.0e+00
1.0e+50
—
7.0e-01
9.8e-01
cases:4.93%
controls:5.73%
cases:2.46%
controls:1.42%
cases:0.85%
controls:0.11%
cases:0.27%
controls:0.00%
—
—
cases:2.16%
controls:1.08%
cases:7.20%
controls:2.83%
110
1279
2122
21041
55
316
2177
22004
19
25
2213
22295
6
0
2226
22320
—
46
232
2085
21246
111
448
1431
15405
Incisional hernia without obstruction or gangrene
K43.2 [45581900]
K43.2 [45581900]
-1.0e+50
—
—
—
—
2.2e+00
2.0e+00
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.07%
cases:0.91%
controls:0.12%
0
9
2232
22311
—
—
—
—
13
14
2118
21464
14
19
1528
15834
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
-1.6e-01
2.1e+00
1.5e+00
—
1.5e-01
6.2e-01
5.9e-02
cases:3.81%
controls:4.45%
cases:15.10%
controls:2.09%
cases:1.61%
controls:0.35%
—
—
cases:0.36%
controls:0.31%
cases:3.99%
controls:2.19%
cases:7.00%
controls:6.63%
85
993
2147
21327
337
466
1895
21854
36
79
2196
22241
—
8
69
2214
22180
85
470
2046
21008
108
1051
1434
14802
Malignant tumor in appendix other or unspecified histology
C18.19 [2000500541]
C18.19 [2000500541]
-1.0e+50
—
—
1.0e+50
—
—
4.3e+00
cases:0.00%
controls:0.03%
—
—
—
—
cases:1.43%
controls:0.00%
—
—
—
—
cases:2.20%
controls:0.03%
0
6
2232
22314
—
—
32
0
2200
22320
—
—
34
5
1508
15848
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
JN1DG [2001305530]
5.1e-01
1.3e+00
—
—
—
2.7e+00
1.5e+00
cases:0.36%
controls:0.22%
cases:0.27%
controls:0.08%
—
—
—
—
—
—
cases:1.03%
controls:0.07%
cases:1.17%
controls:0.25%
8
48
2224
22272
6
17
2226
22303
—
—
—
22
15
2109
21463
18
40
1524
15813
Laparoscopic repair of incisional hernia
JAD11 [2001304419]
JAD11 [2001304419]
—
—
—
—
—
2.3e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.04%
controls:0.16%
—
—
—
—
—
7
7
2124
21471
16
25
1526
15828
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
-8.2e-03
-5.3e-03
1.1e+00
—
3.3e+00
9.2e-01
2.2e-01
cases:1.66%
controls:1.67%
cases:0.85%
controls:0.86%
cases:0.36%
controls:0.13%
—
—
cases:3.33%
controls:0.13%
cases:2.35%
controls:0.95%
cases:4.02%
controls:3.26%
37
373
2195
21947
19
191
2213
22129
8
28
2224
22292
—
74
29
2148
22220
50
204
2081
21274
62
517
1480
15336
Internal Medicine
11 [38004456]
11 [38004456]
-7.7e-02
9.2e-01
1.9e+00
—
5.1e-01
5.0e-01
3.3e-01
cases:25.63%
controls:27.12%
cases:22.36%
controls:10.29%
cases:10.39%
controls:1.67%
—
—
cases:2.61%
controls:1.59%
cases:14.88%
controls:9.59%
cases:27.89%
controls:21.80%
572
6053
1660
16267
499
2296
1733
20024
232
373
2000
21947
—
58
353
2164
21896
317
2060
1814
19418
430
3456
1112
12397
Body height measure
50373000 [4177340]
50373000 [4177340]
-7.4e-01
-4.4e-01
2.0e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
cases:13.08%
controls:24.06%
cases:4.61%
controls:6.98%
cases:5.42%
controls:0.77%
cases:0.76%
controls:0.03%
cases:3.38%
controls:0.00%
cases:11.22%
controls:0.00%
cases:13.75%
controls:0.00%
292
5370
1940
16950
103
1558
2129
20762
121
171
2111
22149
17
6
2215
22314
75
0
2147
22249
239
0
1892
21478
212
0
1330
15853
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
7.1e-02
1.4e+00
1.9e+00
—
1.5e+00
8.6e-01
5.9e-01
cases:1.52%
controls:1.42%
cases:1.66%
controls:0.41%
cases:0.45%
controls:0.07%
—
—
cases:0.27%
controls:0.06%
cases:1.08%
controls:0.46%
cases:2.33%
controls:1.31%
34
317
2198
22003
37
92
2195
22228
10
15
2222
22305
—
6
14
2216
22235
23
99
2108
21379
36
207
1506
15646
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
-1.4e-01
4.1e-02
5.0e-01
3.3e+00
9.0e-01
3.1e-02
2.0e-01
cases:2.20%
controls:2.53%
cases:1.57%
controls:1.51%
cases:0.67%
controls:0.41%
cases:0.81%
controls:0.03%
cases:0.95%
controls:0.39%
cases:1.64%
controls:1.59%
cases:4.28%
controls:3.55%
49
564
2183
21756
35
336
2197
21984
15
91
2217
22229
18
7
2214
22313
21
86
2201
22163
35
342
2096
21136
66
562
1476
15291
PET-CT of upper body metabolism
JN5DR [2001310926]
JN5DR [2001310926]
2.0e-01
—
—
—
—
2.3e+00
1.8e+00
cases:0.22%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:0.78%
controls:0.13%
5
41
2227
22279
—
—
—
—
15
15
2116
21463
12
20
1530
15833
Body mass index
60621009 [4245997]
60621009 [4245997]
-7.4e-01
-4.3e-01
2.0e+00
3.3e+00
1.0e+50
1.0e+50
1.0e+50
cases:13.04%
controls:23.84%
cases:4.61%
controls:6.94%
cases:5.38%
controls:0.75%
cases:0.72%
controls:0.03%
cases:3.38%
controls:0.00%
cases:11.17%
controls:0.00%
cases:13.75%
controls:0.00%
291
5321
1941
16999
103
1549
2129
20771
120
167
2112
22153
16
6
2216
22314
75
0
2147
22249
238
0
1893
21478
212
0
1330
15853
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
-1.0e-01
2.1e+00
1.5e+00
—
-1.5e-01
5.5e-01
-1.4e-01
cases:2.55%
controls:2.83%
cases:11.47%
controls:1.60%
cases:1.21%
controls:0.27%
—
—
cases:0.23%
controls:0.26%
cases:2.77%
controls:1.62%
cases:4.73%
controls:5.43%
57
631
2175
21689
256
357
1976
21963
27
60
2205
22260
—
5
58
2217
22191
59
347
2072
21131
73
861
1469
14992
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
-2.2e-02
5.2e-02
1.2e+00
—
3.2e+00
8.9e-01
2.2e-01
cases:1.61%
controls:1.65%
cases:0.90%
controls:0.85%
cases:0.40%
controls:0.12%
—
—
cases:2.97%
controls:0.12%
cases:2.30%
controls:0.95%
cases:4.02%
controls:3.25%
36
368
2196
21952
20
190
2212
22130
9
26
2223
22294
—
66
27
2156
22222
49
205
2082
21273
62
515
1480
15338
Systemic arterial pressure
364090009 [4238447]
364090009 [4238447]
2.9e-01
—
2.6e+00
1.0e+50
—
1.5e+00
7.3e-01
cases:0.54%
controls:0.40%
—
—
cases:0.36%
controls:0.03%
cases:11.11%
controls:0.00%
—
—
cases:0.66%
controls:0.14%
cases:1.10%
controls:0.54%
12
90
2220
22230
—
8
6
2224
22314
248
0
1984
22320
—
14
31
2117
21447
17
85
1525
15768
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
4533-6 [3024403]
-5.7e-01
2.0e+00
2.1e+00
—
—
5.1e-01
-2.1e-02
cases:0.45%
controls:0.79%
cases:2.78%
controls:0.38%
cases:0.36%
controls:0.04%
—
—
—
—
cases:0.61%
controls:0.37%
cases:1.04%
controls:1.06%
10
176
2222
22144
62
84
2170
22236
8
10
2224
22310
—
—
13
79
2118
21399
16
168
1526
15685
Special examination, unspecified
Z01.9 [45576123]
Z01.9 [45576123]
4.9e-02
1.3e+00
2.8e+00
—
—
4.0e-01
2.5e-01
cases:0.94%
controls:0.90%
cases:1.21%
controls:0.35%
cases:0.54%
controls:0.03%
—
—
—
—
cases:0.42%
controls:0.28%
cases:1.23%
controls:0.96%
21
200
2211
22120
27
78
2205
22242
12
7
2220
22313
—
—
9
61
2122
21417
19
152
1523
15701
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
-4.6e-01
7.7e-01
—
—
3.0e+00
1.1e+00
4.4e-01
cases:0.45%
controls:0.71%
cases:0.63%
controls:0.29%
—
—
—
—
cases:0.54%
controls:0.03%
cases:1.41%
controls:0.48%
cases:2.53%
controls:1.65%
10
158
2222
22162
14
65
2218
22255
—
—
12
6
2210
22243
30
104
2101
21374
39
261
1503
15592
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
1.1e-02
1.0e-02
1.1e+00
—
3.2e+00
8.7e-01
1.9e-01
cases:1.66%
controls:1.64%
cases:0.90%
controls:0.89%
cases:0.40%
controls:0.13%
—
—
cases:3.11%
controls:0.13%
cases:2.35%
controls:0.99%
cases:4.09%
controls:3.41%
37
366
2195
21954
20
198
2212
22122
9
29
2223
22291
—
69
29
2153
22220
50
213
2081
21265
63
540
1479
15313
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
JJ2AT [2001305254]
3.6e-01
—
—
—
—
2.4e+00
1.6e+00
cases:0.22%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.05%
cases:0.71%
controls:0.14%
5
35
2227
22285
—
—
—
—
11
10
2120
21468
11
22
1531
15831
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
-5.5e-02
9.6e-01
2.3e+00
—
—
7.3e-01
2.3e-01
cases:3.99%
controls:4.20%
cases:3.14%
controls:1.22%
cases:1.48%
controls:0.15%
—
—
—
—
cases:2.49%
controls:1.22%
cases:5.25%
controls:4.24%
89
938
2143
21382
70
273
2162
22047
33
33
2199
22287
—
—
53
261
2078
21217
81
672
1461
15181
Multiple cystostatic therapy of methastized malignancy
WD115 [2001310679]
WD115 [2001310679]
-1.0e+50
—
—
—
—
2.3e+00
1.7e+00
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:0.78%
controls:0.15%
0
34
2232
22286
—
—
—
—
15
15
2116
21463
12
23
1530
15830
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
5.7e-02
8.5e-01
4.2e-01
—
1.9e+00
8.9e-01
3.8e-01
cases:4.66%
controls:4.41%
cases:3.54%
controls:1.54%
cases:0.22%
controls:0.15%
—
—
cases:0.90%
controls:0.14%
cases:3.05%
controls:1.28%
cases:6.94%
controls:4.85%
104
985
2128
21335
79
344
2153
21976
5
33
2227
22287
—
20
31
2202
22218
65
274
2066
21204
107
769
1435
15084
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
4.4e-02
4.2e-01
—
1.0e+50
1.8e+00
1.1e+00
1.1e+00
cases:8.78%
controls:8.43%
cases:2.73%
controls:1.81%
—
—
cases:19.27%
controls:0.00%
cases:0.50%
controls:0.09%
cases:3.38%
controls:1.10%
cases:7.07%
controls:2.49%
196
1882
2036
20438
61
405
2171
21915
—
430
0
1802
22320
11
19
2211
22230
72
237
2059
21241
109
395
1433
15458
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
6.2e-02
7.1e-01
2.8e+00
—
—
1.2e+00
2.6e-01
cases:0.90%
controls:0.84%
cases:0.85%
controls:0.42%
cases:0.90%
controls:0.05%
—
—
—
—
cases:1.60%
controls:0.51%
cases:2.08%
controls:1.61%
20
188
2212
22132
19
94
2213
22226
20
12
2212
22308
—
—
34
109
2097
21369
32
256
1510
15597
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
-2.1e-01
1.2e-01
-1.9e-02
-1.0e+50
2.2e+00
1.3e+00
4.3e-01
cases:10.84%
controls:13.01%
cases:6.90%
controls:6.15%
cases:0.94%
controls:0.96%
cases:0.00%
controls:0.04%
cases:7.25%
controls:0.84%
cases:20.13%
controls:6.50%
cases:23.99%
controls:16.97%
242
2903
1990
19417
154
1373
2078
20947
21
214
2211
22106
0
10
2232
22310
161
187
2061
22062
429
1395
1702
20083
370
2691
1172
13162
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
T81.0 [45599741]
-1.7e-01
—
-1.0e+50
—
2.8e+00
1.1e+00
4.0e-01
cases:0.76%
controls:0.90%
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.50%
controls:0.03%
cases:0.61%
controls:0.20%
cases:0.97%
controls:0.66%
17
201
2215
22119
—
0
7
2232
22313
—
11
7
2211
22242
13
42
2118
21436
15
104
1527
15749
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
-1.6e-01
1.6e+00
2.3e+00
—
—
1.9e-01
-3.3e-01
cases:1.30%
controls:1.53%
cases:2.64%
controls:0.53%
cases:0.94%
controls:0.10%
—
—
—
—
cases:0.61%
controls:0.50%
cases:1.23%
controls:1.70%
29
341
2203
21979
59
118
2173
22202
21
22
2211
22298
—
—
13
108
2118
21370
19
270
1523
15583
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
3.7e-01
8.0e-01
—
—
2.3e+00
1.6e+00
6.7e-01
cases:1.03%
controls:0.72%
cases:0.36%
controls:0.16%
—
—
—
—
cases:0.27%
controls:0.03%
cases:1.03%
controls:0.21%
cases:1.43%
controls:0.73%
23
160
2209
22160
8
36
2224
22284
—
—
6
6
2216
22243
22
46
2109
21432
22
116
1520
15737
Initiation and monitoring of IV fluid therapy
SPAT1083 [2001700184]
SPAT1083 [2001700184]
-5.0e-01
1.1e+00
2.8e+00
—
—
6.9e-01
5.7e-01
cases:0.45%
controls:0.73%
cases:0.72%
controls:0.24%
cases:0.36%
controls:0.02%
—
—
—
—
cases:0.52%
controls:0.26%
cases:1.23%
controls:0.70%
10
164
2222
22156
16
53
2216
22267
8
5
2224
22315
—
—
11
56
2120
21422
19
111
1523
15742
Secondary malignant neoplasm of lung
C78.0 [45537839]
C78.0 [45537839]
—
5.4e-01
8.2e-01
—
—
1.5e+00
2.3e+00
—
—
cases:0.31%
controls:0.18%
cases:0.22%
controls:0.10%
—
—
—
—
cases:0.99%
controls:0.21%
cases:3.63%
controls:0.37%
—
7
41
2225
22279
5
22
2227
22298
—
—
21
46
2110
21432
56
58
1486
15795
Metastasis to lung
OMOP4999962 [36770283]
OMOP4999962 [36770283]
—
5.4e-01
8.2e-01
—
—
1.5e+00
2.3e+00
—
—
cases:0.31%
controls:0.18%
cases:0.22%
controls:0.10%
—
—
—
—
cases:0.99%
controls:0.21%
cases:3.63%
controls:0.37%
—
7
41
2225
22279
5
22
2227
22298
—
—
21
46
2110
21432
56
58
1486
15795
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
-8.7e-02
1.1e+00
—
—
2.8e+00
9.0e-01
-2.9e-01
cases:0.49%
controls:0.54%
cases:0.72%
controls:0.24%
—
—
—
—
cases:0.50%
controls:0.03%
cases:0.80%
controls:0.33%
cases:1.04%
controls:1.39%
11
120
2221
22200
16
54
2216
22266
—
—
11
7
2211
22242
17
70
2114
21408
16
220
1526
15633
Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]
K43.9 [45533594]
-2.2e-01
—
—
1.0e+50
—
1.9e+00
1.9e+00
cases:0.45%
controls:0.56%
—
—
—
—
cases:0.31%
controls:0.00%
—
—
cases:1.60%
controls:0.24%
cases:3.63%
controls:0.55%
10
124
2222
22196
—
—
7
0
2225
22320
—
34
51
2097
21427
56
87
1486
15766
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
-4.5e-02
3.8e-01
1.5e+00
—
1.3e+00
7.1e-01
3.5e-01
cases:5.15%
controls:5.38%
cases:3.14%
controls:2.16%
cases:1.25%
controls:0.30%
—
—
cases:0.90%
controls:0.24%
cases:4.04%
controls:2.03%
cases:9.01%
controls:6.54%
115
1200
2117
21120
70
482
2162
21838
28
66
2204
22254
—
20
54
2202
22195
86
435
2045
21043
139
1036
1403
14817
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1951
2618
52.25
307.65
8.4
3.9
7.07
22.70
ug/l
2.82
1772
2139
496
938
6.51
261.08
4.7
3.3
173.65
4612.95
u/ml
0.89
447
807
1407
6254
4.38
252.97
2.7
2.4
3.92
2.89
mg/l
18.76
1271
5352
1091
4114
4.23
245.75
2.5
2.8
10.40
12.26
umol/l
10.58
1050
3825
1008
3592
4.29
245.73
2.3
2.8
17.08
22.07
%
22.40
972
3332
1051
3860
4.26
245.65
2.4
2.7
2.52
2.26
g/l
37.38
1018
3555
1781
10057
4.82
214.21
3.4
2.9
—
—
estimate
—
0
0
1821
10534
4.96
209.75
7.0
5.1
34.86
34.91
g/l
0.14
1779
9855
1642
9105
4.04
193.57
3.7
3.1
86.64
148.72
ug/l
21.98
1534
8344
672
2366
3.63
155.77
2.2
2.2
0.21
0.20
g/l
2.71
658
2199
1125
5581
3.05
144.40
2.7
2.6
—
—
—
0
0
1802
11789
3.74
140.21
10.7
6.7
11.01
12.03
umol/l
2.89
1764
11246
1101
5642
2.88
129.15
4.7
4.2
90.10
85.58
%
6.89
1087
5533
267
551
5.37
124.14
4.8
3.2
68.71
1104.45
u/ml
1.42
252
510
1707
12049
2.77
91.71
13.0
9.6
4.02
4.26
e9/l
4.13
1471
10355
1791
13151
2.83
85.29
6.1
5.3
6.83
6.83
mmol/l
0.00
1745
12603
2046
16280
4.08
82.81
13.3
8.7
83.78
81.46
u/l
1.43
2009
15425
1565
11221
2.32
70.70
17.0
18.4
1.28
1.32
inr
2.69
1342
9413
547
2553
2.51
69.31
7.5
8.0
113.32
120.30
g/l
15.16
542
2490
574
2747
2.47
68.83
7.3
7.6
96.99
95.45
%
16.42
567
2650
404
1725
2.64
60.89
8.3
9.2
95.30
93.81
%
8.84
404
1716
600
3069
2.31
60.87
7.2
7.3
5.22
5.09
kpa
3.60
591
2948
600
3069
2.31
60.87
7.2
7.3
13.82
11.93
kpa
14.96
591
2950
596
3052
2.30
60.21
7.0
7.3
0.31
0.96
mmol/l
4.46
503
2525
1077
7062
2.01
56.01
2.9
2.7
69.45
72.43
u/l
0.06
1031
6515
1478
10888
2.06
54.74
5.8
6.2
1.77
1.89
e9/l
1.16
1252
9386
1580
11946
2.10
54.24
8.4
7.7
1.20
1.21
mmol/l
5.97
1369
10305
1384
10050
1.99
52.19
6.0
6.5
25.30
26.28
%
2.64
1315
9477
1481
11015
2.02
52.10
5.9
6.4
0.19
0.19
e9/l
0.13
1243
9418
492
2484
2.26
50.33
2.1
2.6
69.54
68.97
e9/l
0.14
356
1835
471
2350
2.27
49.49
7.0
7.1
1.14
1.37
mmol/l
6.56
463
2308
2159
19096
4.99
48.38
27.4
19.4
36.57
26.82
mg/l
30.73
2088
16202
1270
9121
1.91
47.53
17.0
12.7
0.00
0.00
e9/l
0.18
1012
7370
1144
8162
1.82
41.48
5.9
3.5
2.36
2.36
mmol/l
0.09
1064
7346
787
5023
1.88
40.76
6.1
3.0
2.47
2.46
mmol/l
0.93
725
4525
473
2535
2.10
40.67
3.1
2.7
8.06
8.74
umol/l
0.27
418
2264
1412
10791
1.84
40.31
7.7
6.8
1.20
1.21
mmol/l
3.72
1338
9940
2189
19962
6.01
38.27
34.5
24.1
3.97
4.00
mmol/l
6.03
2178
19564
2187
19933
5.82
38.19
34.3
23.9
139.38
139.61
mmol/l
4.35
2178
19559
1029
7301
1.76
36.32
1.8
1.8
20.87
20.17
nmol/l
0.81
899
6084
2085
18541
2.89
36.14
29.6
19.4
74.84
73.88
ml/min/173m2
1.57
2004
17394
1820
15331
2.01
35.64
37.3
24.3
14.66
13.86
%
57.93
1812
15123
2193
20247
5.76
32.84
38.2
26.2
80.76
82.11
umol/l
1.09
2188
20002
394
2165
2.00
30.83
2.8
2.4
35.96
38.45
u/l
0.33
339
1805
2171
19996
4.14
30.60
18.7
13.6
24.69
24.88
u/l
0.23
2148
19345
1347
10605
1.68
30.11
2.4
2.3
92.83
95.18
pmol/l
1.09
787
5547
346
1833
2.05
29.92
1.6
1.6
—
—
—
0
0
2193
20374
5.37
29.77
46.0
29.6
252.93
243.55
e9/l
8.07
2156
19918
2193
20375
5.37
29.75
45.9
29.5
90.99
91.81
fl
11.42
2186
20115
2193
20377
5.36
29.70
47.1
30.1
38.31
39.73
%
31.26
2186
20106
2193
20377
5.36
29.70
46.0
29.6
4.30
4.40
e12/l
17.69
2147
19841
2193
20379
5.36
29.65
46.0
29.6
6.92
6.87
e9/l
0.44
2148
19843
2193
20380
5.35
29.63
46.4
29.8
126.63
132.91
g/l
66.94
2187
20128
1119
8441
1.65
29.15
4.7
4.3
109.28
116.79
e6/l
0.11
805
6108
918
6606
1.66
28.61
3.6
3.5
0.58
0.49
e6/l
0.34
677
4941
1025
7640
1.63
27.41
3.9
3.6
118.73
78.56
e6/l
0.34
780
5918
921
6729
1.63
26.40
3.7
3.2
32.27
34.64
u/l
0.85
875
6318
258
1299
2.12
25.35
1.3
1.8
1.79
1.55
g/l
4.31
225
1128
1656
14102
1.68
24.26
5.4
5.4
1039.50
1889.68
e6/l
0.45
22
226
482
3036
1.75
23.90
3.5
4.2
220.56
248.37
u/l
6.79
460
2869
95
305
3.21
23.68
2.3
2.3
3.95
988.64
u/ml
0.61
90
299
1755
15301
1.69
22.08
4.6
4.7
16.26
13.98
mm/h
6.87
1623
14202
1456
12148
1.57
21.82
3.7
3.4
58.04
55.66
u/l
0.35
1372
11179
614
4222
1.63
21.54
1.3
1.3
1.89
1.39
u/ml
0.35
156
1049
569
3855
1.64
21.12
3.7
3.3
2.78
2.30
e6/l
0.50
286
1940
30
16
18.99
19.95
1.0
1.0
—
—
—
0
0
2019
18553
1.92
18.39
7.6
7.4
40.60
40.28
mmol/mol
0.89
1879
17128
2069
19183
2.08
18.19
6.1
6.5
2.46
2.55
mmol/l
5.37
1894
17507
578
4063
1.57
17.95
3.2
3.2
0.81
0.81
mmol/l
0.73
542
3810
2042
18863
1.97
17.88
5.9
5.9
6.16
6.08
mmol/l
2.09
1861
17029
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
175
892
2.04
16.49
1.8
2.9
0.33
0.35
iu/ml
0.25
87
506
1328
11198
1.46
16.29
4.3
4.4
7.71
2.63
estimate
0.43
351
2458
1312
11053
1.45
16.06
4.3
4.4
0.00
0.00
estimate
0.50
345
2385
536
3787
1.55
16.00
1.3
1.5
2.51
2.65
g/l
0.80
291
2189
357
2299
1.66
15.70
2.1
2.2
198.05
151.32
ug/g
0.98
284
1836
1330
11279
1.44
15.40
4.4
4.4
2.93
0.14
estimate
0.47
342
2291
1947
17941
1.67
14.34
5.6
5.7
2.00
2.02
mu/l
0.20
1780
16321
2005
18632
1.75
14.16
5.2
5.5
1.43
1.46
mmol/l
1.72
1833
16950
2017
18778
1.77
14.11
5.2
5.6
4.38
4.47
mmol/l
3.65
1857
17219
569
4218
1.47
13.10
3.6
3.2
1.26
1.24
e6/l
0.03
287
2315
194
1107
1.82
13.05
4.7
5.0
0.88
0.87
%
0.11
189
1041
699
5390
1.43
13.03
2.8
2.8
6.15
5.36
e6/l
0.69
634
4932
353
2369
1.58
12.96
5.3
7.1
9.72
10.77
mmol/l
2.04
345
2265
990
8140
1.39
12.63
3.0
3.4
1526.60
1527.42
ng/l
0.00
868
7135
584
4423
1.43
11.81
1.7
1.8
1217.99
1169.82
nmol/l
0.56
423
3312
503
3721
1.45
11.50
2.2
2.0
30.23
29.77
s
0.89
490
3613
613
4723
1.41
11.16
4.1
4.3
632.62
570.36
ng/l
0.05
529
4058
253
1625
1.63
11.07
7.4
6.5
24.14
24.52
mmol/l
1.03
248
1549
1142
9776
1.34
10.55
2.5
2.5
78.18
79.45
nmol/l
0.82
1037
8646
350
2466
1.50
10.14
4.1
3.8
—
—
—
0
0
290
1965
1.55
10.08
3.9
4.1
1.23
1.23
mmol/l
0.02
257
1699
1912
17882
1.48
9.51
4.4
4.7
1.35
1.28
mmol/l
4.38
1720
16071
146
847
1.77
9.31
1.3
1.3
—
—
—
0
0
443
3343
1.41
8.82
4.6
5.9
1.02
1.03
mmol/l
0.23
409
3105
692
5611
1.34
8.76
4.2
3.9
0.20
0.04
estimate
0.45
284
1861
1042
8956
1.31
8.68
4.2
4.4
34.54
115.03
ng/l
1.09
833
7069
116
649
1.83
8.37
1.3
1.6
—
—
—
0
0
612
4945
1.33
7.77
1.8
1.8
41683819.18
24234624.65
pmol/l
0.29
499
4048
572
4598
1.33
7.49
1.6
1.8
1.41
1.47
mg/l
0.23
456
3643
359
2693
1.40
7.31
3.0
3.6
5.73
5.82
kpa
1.05
352
2620
684
5684
1.29
6.93
3.1
3.4
0.05
0.03
0.10
21
177
66
326
2.06
6.91
1.3
1.3
0.37
0.42
nmol/l
—
6
15
58
274
2.15
6.82
1.3
1.2
0.18
0.19
nmol/l
0.43
46
222
152
979
1.59
6.60
1.1
1.1
—
2.05
—
0
6
250
1795
1.44
6.49
3.6
2.9
61.64
60.69
ml/min/173m2
0.16
113
802
114
692
1.68
6.27
1.3
1.3
—
—
—
0
0
1625
15097
1.28
6.17
4.5
4.5
14.98
15.08
pmol/l
0.84
1468
13623
342
2618
1.36
6.10
3.0
3.6
1.61
1.90
mmol/l
0.71
290
2282
1098
9761
1.25
6.09
2.5
2.4
—
—
—
0
0
94
548
1.75
5.99
1.7
2.5
222.72
205.94
%
0.89
89
524
297
2252
1.37
5.61
2.7
3.0
4.46
4.48
kpa
0.04
290
2187
544
4551
1.26
4.96
3.6
3.5
0.78
0.78
ug/l
0.01
408
3203
113
732
1.57
4.86
1.4
1.5
237.14
267.89
ug/g
0.76
63
444
23
84
2.76
4.78
1.1
1.3
—
—
—
0
0
106
680
1.59
4.75
1.5
1.6
24.16
22.40
u/ml
0.11
21
119
101
654
1.57
4.38
3.1
3.7
0.83
1.93
index
2.45
59
329
522
4427
1.23
4.13
2.0
2.0
—
—
—
0
0
906
8109
1.20
4.12
3.5
3.5
7.31
7.09
mmol/l
0.86
749
6754
52
286
1.84
4.12
1.1
1.1
1.54
1.55
g/l
0.06
52
258
102
672
1.54
4.12
1.6
1.7
—
—
—
0
0
35
169
2.09
4.02
1.7
2.0
7.19
8.52
mmol/l
1.92
35
169
665
5818
1.20
3.81
3.0
3.0
359.41
353.55
umol/l
0.73
588
5016
722
6377
1.20
3.71
4.9
4.5
0.00
0.00
estimate
1.15
306
2179
906
8166
1.18
3.69
4.5
4.5
0.38
0.04
estimate
0.47
285
1953
24
105
2.30
3.52
1.0
4.8
48.56
61.32
mg/l
1.10
18
73
46
258
1.80
3.47
1.5
1.5
23.49
31.44
ng/l
0.88
46
258
95
647
1.49
3.34
3.6
3.4
0.78
0.82
nmol/l
0.35
83
519
252
2013
1.28
3.33
3.1
2.5
0.54
0.45
e6/l
0.32
242
1936
83
551
1.53
3.30
1.3
1.2
—
—
—
0
0
168
1272
1.35
3.26
1.4
1.5
—
—
—
0
0
373
3128
1.23
3.24
1.9
1.9
—
—
—
0
0
397
3364
1.22
3.12
1.8
1.8
—
—
—
0
0
897
8169
1.16
3.06
4.4
4.2
8.38
8.80
mg/mmol
0.12
589
5099
917
8367
1.16
3.04
1.9
2.0
1.41
1.31
mmol/l
2.37
737
6859
87
598
1.47
2.96
1.5
1.6
—
—
—
0
0
49
298
1.66
2.84
1.6
1.4
—
—
—
0
0
62
400
1.57
2.84
1.9
1.8
4.66
4.67
mmol/24h
0.00
52
342
70
467
1.52
2.77
1.2
1.3
—
—
—
0
0
5
6
8.35
2.75
1.0
1.3
17.54
27.77
umol/24h
—
5
6
150
1149
1.33
2.74
2.4
2.5
3.92
3.73
g/l
0.45
130
1043
150
1150
1.33
2.72
2.4
2.5
4.24
4.19
g/l
0.29
130
1044
150
1150
1.33
2.72
2.4
2.5
7.44
7.47
g/l
0.07
130
1042
850
7762
1.15
2.71
6.4
6.1
3.57
3.08
ug/l
0.21
780
6967
133
1004
1.35
2.68
2.2
2.5
10.35
10.43
g/l
0.06
111
888
694
6252
1.16
2.65
4.9
5.0
22.08
21.81
%
0.18
402
3309
48
297
1.63
2.63
1.6
1.4
—
—
—
0
0
146
1122
1.32
2.61
3.4
2.2
0.00
0.82
estimate
0.51
51
309
46
284
1.63
2.55
1.5
1.4
—
—
—
0
0
46
285
1.63
2.52
1.5
1.4
—
—
—
0
0
47
294
1.61
2.48
1.5
1.4
—
—
—
0
0
46
287
1.62
2.46
1.5
1.4
—
—
—
0
0
40
242
1.66
2.41
1.2
1.2
2.11
7.13
u/ml
1.77
19
113
111
831
1.35
2.39
2.3
2.5
0.27
0.03
g/l
0.43
96
751
130
999
1.32
2.36
2.3
2.6
0.83
1.21
g/l
0.50
107
852
138
1072
1.31
2.32
2.4
2.5
2.95
2.97
g/l
0.08
118
966
21
105
2.01
2.31
1.8
1.8
18.70
16.47
nmol/l
0.58
21
96
174
1399
1.26
2.24
2.4
2.6
1.12
1.14
%
0.11
174
1388
60
411
1.47
2.16
3.4
3.9
1.94
1.56
%
0.39
54
368
72
511
1.42
2.16
2.5
2.4
30.38
33.61
umol/l
0.49
65
448
190
1556
1.24
2.10
2.3
2.3
11.71
12.95
nmol/l
1.21
167
1374
118
912
1.31
2.08
2.5
3.3
2.77
3.53
ratio
0.22
72
538
171
1387
1.25
2.07
2.4
2.6
0.57
0.61
%
1.27
171
1379
271
2306
1.20
2.06
3.0
2.8
66.13
66.26
g/l
0.10
242
2109
143
1140
1.27
2.01
2.1
1.9
2.43
1.88
ug/l
0.25
129
1012
39
250
1.57
1.93
1.2
1.2
2.44
3.53
u/ml
0.31
18
80
152
1233
1.25
1.86
3.4
3.8
1.02
1.02
ratio
0.83
138
1136
23
129
1.79
1.85
2.9
1.8
17.52
17.29
%
0.03
23
121
127
1010
1.27
1.84
2.5
3.5
36.75
73.48
mg/l
1.51
116
864
207
1739
1.21
1.82
1.6
1.7
1.58
1.60
%
0.07
174
1441
60
427
1.42
1.81
1.1
1.1
2.99
5.53
eliau/ml
0.43
11
33
127
1013
1.27
1.80
2.5
3.5
91.29
103.06
mg/l
0.06
116
865
26
153
1.71
1.79
1.0
1.2
—
—
—
0
0
39
256
1.53
1.76
1.5
1.6
45.83
63.39
%
1.58
23
163
253
2178
1.18
1.72
2.6
3.1
190.30
222.12
ng/l
0.80
234
2004
10
40
2.51
1.66
5.5
2.8
13.08
14.75
ml/dl
—
10
35
76
573
1.34
1.65
1.1
1.2
—
—
—
0
0
22
127
1.74
1.64
1.5
1.3
45.01
31.02
u/l
0.68
17
106
22
127
1.74
1.64
2.6
1.7
—
—
—
0
0
390
3496
1.14
1.56
1.3
1.3
39.79
38.80
iu/ml
0.05
124
1084
102
810
1.27
1.54
2.1
2.5
0.02
0.00
g/l
0.49
88
715
20
115
1.75
1.52
1.6
1.5
0.19
0.24
nmol/l
0.31
12
83
792
7409
1.11
1.52
2.1
2.3
186.09
226.74
u/l
1.03
749
7008
80
619
1.30
1.48
1.4
1.5
0.24
11.07
iu/ml
—
10
122
17
94
1.81
1.47
1.1
1.1
—
—
—
0
0
23
142
1.63
1.38
1.3
1.4
—
—
—
0
0
23
142
1.63
1.38
1.3
1.4
—
—
—
0
0
73
566
1.30
1.35
1.1
1.2
—
—
—
0
0
10
47
2.13
1.33
1.1
1.4
1.76
3.11
umol/l
—
10
39
104
845
1.24
1.33
1.1
1.0
—
—
—
0
0
11
54
2.04
1.32
2.5
2.9
8.55
52.02
ug/l
0.44
11
54
24
152
1.59
1.31
1.2
1.5
—
—
—
0
0
42
301
1.40
1.29
1.7
1.3
13.09
9.86
u/l
0.63
32
236
231
2026
1.16
1.29
2.9
2.2
401.75
383.76
nmol/l
0.64
221
1866
35
244
1.44
1.25
3.1
3.5
17.06
11.02
index
0.99
18
128
27
179
1.51
1.23
2.3
2.2
881.08
648.90
ml
0.67
13
112
93
754
1.24
1.23
2.2
2.5
0.00
0.00
g/l
-0.00
88
714
43
313
1.38
1.22
1.2
1.5
—
—
—
0
0
18
108
1.67
1.22
1.6
1.4
—
—
—
0
0
18
108
1.67
1.22
1.6
1.4
—
—
—
0
0
32
455
0.70
1.22
1.2
1.3
—
—
—
0
0
16
263
0.61
1.20
1.1
1.1
—
19.00
—
0
44
12
65
1.85
1.13
2.5
1.5
1.77
1.68
ratio
0.06
12
60
25
168
1.49
1.09
2.9
2.7
44.53
31.05
mg/l
0.44
15
128
24
161
1.50
1.06
1.6
1.3
—
—
—
0
0
28
195
1.44
1.04
1.0
1.1
2.51
2.39
eliau/ml
0.04
11
61
229
2044
1.13
1.03
3.6
3.8
100.60
94.44
ng/l
0.48
202
1732
36
265
1.36
1.00
1.4
1.4
—
—
—
0
0
18
115
1.57
0.99
1.1
1.1
—
—
—
0
0
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
29
207
1.41
0.96
1.2
1.5
—
—
—
0
0
10
54
1.86
0.96
2.7
1.9
30.10
28.48
%
—
10
46
68
551
1.24
0.95
2.0
2.0
11.76
12.46
mg/l
0.25
59
506
43
329
1.31
0.94
1.4
1.3
37.94
31.65
iu/l
0.51
36
277
51
400
1.28
0.93
1.4
1.3
—
—
—
0
0
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
15
94
1.60
0.90
2.0
1.8
58.80
49.84
ug/l
0.36
15
89
37
279
1.33
0.90
3.0
3.9
59.00
59.01
%
0.00
32
242
243
2198
1.12
0.90
2.1
2.5
4.64
7.28
ug/l
2.39
207
1942
106
905
1.18
0.89
2.3
1.9
38.78
39.44
u/l
0.11
98
786
20
135
1.49
0.89
1.6
1.5
3.29
6.39
u/l
0.91
14
112
23
160
1.44
0.89
1.6
1.3
—
—
—
0
0
20
289
0.69
0.88
1.5
1.4
—
—
—
0
0
76
630
1.21
0.88
1.4
1.4
—
—
—
0
0
31
229
1.36
0.86
1.2
1.1
115.50
114.27
%
0.06
26
211
18
120
1.50
0.85
3.4
1.7
—
—
—
0
0
18
120
1.50
0.85
3.4
1.7
—
—
—
0
0
18
120
1.50
0.85
3.4
1.7
—
—
—
0
0
18
120
1.50
0.85
3.4
1.7
—
—
—
0
0
355
3286
1.10
0.85
1.3
1.3
23.59
14.26
u/ml
0.94
120
1132
21
145
1.45
0.85
1.2
1.5
—
—
—
0
0
13
80
1.63
0.84
1.9
2.7
11.08
10.14
kpa
0.60
13
80
13
80
1.63
0.84
1.9
2.7
4.62
4.87
kpa
0.52
13
80
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
6
31
1.94
0.84
1.7
1.4
20.80
38.25
pmol/l
—
6
24
89
757
1.18
0.80
1.1
1.3
—
—
—
0
0
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
27
200
1.35
0.76
1.5
1.5
43.56
29.41
%
0.94
16
125
10
59
1.70
0.75
1.7
1.5
0.30
0.36
ug/l
—
5
37
5
24
2.09
0.74
2.4
1.5
—
—
—
0
0
250
2719
0.91
0.73
10.6
7.7
—
—
—
0
0
183
1655
1.12
0.71
3.0
2.9
11.28
10.81
g/l
0.50
169
1513
80
683
1.18
0.71
1.5
1.5
0.34
0.33
mg/l
0.06
37
299
53
436
1.22
0.70
2.0
1.6
—
—
—
0
0
10
61
1.64
0.68
1.0
1.1
—
13.40
—
0
10
16
110
1.46
0.68
7.3
6.6
1.43
34.31
ug/l
—
10
65
5
94
0.53
0.66
1.0
1.3
6.82
14.62
umol/l
—
5
58
128
1143
1.13
0.64
3.1
3.4
4.37
4.35
pmol/l
0.06
110
1006
260
2798
0.92
0.62
5.4
5.4
35.46
33.46
%
1.97
154
1775
17
121
1.41
0.62
2.9
1.9
—
—
—
0
0
110
975
1.13
0.62
2.4
2.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
103
913
1.13
0.59
1.9
1.9
—
—
—
0
0
57
668
0.85
0.57
1.7
1.7
—
—
—
0
0
22
167
1.32
0.56
1.2
1.4
—
—
—
0
0
74
644
1.15
0.56
2.5
2.8
1.87
1.72
mg/l
0.67
65
572
13
90
1.45
0.55
1.1
1.5
2.99
2.94
mmol/l
0.02
13
80
94
833
1.13
0.55
1.9
1.7
6.05
7.37
iu/ml
0.19
24
192
51
601
0.85
0.55
1.7
1.7
—
—
—
0
0
19
142
1.34
0.54
1.1
1.0
0.08
1.25
u/ml
—
7
73
6
38
1.58
0.54
1.2
1.6
—
—
—
0
0
14
99
1.42
0.54
2.4
2.8
960.14
1274.51
u/ml
0.43
14
99
9
62
1.45
0.53
1.2
1.7
74.33
634.74
nmol/24h
—
9
62
14
100
1.40
0.51
1.6
1.8
1.35
10.35
nmol/l
1.29
14
87
6
40
1.50
0.51
1.8
1.3
—
—
—
0
0
17
126
1.35
0.51
1.2
1.6
92.47
89.25
umol/l
0.11
17
126
12
85
1.41
0.47
1.2
1.9
45525.71
25052.57
e6/l
—
7
49
7
50
1.40
0.45
1.0
1.4
1.19
1.17
mmol/l
—
7
50
7
50
1.40
0.45
1.7
2.3
—
—
—
0
0
38
320
1.19
0.45
1.1
1.1
—
0.98
—
0
8
230
2160
1.07
0.44
1.4
1.4
—
—
—
0
0
28
229
1.23
0.44
1.1
1.1
—
—
—
0
0
13
95
1.37
0.43
1.2
2.2
52436.50
1154.97
e6/l
—
8
72
14
185
0.76
0.43
1.0
1.0
65.60
41.94
ng/l
—
9
118
14
185
0.76
0.43
1.0
1.0
797.67
683.45
ng/l
—
9
119
24
194
1.24
0.42
2.1
2.1
1.77
1.58
u/field
0.09
13
97
14
184
0.76
0.41
1.0
1.0
481.22
305.67
ng/l
—
9
120
179
1672
1.08
0.41
3.5
3.8
5.02
5.16
kpa
1.39
173
1604
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
103
1128
0.91
0.41
1.3
1.3
182.46
229.36
u/ml
0.54
94
1044
23
186
1.24
0.40
1.1
1.2
—
—
—
0
0
70
625
1.12
0.40
1.6
2.3
123.09
127.13
g/l
0.59
58
497
70
626
1.12
0.39
1.8
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
101
924
1.10
0.38
2.1
2.7
—
—
—
0
0
26
215
1.21
0.38
1.6
1.3
255628.00
127511.75
e6/l
0.25
17
147
9
69
1.31
0.37
1.0
1.0
1526.67
1597.17
miu/ml
—
9
69
75
829
0.90
0.37
1.6
1.8
3.32
3.41
mmol/l
0.26
57
610
12
90
1.34
0.35
4.6
1.8
—
—
—
0
0
12
90
1.34
0.35
4.6
1.8
—
—
—
0
0
5
76
0.66
0.35
1.2
1.3
—
—
—
0
0
19
153
1.24
0.35
1.2
1.2
—
—
—
0
0
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
19
154
1.24
0.34
1.1
1.2
1.96
2.17
mmol/l
1.00
19
142
37
321
1.16
0.33
1.2
1.5
—
—
—
0
0
23
191
1.21
0.33
1.2
1.2
—
—
—
0
0
22
182
1.21
0.33
1.1
1.2
105.64
99.80
pmol/l
0.21
22
182
6
86
0.70
0.33
1.0
1.5
—
—
—
0
0
152
1427
1.07
0.33
3.0
3.6
2.27
2.07
mmol/l
0.24
108
1050
11
83
1.33
0.32
1.1
1.1
—
—
—
0
0
12
92
1.31
0.31
4.6
1.8
—
—
—
0
0
14
110
1.27
0.31
2.1
1.8
40.57
39.70
g/l
0.25
14
110
14
110
1.27
0.31
1.0
1.0
—
—
—
0
0
51
456
1.12
0.31
1.2
1.4
—
—
—
0
0
62
561
1.11
0.31
2.6
2.3
97.80
94.33
ug/min
0.02
37
334
7
53
1.32
0.30
1.7
2.2
—
—
—
0
0
23
272
0.84
0.30
1.1
1.3
230.00
196.66
miu/ml
—
6
91
7
55
1.27
0.30
1.0
1.3
0.32
0.29
g/l
—
7
42
35
306
1.15
0.30
1.0
1.2
248.40
288.21
u/ml
0.43
15
171
32
278
1.15
0.29
1.2
1.4
—
—
—
0
0
19
157
1.21
0.29
1.2
1.1
—
—
—
0
0
19
157
1.21
0.29
1.2
1.1
—
—
—
0
0
20
167
1.20
0.28
1.2
1.1
—
—
—
0
0
182
1732
1.06
0.27
1.6
1.4
—
—
—
0
0
18
150
1.20
0.26
1.2
1.2
—
—
—
0
0
18
214
0.84
0.26
2.2
1.8
4.63
4.68
mg/l
0.01
18
207
26
225
1.16
0.26
1.8
1.8
—
—
—
0
0
5
75
0.67
0.25
1.4
1.2
—
—
—
0
0
11
87
1.27
0.24
1.0
1.2
—
77.00
—
0
12
6
82
0.73
0.24
1.0
1.0
—
—
—
0
0
140
1330
1.06
0.23
2.1
1.8
1.88
1.47
g/l
0.44
129
1201
14
115
1.22
0.23
1.0
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
18
210
0.86
0.22
1.8
1.5
22.67
24.25
u/ml
—
6
28
32
286
1.12
0.21
1.1
1.4
6.84
6.56
mmol/l
0.17
32
273
30
267
1.13
0.21
1.7
1.8
—
—
—
0
0
14
167
0.84
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
4.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
2.55
—
0
11
42
382
1.10
0.21
1.2
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
6.17
—
0
12
111
1170
0.95
0.21
2.0
2.1
3.41
3.43
ratio
0.06
95
953
17
198
0.86
0.20
1.4
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
65
606
1.07
0.20
1.6
1.6
7129.28
15069.25
e6/l
2.43
47
416
16
136
1.18
0.20
1.5
1.8
—
—
—
0
0
13
108
1.20
0.20
1.2
1.2
639.15
291.19
u/l
0.31
13
100
125
1193
1.05
0.19
1.4
1.3
62.08
57.27
au/ml
—
10
84
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
6
53
1.13
0.18
1.0
1.0
230.67
275.97
pmol/l
—
6
36
56
521
1.08
0.18
1.2
1.4
—
—
—
0
0
59
551
1.07
0.18
1.5
1.6
—
—
—
0
0
10
121
0.83
0.18
1.0
1.1
—
—
—
0
0
68
639
1.07
0.17
1.9
1.6
—
—
—
0
0
12
142
0.84
0.17
2.3
2.4
—
—
—
0
0
10
82
1.22
0.17
4.0
2.0
0.59
0.61
mmol/l
—
10
82
23
257
0.89
0.17
3.2
1.6
—
—
—
0
0
111
1062
1.05
0.16
1.1
1.2
148.22
139.47
u/ml
0.07
31
364
11
92
1.20
0.16
1.1
1.3
117.36
162.91
mmol/24h
1.50
11
92
9
79
1.14
0.15
1.0
1.2
473.94
229.42
iu/ml
—
9
79
46
429
1.07
0.15
1.4
1.3
—
—
—
0
0
14
161
0.87
0.15
1.1
1.0
—
—
—
0
0
26
237
1.10
0.14
2.9
2.9
—
—
—
0
0
58
549
1.06
0.13
1.5
1.5
—
—
—
0
0
32
296
1.08
0.13
1.3
1.2
1.58
1.55
g/l
0.29
32
296
42
447
0.94
0.12
1.8
1.3
273.85
597.62
e6/l
0.46
33
350
52
493
1.06
0.11
1.2
1.3
—
—
—
0
0
52
493
1.06
0.11
1.2
1.3
—
—
—
0
0
28
259
1.08
0.11
1.1
1.2
0.45
0.66
ratio
—
6
48
135
1313
1.03
0.10
2.5
2.5
26.21
21.74
au/ml
—
7
97
22
202
1.09
0.10
1.1
1.1
0.45
1.73
u/ml
—
10
108
16
144
1.11
0.10
1.3
1.3
2.15
1.11
u/ml
—
10
80
10
114
0.88
0.09
3.6
1.9
0.65
0.71
e9/l
—
10
107
42
442
0.95
0.09
1.8
1.3
7.37
48.06
e6/l
1.35
30
325
13
116
1.12
0.09
2.8
1.3
—
—
—
0
0
13
116
1.12
0.09
4.3
3.3
1.42
1.13
%
0.20
13
116
52
543
0.96
0.09
1.6
1.8
4.25
5.14
mg/l
0.22
43
423
6
55
1.09
0.09
1.0
2.7
198.50
215.66
%
—
6
50
6
57
1.05
0.08
1.0
1.3
29.33
10.25
mm/h
—
6
57
5
65
0.77
0.08
3.6
2.4
33.64
139.89
ug/l
—
5
58
13
117
1.11
0.08
1.0
1.2
147.92
138.77
nmol/l
0.45
13
117
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
7
66
1.06
0.08
1.1
1.1
—
—
—
0
0
6
70
0.86
0.07
1.0
1.1
—
—
—
0
0
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
8
76
1.05
0.07
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
9
85
1.06
0.07
1.2
1.1
—
—
—
0
0
8
91
0.88
0.06
2.4
2.2
40.11
49.33
umol/l
—
8
73
8
91
0.88
0.06
1.0
1.2
—
—
—
0
0
14
128
1.09
0.06
3.6
3.8
—
—
—
0
0
47
488
0.96
0.06
3.3
3.8
25.29
28.53
mg/l
0.33
29
338
11
99
1.11
0.06
1.3
1.2
—
—
—
0
0
89
870
1.02
0.06
3.9
4.0
25.05
24.93
mmol/l
0.10
78
800
23
243
0.95
0.05
3.2
1.7
—
—
—
0
0
10
90
1.11
0.05
1.2
1.3
184.40
164.11
pmol/l
—
10
90
41
424
0.97
0.05
5.8
5.2
260.00
721.81
iu/ml
—
6
58
59
577
1.02
0.03
1.2
1.2
3.52
3.82
u/ml
—
8
55
15
159
0.94
0.03
1.0
1.0
328.40
289.90
mg/l
0.72
15
139
59
578
1.02
0.03
1.2
1.2
1.94
6.28
u/ml
—
10
87
59
602
0.98
0.03
1.7
1.5
1.16
1.18
g/l
0.25
59
576
21
201
1.05
0.03
1.5
1.2
—
—
—
0
0
28
289
0.97
0.02
5.0
3.8
—
—
—
0
0
34
331
1.03
0.02
1.2
1.1
—
—
—
0
0
51
501
1.02
0.02
1.9
1.9
3.99
15.83
iu/l
0.48
17
191
32
312
1.03
0.02
1.2
1.3
146.00
159.86
au/ml
0.34
12
97
16
153
1.05
0.01
1.0
1.1
17.59
9.75
nmol/l
—
5
36
31
317
0.98
0.01
1.7
2.3
15.58
21.41
mg/l
0.55
12
109
489
4899
1.00
0.01
4.1
4.7
1.02
1.02
kg/l
0.28
360
3332
21
204
1.03
0.00
3.1
1.6
—
—
—
0
0
21
204
1.03
0.00
3.1
1.6
—
—
—
0
0
21
204
1.03
0.00
3.1
1.6
—
—
—
0
0
28
274
1.02
0.00
1.2
1.3
276.87
274.67
mosm/kgh2o
0.16
23
195
31
304
1.02
0.00
1.1
1.1
18.00
56.35
iu/ml
—
6
50
13
131
0.99
0.00
1.0
1.2
—
—
—
0
0
13
131
0.99
0.00
1.0
1.2
—
—
—
0
0
16
159
1.01
0.00
2.4
1.7
136.25
112.10
ng/l
0.41
16
159
27
271
1.00
0.00
1.1
1.1
—
—
—
0
0
36
364
0.99
0.00
1.3
1.4
2231.11
3908.30
e6/l
0.31
28
253
46
456
1.01
0.00
1.2
1.4
—
—
—
0
0
28
282
0.99
0.00
4.0
4.8
345.48
344.42
umol/l
0.01
21
249
32
317
1.01
0.00
1.3
1.4
355719.00
73086.06
e6/l
0.63
20
176
61
607
1.01
0.00
1.2
1.2
47.80
38.96
u/ml
—
5
32
23
227
1.01
0.00
2.0
1.3
—
—
—
0
0
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.00
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
7.61
—
0
7
0
5
0.00
-0.00
0.0
8.4
—
74.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.3
8.12
9.12
ug/l
—
6
59
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
7
75
0.93
-0.00
1.0
1.1
—
—
—
0
0
36
360
1.00
-0.00
1.3
1.3
—
18.78
—
0
10
6
66
0.91
-0.00
1.0
1.1
—
—
—
0
0
218
2180
1.00
-0.00
1.2
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.2
—
386.50
—
0
6
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: OPER_JFB31 – Laparoscopic right hemicolectomy
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).